{"get":[{"name":"map00500","response":"ENTRY       map00500                    Pathway\nNAME        Starch and sucrose metabolism\nCLASS       Metabolism; Carbohydrate metabolism\nPATHWAY_MAP map00500  Starch and sucrose metabolism\nMODULE      M00565  Trehalose biosynthesis, D-glucose 1P => trehalose [PATH:map00500]\n            M00854  Glycogen biosynthesis, glucose-1P => glycogen/starch [PATH:map00500]\n            M00855  Glycogen degradation, glycogen => glucose-6P [PATH:map00500]\nDBLINKS     GO: 0005982 0005985\nREL_PATHWAY map00010  Glycolysis / Gluconeogenesis\n            map00520  Amino sugar and nucleotide sugar metabolism\nKO_PATHWAY  ko00500\n///\n","added":1656608379198},{"name":"map00521","response":"ENTRY       map00521                    Pathway\nNAME        Streptomycin biosynthesis\nDESCRIPTION Streptomycin is an aminocyclitol-aminoglycoside antibiotic produced by Streptomyces griseus. Streptomycin consists of aminocyclitol (streptidine), 6-deoxyhexose (streptose), and N-methyl-L-glucosamine moieties, which are formed by independent biosynthetic pathways. All of the moieties are derived from D-glucose. The streptidine moiety is synthesized via myo-inositol, which is then oxidized at C-1 and transaminated to give scyllo-inosamine. After phosphorylation, the compound is transamidinated by arginine. The same procedure is repeated at the C-3 position. The streptose moiety is made from D-glucose via a dTDP-glucose pathway. The exact biosynthetic route for the N-methyl-L-glucosamine moiety is unknown, though the biosynthetic gene cluster have been proposed.\nCLASS       Metabolism; Biosynthesis of other secondary metabolites\nPATHWAY_MAP map00521  Streptomycin biosynthesis\nMODULE      M00793  dTDP-L-rhamnose biosynthesis [PATH:map00521]\nDRUG        D08531  Streptomycin (INN)\nDBLINKS     GO: 0019872\nREFERENCE   PMID:19362651\n  AUTHORS   Wehmeier UF, Piepersberg W\n  TITLE     Enzymology of aminoglycoside biosynthesis-deduction from gene clusters.\n  JOURNAL   Methods Enzymol 459:459-91 (2009)\n            DOI:10.1016/S0076-6879(09)04619-9\nREFERENCE   PMID:17390001\n  AUTHORS   Flatt PM, Mahmud T\n  TITLE     Biosynthesis of aminocyclitol-aminoglycoside antibiotics and related compounds.\n  JOURNAL   Nat Prod Rep 24:358-92 (2007)\n            DOI:10.1039/b603816f\nREFERENCE   PMID:1698764\n  AUTHORS   Walker JB\n  TITLE     Possible evolutionary relationships between streptomycin and bluensomycin biosynthetic pathways: detection of novel inositol kinase and O-carbamoyltransferase activities.\n  JOURNAL   J Bacteriol 172:5844-51 (1990)\n            DOI:10.1128/JB.172.10.5844-5851.1990\nREFERENCE   PMID:2995326\n  AUTHORS   Ohnuki T, Imanaka T, Aiba S\n  TITLE     Self-cloning in Streptomyces griseus of an str gene cluster for streptomycin biosynthesis and streptomycin resistance.\n  JOURNAL   J Bacteriol 164:85-94 (1985)\n            DOI:10.1128/JB.164.1.85-94.1985\nREFERENCE   PMID:9238101\n  AUTHORS   Ahlert J, Distler J, Mansouri K, Piepersberg W\n  TITLE     Identification of stsC, the gene encoding the L-glutamine:scyllo-inosose aminotransferase from streptomycin-producing Streptomycetes.\n  JOURNAL   Arch Microbiol 168:102-13 (1997)\n            DOI:10.1007/s002030050475\nREFERENCE   PMID:1377151\n  AUTHORS   Distler J, Mansouri K, Mayer G, Stockmann M, Piepersberg W\n  TITLE     Streptomycin biosynthesis and its regulation in Streptomycetes.\n  JOURNAL   Gene 115:105-11 (1992)\n            DOI:10.1016/0378-1119(92)90547-3\nREFERENCE   PMID:1654502\n  AUTHORS   Mansouri K, Piepersberg W.\n  TITLE     Genetics of streptomycin production in Streptomyces griseus: nucleotide sequence of five genes, strFGHIK, including a phosphatase gene.\n  JOURNAL   Mol Gen Genet 228:459-69 (1991)\n            DOI:10.1007/BF00260640\nREFERENCE   PMID:9922132\n  AUTHORS   Fritsche E, Bergner A, Humm A, Piepersberg W, Huber R\n  TITLE     Crystal structure of L-arginine:inosamine-phosphate amidinotransferase StrB1 from Streptomyces griseus: an enzyme involved in streptomycin biosynthesis.\n  JOURNAL   Biochemistry 37:17664-72 (1998)\n            DOI:10.1021/bi981949p\nREL_PATHWAY map00523  Polyketide sugar unit biosynthesis\n            map00524  Neomycin, kanamycin and gentamicin biosynthesis\n            map07021  Aminoglycosides\nKO_PATHWAY  ko00521\n///\n","added":1656608380035},{"name":"map00524","response":"ENTRY       map00524                    Pathway\nNAME        Neomycin, kanamycin and gentamicin biosynthesis\nCLASS       Metabolism; Biosynthesis of other secondary metabolites\nPATHWAY_MAP map00524  Neomycin, kanamycin and gentamicin biosynthesis\nDRUG        D00063  Tobramycin (JP18/USP)\n            D02322  Apramycin (USAN/INN)\n            D05140  Framycetin (INN)\n            D07467  Paromomycin (INN)\n            D07497  Bekanamycin (INN)\n            D08219  Micronomicin (DCF)\n            D08478  Ribostamycin (INN)\nDBLINKS     GO: 1901158 1901133 1901130\nREFERENCE   PMID:19362652\n  AUTHORS   Kudo F, Eguchi T\n  TITLE     Biosynthetic enzymes for the aminoglycosides butirosin and neomycin.\n  JOURNAL   Methods Enzymol 459:493-519 (2009)\n            DOI:10.1016/S0076-6879(09)04620-5\nREFERENCE   PMID:19644520\n  AUTHORS   Kudo F, Eguchi T\n  TITLE     Biosynthetic genes for aminoglycoside antibiotics.\n  JOURNAL   J Antibiot (Tokyo) 62:471-81 (2009)\n            DOI:10.1038/ja.2009.76\nREFERENCE   PMID:17879343\n  AUTHORS   Nango E, Kumasaka T, Hirayama T, Tanaka N, Eguchi T\n  TITLE     Structure of 2-deoxy-scyllo-inosose synthase, a key enzyme in the biosynthesis of 2-deoxystreptamine-containing aminoglycoside antibiotics, in complex with a mechanism-based inhibitor and NAD+.\n  JOURNAL   Proteins 70:517-27 (2008)\n            DOI:10.1002/prot.21526\nREFERENCE   PMID:15839685\n  AUTHORS   Yokoyama K, Kudo F, Kuwahara M, Inomata K, Tamegai H, Eguchi T, Kakinuma K\n  TITLE     Stereochemical recognition of doubly functional aminotransferase in 2-deoxystreptamine biosynthesis.\n  JOURNAL   J Am Chem Soc 127:5869-74 (2005)\n            DOI:10.1021/ja0445948\nREFERENCE   PMID:12374384\n  AUTHORS   Tamegai H, Nango E, Kuwahara M, Yamamoto H, Ota Y, Kuriki H, Eguchi T, Kakinuma K\n  TITLE     Identification of L-glutamine: 2-deoxy-scyllo-inosose aminotransferase required for the biosynthesis of butirosin in Bacillus circulans.\n  JOURNAL   J Antibiot (Tokyo) 55:707-14 (2002)\n            DOI:10.7164/antibiotics.55.707\nREFERENCE   PMID:16506694\n  AUTHORS   Kudo F, Yamamoto Y, Yokoyama K, Eguchi T, Kakinuma K\n  TITLE     Biosynthesis of 2-deoxystreptamine by three crucial enzymes in Streptomyces fradiae NBRC 12773.\n  JOURNAL   J Antibiot (Tokyo) 58:766-74 (2005)\n            DOI:10.1038/ja.2005.104\nREFERENCE   PMID:18672902\n  AUTHORS   Yokoyama K, Ohmori D, Kudo F, Eguchi T\n  TITLE     Mechanistic study on the reaction of a radical SAM dehydrogenase BtrN by electron paramagnetic resonance spectroscopy.\n  JOURNAL   Biochemistry 47:8950-60 (2008)\n            DOI:10.1021/bi800509x\nREFERENCE   PMID:18001019\n  AUTHORS   Yokoyama K, Numakura M, Kudo F, Ohmori D, Eguchi T\n  TITLE     Characterization and mechanistic study of a radical SAM dehydrogenase in the biosynthesis of butirosin.\n  JOURNAL   J Am Chem Soc 129:15147-55 (2007)\n            DOI:10.1021/ja072481t\nREFERENCE   PMID:18311744\n  AUTHORS   Yokoyama K, Yamamoto Y, Kudo F, Eguchi T\n  TITLE     Involvement of two distinct N-acetylglucosaminyltransferases and a dual-function deacetylase in neomycin biosynthesis.\n  JOURNAL   Chembiochem 9:865-9 (2008)\n            DOI:10.1002/cbic.200700717\nREFERENCE   PMID:18802637\n  AUTHORS   Fan Q, Huang F, Leadlay PF, Spencer JB\n  TITLE     The neomycin biosynthetic gene cluster of Streptomyces fradiae NCIMB 8233: genetic and biochemical evidence for the roles of two glycosyltransferases and a deacetylase.\n  JOURNAL   Org Biomol Chem 6:3306-14 (2008)\n            DOI:10.1039/b808734b\nREFERENCE   PMID:17226887\n  AUTHORS   Truman AW, Huang F, Llewellyn NM, Spencer JB\n  TITLE     Characterization of the enzyme BtrD from Bacillus circulans and revision of its functional assignment in the biosynthesis of butirosin.\n  JOURNAL   Angew Chem Int Ed Engl 46:1462-4 (2007)\n            DOI:10.1002/anie.200604194\nREFERENCE   PMID:17482823\n  AUTHORS   Kudo F, Fujii T, Kinoshita S, Eguchi T\n  TITLE     Unique O-ribosylation in the biosynthesis of butirosin.\n  JOURNAL   Bioorg Med Chem 15:4360-8 (2007)\n            DOI:10.1016/j.bmc.2007.04.040\nREFERENCE   PMID:12870817\n  AUTHORS   Yukita T, Nishida H, Eguchi T, Kakinuma K\n  TITLE     Biosynthesis of (2R)-4-amino-2-hydroxybutyric acid, unique and biologically significant substituent in butirosins.\n  JOURNAL   J Antibiot (Tokyo) 56:497-500 (2003)\n            DOI:10.7164/antibiotics.56.497\nREFERENCE   PMID:15975512\n  AUTHORS   Li Y, Llewellyn NM, Giri R, Huang F, Spencer JB\n  TITLE     Biosynthesis of the unique amino acid side chain of butirosin: possible protective-group chemistry in an acyl carrier protein-mediated pathway.\n  JOURNAL   Chem Biol 12:665-75 (2005)\n            DOI:10.1016/j.chembiol.2005.04.010\nREFERENCE   PMID:17462573\n  AUTHORS   Llewellyn NM, Li Y, Spencer JB\n  TITLE     Biosynthesis of butirosin: transfer and deprotection of the unique amino acid side chain.\n  JOURNAL   Chem Biol 14:379-86 (2007)\n            DOI:10.1016/j.chembiol.2007.02.005\nREFERENCE   PMID:18685777\n  AUTHORS   Llewellyn NM, Spencer JB\n  TITLE     Chemoenzymatic acylation of aminoglycoside antibiotics.\n  JOURNAL   Chem Commun (Camb) 3786-8 (2008)\n            DOI:10.1039/b802248h\nREFERENCE   PMID:19466609\n  AUTHORS   Nepal KK, Oh TJ, Sohng JK\n  TITLE     Heterologous production of paromamine in Streptomyces lividans TK24 using kanamycin biosynthetic genes from Streptomyces kanamyceticus ATCC12853.\n  JOURNAL   Mol Cells 27:601-8 (2009)\n            DOI:10.1007/s10059-009-0080-5\nREFERENCE   PMID:21983602\n  AUTHORS   Park JW, Park SR, Nepal KK, Han AR, Ban YH, Yoo YJ, Kim EJ, Kim EM, Kim D, Sohng JK, Yoon YJ\n  TITLE     Discovery of parallel pathways of kanamycin biosynthesis allows antibiotic manipulation.\n  JOURNAL   Nat Chem Biol 7:843-52 (2011)\n            DOI:10.1038/nchembio.671\nREFERENCE   \n  AUTHORS   Arya DP (ed).\n  TITLE     Aminoglycoside antibiotics: From chemical biology to drug discovery\n  JOURNAL   Wiley-Interscience (2007)\nREFERENCE   PMID:23179168\n  AUTHORS   Park SR, Park JW, Ban YH, Sohng JK, Yoon YJ\n  TITLE     2-Deoxystreptamine-containing aminoglycoside antibiotics: recent advances in the characterization and manipulation of their biosynthetic pathways.\n  JOURNAL   Nat Prod Rep 30:11-20 (2013)\n            DOI:10.1039/c2np20092a\nREFERENCE   PMID:17119636\n  AUTHORS   Llewellyn NM, Spencer JB\n  TITLE     Biosynthesis of 2-deoxystreptamine-containing aminoglycoside antibiotics.\n  JOURNAL   Nat Prod Rep 23:864-74 (2006)\n            DOI:10.1039/b604709m\nREFERENCE   PMID:26455715\n  AUTHORS   Kudo F, Eguchi T\n  TITLE     Aminoglycoside Antibiotics: New Insights into the Biosynthetic Machinery of Old Drugs.\n  JOURNAL   Chem Rec 16:4-18 (2016)\n            DOI:10.1002/tcr.201500210\nREFERENCE   PMID:25600434\n  AUTHORS   Takeishi R, Kudo F, Numakura M, Eguchi T\n  TITLE     Epimerization at C-3'' in butirosin biosynthesis by an NAD(+) -dependent dehydrogenase BtrE and an NADPH-dependent reductase BtrF.\n  JOURNAL   Chembiochem 16:487-95 (2015)\n            DOI:10.1002/cbic.201402612\nREFERENCE   PMID:27120352\n  AUTHORS   Lv M, Ji X, Zhao J, Li Y, Zhang C, Su L, Ding W, Deng Z, Yu Y, Zhang Q\n  TITLE     Characterization of a C3 Deoxygenation Pathway Reveals a Key Branch Point in Aminoglycoside Biosynthesis.\n  JOURNAL   J Am Chem Soc 138:6427-35 (2016)\n            DOI:10.1021/jacs.6b02221\nREFERENCE   PMID:21689223\n  AUTHORS   Clausnitzer D, Piepersberg W, Wehmeier UF\n  TITLE     The oxidoreductases LivQ and NeoQ are responsible for the different 6'-modifications in the aminoglycosides lividomycin and neomycin.\n  JOURNAL   J Appl Microbiol 111:642-51 (2011)\n            DOI:10.1111/j.1365-2672.2011.05082.x\nREFERENCE   PMID:18550838\n  AUTHORS   Park JW, Hong JS, Parajuli N, Jung WS, Park SR, Lim SK, Sohng JK, Yoon YJ\n  TITLE     Genetic dissection of the biosynthetic route to gentamicin A2 by heterologous expression of its minimal gene set.\n  JOURNAL   Proc Natl Acad Sci U S A 105:8399-404 (2008)\n            DOI:10.1073/pnas.0803164105\nREFERENCE   PMID:25641167\n  AUTHORS   Huang C, Huang F, Moison E, Guo J, Jian X, Duan X, Deng Z, Leadlay PF, Sun Y\n  TITLE     Delineating the biosynthesis of gentamicin x2, the common precursor of the gentamicin C antibiotic complex.\n  JOURNAL   Chem Biol 22:251-61 (2015)\n            DOI:10.1016/j.chembiol.2014.12.012\nREFERENCE   PMID:24746560\n  AUTHORS   Guo J, Huang F, Huang C, Duan X, Jian X, Leeper F, Deng Z, Leadlay PF, Sun Y\n  TITLE     Specificity and promiscuity at the branch point in gentamicin biosynthesis.\n  JOURNAL   Chem Biol 21:608-18 (2014)\n            DOI:10.1016/j.chembiol.2014.03.005\nREFERENCE   PMID:26083124\n  AUTHORS   Gu Y, Ni X, Ren J, Gao H, Wang D, Xia H\n  TITLE     Biosynthesis of Epimers C2 and C2a in the Gentamicin C Complex.\n  JOURNAL   Chembiochem 16:1933-42 (2015)\n            DOI:10.1002/cbic.201500258\nREFERENCE   PMID:23679096\n  AUTHORS   Kim HJ, McCarty RM, Ogasawara Y, Liu YN, Mansoorabadi SO, LeVieux J, Liu HW\n  TITLE     GenK-catalyzed C-6' methylation in the biosynthesis of gentamicin: isolation and characterization of a cobalamin-dependent radical SAM enzyme.\n  JOURNAL   J Am Chem Soc 135:8093-6 (2013)\n            DOI:10.1021/ja312641f\nREL_PATHWAY map00520  Amino sugar and nucleotide sugar metabolism\n            map00521  Streptomycin biosynthesis\nKO_PATHWAY  ko00524\n///\n","added":1656608380867},{"name":"map00562","response":"ENTRY       map00562                    Pathway\nNAME        Inositol phosphate metabolism\nCLASS       Metabolism; Carbohydrate metabolism\nPATHWAY_MAP map00562  Inositol phosphate metabolism\nMODULE      M00130  Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4 [PATH:map00562]\n            M00131  Inositol phosphate metabolism, Ins(1,3,4,5)P4 => Ins(1,3,4)P3 => myo-inositol [PATH:map00562]\n            M00132  Inositol phosphate metabolism, Ins(1,3,4)P3 => phytate [PATH:map00562]\nDBLINKS     GO: 0006020\nREFERENCE   PMID:14993306\n  AUTHORS   Yoshida K, Yamaguchi M, Ikeda H, Omae K, Tsurusaki K, Fujita Y\n  TITLE     The fifth gene of the iol operon of Bacillus subtilis, iolE, encodes 2-keto-myo-inositol dehydratase.\n  JOURNAL   Microbiology 150:571-80 (2004)\n            DOI:10.1099/mic.0.26768-0\nREFERENCE   PMID:18310071\n  AUTHORS   Yoshida K, Yamaguchi M, Morinaga T, Kinehara M, Ikeuchi M, Ashida H, Fujita Y.\n  TITLE     myo-Inositol catabolism in Bacillus subtilis.\n  JOURNAL   J Biol Chem 283:10415-24 (2008)\n            DOI:10.1074/jbc.M708043200\nREL_PATHWAY map00010  Glycolysis / Gluconeogenesis\n            map00020  Citrate cycle (TCA cycle)\n            map00040  Pentose and glucuronate interconversions\n            map00564  Glycerophospholipid metabolism\nKO_PATHWAY  ko00562\n///\n","added":1656608381706},{"name":"map00998","response":"ENTRY       map00998                    Pathway\nNAME        Biosynthesis of various antibiotics\nCLASS       Metabolism; Biosynthesis of other secondary metabolites\nPATHWAY_MAP map00998  Biosynthesis of various antibiotics\nMODULE      M00785  Cycloserine biosynthesis, arginine/serine => cycloserine [PATH:map00998]\n            M00787  Bacilysin biosynthesis, prephenate => bacilysin [PATH:map00998]\n            M00788  Terpentecin biosynthesis, GGAP => terpentecin [PATH:map00998]\n            M00819  Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone [PATH:map00998]\n            M00848  Aurachin biosynthesis, anthranilate => aurachin A [PATH:map00998]\n            M00877  Kanosamine biosynthesis, glucose 6-phosphate => kanosamine [PATH:map00998]\n            M00889  Puromycin biosynthesis, ATP => puromycin [PATH:map00998]\n            M00890  Roseoflavin biosynthesis, FMN => roseoflavin [PATH:map00998]\n            M00903  Fosfomycin biosynthesis, phosphoenolpyruvate => fosfomycin [PATH:map00998]\n            M00904  Dapdiamides biosynthesis, L-2,3-diaminopropanoate => dapdiamide A/B/C [PATH:map00998]\nDRUG        D05653  Puromycin (USAN)\nREFERENCE   PMID:17335090\n  AUTHORS   Sandmann A, Dickschat J, Jenke-Kodama H, Kunze B, Dittmann E, Muller R\n  TITLE     A Type II polyketide synthase from the gram-negative Bacterium Stigmatella aurantiaca is involved in Aurachin alkaloid biosynthesis.\n  JOURNAL   Angew Chem Int Ed Engl 46:2712-6 (2007)\n            DOI:10.1002/anie.200603513\nREFERENCE   PMID:23586652\n  AUTHORS   Vetter ND, Langill DM, Anjum S, Boisvert-Martel J, Jagdhane RC, Omene E, Zheng H, van Straaten KE, Asiamah I, Krol ES, Sanders DA, Palmer DR\n  TITLE     A previously unrecognized kanosamine biosynthesis pathway in Bacillus subtilis.\n  JOURNAL   J Am Chem Soc 135:5970-3 (2013)\n            DOI:10.1021/ja4010255\nREFERENCE   PMID:25644640\n  AUTHORS   Ozcengiz G, Ogulur I\n  TITLE     Biochemistry, genetics and regulation of bacilysin biosynthesis and its significance more than an antibiotic.\n  JOURNAL   N Biotechnol 32:612-9 (2015)\n            DOI:10.1016/j.nbt.2015.01.006\nREFERENCE   PMID:8576156\n  AUTHORS   Tercero JA, Espinosa JC, Lacalle RA, Jimenez A.\n  TITLE     The biosynthetic pathway of the aminonucleoside antibiotic puromycin, as deduced from the molecular analysis of the pur cluster of Streptomyces alboniger.\n  JOURNAL   J Biol Chem 271:1579-90 (1996)\n            DOI:10.1074/jbc.271.3.1579\nREFERENCE   PMID:19807062\n  AUTHORS   Hollenhorst MA, Clardy J, Walsh CT\n  TITLE     The ATP-dependent amide ligases DdaG and DdaF assemble the fumaramoyl-dipeptide scaffold of the dapdiamide antibiotics.\n  JOURNAL   Biochemistry 48:10467-72 (2009)\n            DOI:10.1021/bi9013165\nREFERENCE   PMID:27062037\n  AUTHORS   Schwarz J, Konjik V, Jankowitsch F, Sandhoff R, Mack M\n  TITLE     Identification of the Key Enzyme of Roseoflavin Biosynthesis.\n  JOURNAL   Angew Chem Int Ed Engl 55:6103-6 (2016)\n            DOI:10.1002/anie.201600581\nREFERENCE   PMID:20086163\n  AUTHORS   Kumagai T, Koyama Y, Oda K, Noda M, Matoba Y, Sugiyama M\n  TITLE     Molecular cloning and heterologous expression of a biosynthetic gene cluster for the antitubercular agent D-cycloserine produced by Streptomyces lavendulae.\n  JOURNAL   Antimicrob Agents Chemother 54:1132-9 (2010)\n            DOI:10.1128/AAC.01226-09\nREFERENCE   PMID:12138123\n  AUTHORS   Hamano Y, Kuzuyama T, Itoh N, Furihata K, Seto H, Dairi T\n  TITLE     Functional analysis of eubacterial diterpene cyclases responsible for biosynthesis of a diterpene antibiotic, terpentecin.\n  JOURNAL   J Biol Chem 277:37098-104 (2002)\n            DOI:10.1074/jbc.M206382200\nREFERENCE   PMID:17017767\n  AUTHORS   Quaderer R, Omura S, Ikeda H, Cane DE\n  TITLE     Pentalenolactone biosynthesis. Molecular cloning and assignment of biochemical function to PtlI, a cytochrome P450 of Streptomyces avermitilis.\n  JOURNAL   J Am Chem Soc 128:13036-7 (2006)\n            DOI:10.1021/ja0639214\nREFERENCE   PMID:7500951\n  AUTHORS   Hidaka T, Goda M, Kuzuyama T, Takei N, Hidaka M, Seto H\n  TITLE     Cloning and nucleotide sequence of fosfomycin biosynthetic genes of Streptomyces wedmorensis.\n  JOURNAL   Mol Gen Genet 249:274-80 (1995)\n            DOI:10.1007/BF00290527\nREL_PATHWAY map00010  Glycolysis / Gluconeogenesis\n            map00020  Citrate cycle (TCA cycle)\n            map00030  Pentose phosphate pathway\n            map00220  Arginine biosynthesis\n            map00250  Alanine, aspartate and glutamate metabolism\n            map00260  Glycine, serine and threonine metabolism\n            map00400  Phenylalanine, tyrosine and tryptophan biosynthesis\n            map00440  Phosphonate and phosphinate metabolism\n            map00900  Terpenoid backbone biosynthesis\nKO_PATHWAY  ko00998\n///\n","added":1656608382513},{"name":"map01062","response":"ENTRY       map01062                    Pathway\nNAME        Biosynthesis of terpenoids and steroids\nPATHWAY_MAP map01062  Biosynthesis of terpenoids and steroids\nREL_PATHWAY map00281  Geraniol degradation\n            map00900  Terpenoid backbone biosynthesis\n            map00901  Indole alkaloid biosynthesis\n            map00902  Monoterpenoid biosynthesis\n            map00903  Limonene and pinene degradation\n            map00904  Diterpenoid biosynthesis\n            map00905  Brassinosteroid biosynthesis\n            map00906  Carotenoid biosynthesis\n            map00908  Zeatin biosynthesis\n            map00909  Sesquiterpenoid and triterpenoid biosynthesis\n            map07042  Antineoplastics - agents from natural products\nKO_PATHWAY  ko01062\n///\n","added":1656608383341},{"name":"map01100","response":"ENTRY       map01100          Global    Pathway\nNAME        Metabolic pathways\nPATHWAY_MAP map01100  Metabolic pathways\nMODULE      M00001  Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate [PATH:map01100]\n            M00002  Glycolysis, core module involving three-carbon compounds [PATH:map01100]\n            M00003  Gluconeogenesis, oxaloacetate => fructose-6P [PATH:map01100]\n            M00004  Pentose phosphate pathway (Pentose phosphate cycle) [PATH:map01100]\n            M00005  PRPP biosynthesis, ribose 5P => PRPP [PATH:map01100]\n            M00006  Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P [PATH:map01100]\n            M00007  Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P [PATH:map01100]\n            M00008  Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate [PATH:map01100]\n            M00009  Citrate cycle (TCA cycle, Krebs cycle) [PATH:map01100]\n            M00010  Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate [PATH:map01100]\n            M00011  Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate [PATH:map01100]\n            M00012  Glyoxylate cycle [PATH:map01100]\n            M00013  Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA [PATH:map01100]\n            M00014  Glucuronate pathway (uronate pathway) [PATH:map01100]\n            M00015  Proline biosynthesis, glutamate => proline [PATH:map01100]\n            M00016  Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine [PATH:map01100]\n            M00017  Methionine biosynthesis, aspartate => homoserine => methionine [PATH:map01100]\n            M00018  Threonine biosynthesis, aspartate => homoserine => threonine [PATH:map01100]\n            M00019  Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine [PATH:map01100]\n            M00020  Serine biosynthesis, glycerate-3P => serine [PATH:map01100]\n            M00021  Cysteine biosynthesis, serine => cysteine [PATH:map01100]\n            M00022  Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate [PATH:map01100]\n            M00023  Tryptophan biosynthesis, chorismate => tryptophan [PATH:map01100]\n            M00024  Phenylalanine biosynthesis, chorismate => phenylpyruvate => phenylalanine [PATH:map01100]\n            M00025  Tyrosine biosynthesis, chorismate => HPP => tyrosine [PATH:map01100]\n            M00026  Histidine biosynthesis, PRPP => histidine [PATH:map01100]\n            M00027  GABA (gamma-Aminobutyrate) shunt [PATH:map01100]\n            M00028  Ornithine biosynthesis, glutamate => ornithine [PATH:map01100]\n            M00029  Urea cycle [PATH:map01100]\n            M00030  Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine [PATH:map01100]\n            M00031  Lysine biosynthesis, mediated by LysW, 2-aminoadipate => lysine [PATH:map01100]\n            M00032  Lysine degradation, lysine => saccharopine => acetoacetyl-CoA [PATH:map01100]\n            M00033  Ectoine biosynthesis, aspartate => ectoine [PATH:map01100]\n            M00034  Methionine salvage pathway [PATH:map01100]\n            M00035  Methionine degradation [PATH:map01100]\n            M00036  Leucine degradation, leucine => acetoacetate + acetyl-CoA [PATH:map01100]\n            M00037  Melatonin biosynthesis, animals, tryptophan => serotonin => melatonin [PATH:map01100]\n            M00038  Tryptophan metabolism, tryptophan => kynurenine => 2-aminomuconate [PATH:map01100]\n            M00039  Monolignol biosynthesis, phenylalanine/tyrosine => monolignol [PATH:map01100]\n            M00040  Tyrosine biosynthesis, chorismate => arogenate => tyrosine [PATH:map01100]\n            M00042  Catecholamine biosynthesis, tyrosine => dopamine => noradrenaline => adrenaline [PATH:map01100]\n            M00043  Thyroid hormone biosynthesis, tyrosine => triiodothyronine/thyroxine [PATH:map01100]\n            M00044  Tyrosine degradation, tyrosine => homogentisate [PATH:map01100]\n            M00045  Histidine degradation, histidine => N-formiminoglutamate => glutamate [PATH:map01100]\n            M00046  Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate [PATH:map01100]\n            M00047  Creatine pathway [PATH:map01100]\n            M00048  De novo purine biosynthesis, PRPP + glutamine => IMP [PATH:map01100]\n            M00049  Adenine ribonucleotide biosynthesis, IMP => ADP,ATP [PATH:map01100]\n            M00050  Guanine ribonucleotide biosynthesis, IMP => GDP,GTP [PATH:map01100]\n            M00051  De novo pyrimidine biosynthesis, glutamine (+ PRPP) => UMP [PATH:map01100]\n            M00052  Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP [PATH:map01100]\n            M00053  Deoxyribonucleotide biosynthesis, ADP/GDP/CDP/UDP => dATP/dGTP/dCTP/dUTP [PATH:map01100]\n            M00055  N-glycan precursor biosynthesis [PATH:map01100]\n            M00056  O-glycan biosynthesis, mucin type core [PATH:map01100]\n            M00057  Glycosaminoglycan biosynthesis, linkage tetrasaccharide [PATH:map01100]\n            M00058  Glycosaminoglycan biosynthesis, chondroitin sulfate backbone [PATH:map01100]\n            M00059  Glycosaminoglycan biosynthesis, heparan sulfate backbone [PATH:map01100]\n            M00060  KDO2-lipid A biosynthesis, Raetz pathway, LpxL-LpxM type [PATH:map01100]\n            M00061  D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P [PATH:map01100]\n            M00063  CMP-KDO biosynthesis [PATH:map01100]\n            M00064  ADP-L-glycero-D-manno-heptose biosynthesis [PATH:map01100]\n            M00065  GPI-anchor biosynthesis, core oligosaccharide [PATH:map01100]\n            M00066  Lactosylceramide biosynthesis [PATH:map01100]\n            M00067  Sulfoglycolipids biosynthesis, ceramide/1-alkyl-2-acylglycerol => sulfatide/seminolipid [PATH:map01100]\n            M00068  Glycosphingolipid biosynthesis, globo-series, LacCer => Gb4Cer [PATH:map01100]\n            M00069  Glycosphingolipid biosynthesis, ganglio series, LacCer => GT3 [PATH:map01100]\n            M00070  Glycosphingolipid biosynthesis, lacto-series, LacCer => Lc4Cer [PATH:map01100]\n            M00071  Glycosphingolipid biosynthesis, neolacto-series, LacCer => nLc4Cer [PATH:map01100]\n            M00072  N-glycosylation by oligosaccharyltransferase [PATH:map01100]\n            M00073  N-glycan precursor trimming [PATH:map01100]\n            M00074  N-glycan biosynthesis, high-mannose type [PATH:map01100]\n            M00075  N-glycan biosynthesis, complex type [PATH:map01100]\n            M00076  Dermatan sulfate degradation [PATH:map01100]\n            M00077  Chondroitin sulfate degradation [PATH:map01100]\n            M00078  Heparan sulfate degradation [PATH:map01100]\n            M00079  Keratan sulfate degradation [PATH:map01100]\n            M00081  Pectin degradation [PATH:map01100]\n            M00082  Fatty acid biosynthesis, initiation [PATH:map01100]\n            M00083  Fatty acid biosynthesis, elongation [PATH:map01100]\n            M00085  Fatty acid elongation in mitochondria [PATH:map01100]\n            M00086  beta-Oxidation, acyl-CoA synthesis [PATH:map01100]\n            M00087  beta-Oxidation [PATH:map01100]\n            M00088  Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone [PATH:map01100]\n            M00089  Triacylglycerol biosynthesis [PATH:map01100]\n            M00090  Phosphatidylcholine (PC) biosynthesis, choline => PC [PATH:map01100]\n            M00091  Phosphatidylcholine (PC) biosynthesis, PE => PC [PATH:map01100]\n            M00092  Phosphatidylethanolamine (PE) biosynthesis, ethanolamine => PE [PATH:map01100]\n            M00093  Phosphatidylethanolamine (PE) biosynthesis, PA => PS => PE [PATH:map01100]\n            M00094  Ceramide biosynthesis [PATH:map01100]\n            M00095  C5 isoprenoid biosynthesis, mevalonate pathway [PATH:map01100]\n            M00096  C5 isoprenoid biosynthesis, non-mevalonate pathway [PATH:map01100]\n            M00097  beta-Carotene biosynthesis, GGAP => beta-carotene [PATH:map01100]\n            M00098  Acylglycerol degradation [PATH:map01100]\n            M00099  Sphingosine biosynthesis [PATH:map01100]\n            M00100  Sphingosine degradation [PATH:map01100]\n            M00101  Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol [PATH:map01100]\n            M00102  Ergocalciferol biosynthesis, squalene 2,3-epoxide => ergosterol/ergocalciferol [PATH:map01100]\n            M00103  Cholecalciferol biosynthesis [PATH:map01100]\n            M00104  Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate [PATH:map01100]\n            M00106  Conjugated bile acid biosynthesis, cholate => taurocholate/glycocholate [PATH:map01100]\n            M00107  Steroid hormone biosynthesis, cholesterol => prognenolone => progesterone [PATH:map01100]\n            M00108  C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone [PATH:map01100]\n            M00109  C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone [PATH:map01100]\n            M00110  C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone [PATH:map01100]\n            M00112  Tocopherol/tocotorienol biosynthesis, homogentisate + phytyl/geranylgeranyl-PP => tocopherol/tocotorienol [PATH:map01100]\n            M00113  Jasmonic acid biosynthesis [PATH:map01100]\n            M00114  Ascorbate biosynthesis, plants, fructose-6P => ascorbate [PATH:map01100]\n            M00115  NAD biosynthesis, aspartate => quinolinate => NAD [PATH:map01100]\n            M00116  Menaquinone biosynthesis, chorismate (+ polyprenyl-PP) => menaquinol [PATH:map01100]\n            M00117  Ubiquinone biosynthesis, prokaryotes, chorismate (+ polyprenyl-PP) => ubiquinol [PATH:map01100]\n            M00118  Glutathione biosynthesis, glutamate => glutathione [PATH:map01100]\n            M00119  Pantothenate biosynthesis, valine/L-aspartate => pantothenate [PATH:map01100]\n            M00120  Coenzyme A biosynthesis, pantothenate => CoA [PATH:map01100]\n            M00121  Heme biosynthesis, plants and bacteria, glutamate => heme [PATH:map01100]\n            M00122  Cobalamin biosynthesis, cobyrinate a,c-diamide => cobalamin [PATH:map01100]\n            M00123  Biotin biosynthesis, pimeloyl-ACP/CoA => biotin [PATH:map01100]\n            M00124  Pyridoxal-P biosynthesis, erythrose-4P => pyridoxal-P [PATH:map01100]\n            M00125  Riboflavin biosynthesis, plants and bacteria, GTP => riboflavin/FMN/FAD [PATH:map01100]\n            M00126  Tetrahydrofolate biosynthesis, GTP => THF [PATH:map01100]\n            M00127  Thiamine biosynthesis, prokaryotes, AIR (+ DXP/tyrosine) => TMP/TPP [PATH:map01100]\n            M00128  Ubiquinone biosynthesis, eukaryotes, 4-hydroxybenzoate + polyprenyl-PP => ubiquinol [PATH:map01100]\n            M00129  Ascorbate biosynthesis, animals, glucose-1P => ascorbate [PATH:map01100]\n            M00130  Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4 [PATH:map01100]\n            M00131  Inositol phosphate metabolism, Ins(1,3,4,5)P4 => Ins(1,3,4)P3 => myo-inositol [PATH:map01100]\n            M00132  Inositol phosphate metabolism, Ins(1,3,4)P3 => phytate [PATH:map01100]\n            M00133  Polyamine biosynthesis, arginine => agmatine => putrescine => spermidine [PATH:map01100]\n            M00134  Polyamine biosynthesis, arginine => ornithine => putrescine [PATH:map01100]\n            M00135  GABA biosynthesis, eukaryotes, putrescine => GABA [PATH:map01100]\n            M00136  GABA biosynthesis, prokaryotes, putrescine => GABA [PATH:map01100]\n            M00137  Flavanone biosynthesis, phenylalanine => naringenin [PATH:map01100]\n            M00138  Flavonoid biosynthesis, naringenin => pelargonidin [PATH:map01100]\n            M00140  C1-unit interconversion, prokaryotes [PATH:map01100]\n            M00141  C1-unit interconversion, eukaryotes [PATH:map01100]\n            M00165  Reductive pentose phosphate cycle (Calvin cycle) [PATH:map01100]\n            M00166  Reductive pentose phosphate cycle, ribulose-5P => glyceraldehyde-3P [PATH:map01100]\n            M00167  Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P [PATH:map01100]\n            M00168  CAM (Crassulacean acid metabolism), dark [PATH:map01100]\n            M00169  CAM (Crassulacean acid metabolism), light [PATH:map01100]\n            M00170  C4-dicarboxylic acid cycle, phosphoenolpyruvate carboxykinase type [PATH:map01100]\n            M00171  C4-dicarboxylic acid cycle, NAD - malic enzyme type [PATH:map01100]\n            M00172  C4-dicarboxylic acid cycle, NADP - malic enzyme type [PATH:map01100]\n            M00173  Reductive citrate cycle (Arnon-Buchanan cycle) [PATH:map01100]\n            M00174  Methane oxidation, methanotroph, methane => formaldehyde [PATH:map01100]\n            M00175  Nitrogen fixation, nitrogen => ammonia [PATH:map01100]\n            M00176  Assimilatory sulfate reduction, sulfate => H2S [PATH:map01100]\n            M00307  Pyruvate oxidation, pyruvate => acetyl-CoA [PATH:map01100]\n            M00308  Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P [PATH:map01100]\n            M00309  Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate [PATH:map01100]\n            M00338  Cysteine biosynthesis, homocysteine + serine => cysteine [PATH:map01100]\n            M00344  Formaldehyde assimilation, xylulose monophosphate pathway [PATH:map01100]\n            M00345  Formaldehyde assimilation, ribulose monophosphate pathway [PATH:map01100]\n            M00346  Formaldehyde assimilation, serine pathway [PATH:map01100]\n            M00356  Methanogenesis, methanol => methane [PATH:map01100]\n            M00357  Methanogenesis, acetate => methane [PATH:map01100]\n            M00358  Coenzyme M biosynthesis [PATH:map01100]\n            M00364  C10-C20 isoprenoid biosynthesis, bacteria [PATH:map01100]\n            M00365  C10-C20 isoprenoid biosynthesis, archaea [PATH:map01100]\n            M00366  C10-C20 isoprenoid biosynthesis, plants [PATH:map01100]\n            M00367  C10-C20 isoprenoid biosynthesis, non-plant eukaryotes [PATH:map01100]\n            M00368  Ethylene biosynthesis, methionine => ethylene [PATH:map01100]\n            M00369  Cyanogenic glycoside biosynthesis, tyrosine => dhurrin [PATH:map01100]\n            M00370  Glucosinolate biosynthesis, tryptophan => glucobrassicin [PATH:map01100]\n            M00371  Castasterone biosynthesis, campesterol => castasterone [PATH:map01100]\n            M00372  Abscisic acid biosynthesis, beta-carotene => abscisic acid [PATH:map01100]\n            M00373  Ethylmalonyl pathway [PATH:map01100]\n            M00374  Dicarboxylate-hydroxybutyrate cycle [PATH:map01100]\n            M00375  Hydroxypropionate-hydroxybutylate cycle [PATH:map01100]\n            M00376  3-Hydroxypropionate bi-cycle [PATH:map01100]\n            M00377  Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway) [PATH:map01100]\n            M00378  F420 biosynthesis, archaea [PATH:map01100]\n            M00415  Fatty acid elongation in endoplasmic reticulum [PATH:map01100]\n            M00418  Toluene degradation, anaerobic, toluene => benzoyl-CoA [PATH:map01100]\n            M00419  Cymene degradation, p-cymene => p-cumate [PATH:map01100]\n            M00422  Acetyl-CoA pathway, CO2 => acetyl-CoA [PATH:map01100]\n            M00432  Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate [PATH:map01100]\n            M00433  Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate [PATH:map01100]\n            M00525  Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine [PATH:map01100]\n            M00526  Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine [PATH:map01100]\n            M00527  Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine [PATH:map01100]\n            M00528  Nitrification, ammonia => nitrite [PATH:map01100]\n            M00529  Denitrification, nitrate => nitrogen [PATH:map01100]\n            M00530  Dissimilatory nitrate reduction, nitrate => ammonia [PATH:map01100]\n            M00531  Assimilatory nitrate reduction, nitrate => ammonia [PATH:map01100]\n            M00532  Photorespiration [PATH:map01100]\n            M00533  Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate [PATH:map01100]\n            M00534  Naphthalene degradation, naphthalene => salicylate [PATH:map01100]\n            M00535  Isoleucine biosynthesis, pyruvate => 2-oxobutanoate [PATH:map01100]\n            M00537  Xylene degradation, xylene => methylbenzoate [PATH:map01100]\n            M00538  Toluene degradation, toluene => benzoate [PATH:map01100]\n            M00539  Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate [PATH:map01100]\n            M00540  Benzoate degradation, cyclohexanecarboxylic acid =>pimeloyl-CoA [PATH:map01100]\n            M00541  Benzoyl-CoA degradation, benzoyl-CoA => 3-hydroxypimeloyl-CoA [PATH:map01100]\n            M00543  Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate [PATH:map01100]\n            M00544  Carbazole degradation, carbazole => 2-oxopent-4-enoate + anthranilate [PATH:map01100]\n            M00545  Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA [PATH:map01100]\n            M00546  Purine degradation, xanthine => urea [PATH:map01100]\n            M00547  Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol [PATH:map01100]\n            M00548  Benzene degradation, benzene => catechol [PATH:map01100]\n            M00549  Nucleotide sugar biosynthesis, glucose => UDP-glucose [PATH:map01100]\n            M00550  Ascorbate degradation, ascorbate => D-xylulose-5P [PATH:map01100]\n            M00551  Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol [PATH:map01100]\n            M00552  D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P [PATH:map01100]\n            M00554  Nucleotide sugar biosynthesis, galactose => UDP-galactose [PATH:map01100]\n            M00555  Betaine biosynthesis, choline => betaine [PATH:map01100]\n            M00563  Methanogenesis, methylamine/dimethylamine/trimethylamine => methane [PATH:map01100]\n            M00565  Trehalose biosynthesis, D-glucose 1P => trehalose [PATH:map01100]\n            M00567  Methanogenesis, CO2 => methane [PATH:map01100]\n            M00568  Catechol ortho-cleavage, catechol => 3-oxoadipate [PATH:map01100]\n            M00569  Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA [PATH:map01100]\n            M00570  Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine [PATH:map01100]\n            M00572  Pimeloyl-ACP biosynthesis, BioC-BioH pathway, malonyl-ACP => pimeloyl-ACP [PATH:map01100]\n            M00573  Biotin biosynthesis, BioI pathway, long-chain-acyl-ACP => pimeloyl-ACP => biotin [PATH:map01100]\n            M00577  Biotin biosynthesis, BioW pathway, pimelate => pimeloyl-CoA => biotin [PATH:map01100]\n            M00579  Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate [PATH:map01100]\n            M00580  Pentose phosphate pathway, archaea, fructose 6P => ribose 5P [PATH:map01100]\n            M00595  Thiosulfate oxidation by SOX complex, thiosulfate => sulfate [PATH:map01100]\n            M00596  Dissimilatory sulfate reduction, sulfate => H2S [PATH:map01100]\n            M00608  2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate [PATH:map01100]\n            M00609  Cysteine biosynthesis, methionine => cysteine [PATH:map01100]\n            M00620  Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate [PATH:map01100]\n            M00622  Nicotinate degradation, nicotinate => fumarate [PATH:map01100]\n            M00623  Phthalate degradation, phthalate => protocatechuate [PATH:map01100]\n            M00624  Terephthalate degradation, terephthalate => 3,4-dihydroxybenzoate [PATH:map01100]\n            M00630  D-Galacturonate degradation (fungi), D-galacturonate => glycerol [PATH:map01100]\n            M00631  D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P [PATH:map01100]\n            M00632  Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P [PATH:map01100]\n            M00633  Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P [PATH:map01100]\n            M00636  Phthalate degradation, phthalate => protocatechuate [PATH:map01100]\n            M00637  Anthranilate degradation, anthranilate => catechol [PATH:map01100]\n            M00638  Salicylate degradation, salicylate => gentisate [PATH:map01100]\n            M00661  Paspaline biosynthesis, geranylgeranyl-PP + indoleglycerol phosphate => paspaline [PATH:map01100]\n            M00672  Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin [PATH:map01100]\n            M00673  Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C [PATH:map01100]\n            M00674  Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate [PATH:map01100]\n            M00675  Carbapenem-3-carboxylate biosynthesis, pyrroline-5-carboxylate + malonyl-CoA => carbapenem-3-carboxylate [PATH:map01100]\n            M00736  Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A [PATH:map01100]\n            M00740  Methylaspartate cycle [PATH:map01100]\n            M00741  Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA [PATH:map01100]\n            M00761  Undecaprenylphosphate alpha-L-Ara4N biosynthesis, UDP-GlcA => undecaprenyl phosphate alpha-L-Ara4N [PATH:map01100]\n            M00763  Ornithine biosynthesis, mediated by LysW, glutamate => ornithine [PATH:map01100]\n            M00773  Tylosin biosynthesis, methylmalonyl-CoA + malonyl-CoA => tylactone => tylosin [PATH:map01100]\n            M00774  Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B [PATH:map01100]\n            M00775  Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin [PATH:map01100]\n            M00776  Pikromycin/methymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin [PATH:map01100]\n            M00777  Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b [PATH:map01100]\n            M00778  Type II polyketide backbone biosynthesis, acyl-CoA + malonyl-CoA => polyketide [PATH:map01100]\n            M00779  Dihydrokalafungin biosynthesis, octaketide => dihydrokalafungin [PATH:map01100]\n            M00780  Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline [PATH:map01100]\n            M00781  Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone [PATH:map01100]\n            M00782  Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin [PATH:map01100]\n            M00783  Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C [PATH:map01100]\n            M00784  Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A [PATH:map01100]\n            M00785  Cycloserine biosynthesis, arginine/serine => cycloserine [PATH:map01100]\n            M00786  Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A [PATH:map01100]\n            M00787  Bacilysin biosynthesis, prephenate => bacilysin [PATH:map01100]\n            M00788  Terpentecin biosynthesis, GGAP => terpentecin [PATH:map01100]\n            M00789  Rebeccamycin biosynthesis, tryptophan => rebeccamycin [PATH:map01100]\n            M00790  Pyrrolnitrin biosynthesis, tryptophan => pyrrolnitrin [PATH:map01100]\n            M00793  dTDP-L-rhamnose biosynthesis [PATH:map01100]\n            M00794  dTDP-6-deoxy-D-allose biosynthesis [PATH:map01100]\n            M00795  dTDP-beta-L-noviose biosynthesis [PATH:map01100]\n            M00796  dTDP-D-mycaminose biosynthesis [PATH:map01100]\n            M00797  dTDP-D-desosamine biosynthesis [PATH:map01100]\n            M00798  dTDP-L-mycarose biosynthesis [PATH:map01100]\n            M00799  dTDP-L-oleandrose biosynthesis [PATH:map01100]\n            M00800  dTDP-L-megosamine biosynthesis [PATH:map01100]\n            M00801  dTDP-L-olivose biosynthesis [PATH:map01100]\n            M00802  dTDP-D-forosamine biosynthesis [PATH:map01100]\n            M00803  dTDP-D-angolosamine biosynthesis [PATH:map01100]\n            M00804  Complete nitrification, comammox, ammonia => nitrite => nitrate [PATH:map01100]\n            M00805  Staurosporine biosynthesis, tryptophan => staurosporine [PATH:map01100]\n            M00808  Violacein biosynthesis, tryptophan => violacein [PATH:map01100]\n            M00810  Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde [PATH:map01100]\n            M00811  Nicotine degradation, pyrrolidine pathway, nicotine => succinate semialdehyde [PATH:map01100]\n            M00814  Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose [PATH:map01100]\n            M00815  Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A [PATH:map01100]\n            M00819  Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone [PATH:map01100]\n            M00823  Chlortetracycline biosynthesis, pretetramide => chlortetracycline [PATH:map01100]\n            M00824  9-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 9-membered enediyne core [PATH:map01100]\n            M00825  10-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 10-membered enediyne core [PATH:map01100]\n            M00826  C-1027 benzoxazolinate moiety biosynthesis, chorismate => benzoxazolinyl-CoA [PATH:map01100]\n            M00827  C-1027 beta-amino acid moiety biosynthesis, tyrosine => 3-chloro-4,5-dihydroxy-beta-phenylalanyl-PCP [PATH:map01100]\n            M00828  Maduropeptin beta-hydroxy acid moiety biosynthesis, tyrosine => 3-(4-hydroxyphenyl)-3-oxopropanoyl-PCP [PATH:map01100]\n            M00829  3,6-Dimethylsalicylyl-CoA biosynthesis, malonyl-CoA => 6-methylsalicylate => 3,6-dimethylsalicylyl-CoA [PATH:map01100]\n            M00830  Neocarzinostatin naphthoate moiety biosynthesis, malonyl-CoA => 2-hydroxy-5-methyl-1-naphthoate => 2-hydroxy-7-methoxy-5-methyl-1-naphthoyl-CoA [PATH:map01100]\n            M00831  Kedarcidin 2-hydroxynaphthoate moiety biosynthesis, malonyl-CoA => 3,6,8-trihydroxy-2-naphthoate => 3-hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA [PATH:map01100]\n            M00832  Kedarcidin 2-aza-3-chloro-beta-tyrosine moiety biosynthesis, azatyrosine => 2-aza-3-chloro-beta-tyrosyl-PCP [PATH:map01100]\n            M00833  Calicheamicin biosynthesis, calicheamicinone => calicheamicin [PATH:map01100]\n            M00834  Calicheamicin orsellinate moiety biosynthesis, malonyl-CoA => orsellinate-ACP => 5-iodo-2,3-dimethoxyorsellinate-ACP [PATH:map01100]\n            M00835  Pyocyanine biosynthesis, chorismate => pyocyanine [PATH:map01100]\n            M00836  Coenzyme F430 biosynthesis, sirohydrochlorin => coenzyme F430 [PATH:map01100]\n            M00837  Prodigiosin biosynthesis, L-proline => prodigiosin [PATH:map01100]\n            M00838  Undecylprodigiosin biosynthesis, L-proline => undecylprodigiosin [PATH:map01100]\n            M00840  Tetrahydrofolate biosynthesis, mediated by ribA and trpF, GTP => THF [PATH:map01100]\n            M00841  Tetrahydrofolate biosynthesis, mediated by PTPS, GTP => THF [PATH:map01100]\n            M00842  Tetrahydrobiopterin biosynthesis, GTP => BH4 [PATH:map01100]\n            M00843  L-threo-Tetrahydrobiopterin biosynthesis, GTP => L-threo-BH4 [PATH:map01100]\n            M00844  Arginine biosynthesis, ornithine => arginine [PATH:map01100]\n            M00845  Arginine biosynthesis, glutamate => acetylcitrulline => arginine [PATH:map01100]\n            M00846  Siroheme biosynthesis, glutamyl-tRNA => siroheme [PATH:map01100]\n            M00847  Heme biosynthesis, archaea, siroheme => heme [PATH:map01100]\n            M00848  Aurachin biosynthesis, anthranilate => aurachin A [PATH:map01100]\n            M00849  C5 isoprenoid biosynthesis, mevalonate pathway, archaea [PATH:map01100]\n            M00854  Glycogen biosynthesis, glucose-1P => glycogen/starch [PATH:map01100]\n            M00855  Glycogen degradation, glycogen => glucose-6P [PATH:map01100]\n            M00861  beta-Oxidation, peroxisome, VLCFA [PATH:map01100]\n            M00862  beta-Oxidation, peroxisome, tri/dihydroxycholestanoyl-CoA => choloyl/chenodeoxycholoyl-CoA [PATH:map01100]\n            M00866  KDO2-lipid A biosynthesis, Raetz pathway, non-LpxL-LpxM type [PATH:map01100]\n            M00867  KDO2-lipid A modification pathway [PATH:map01100]\n            M00868  Heme biosynthesis, animals and fungi, glycine => heme [PATH:map01100]\n            M00872  O-glycan biosynthesis, mannose type (core M3) [PATH:map01100]\n            M00873  Fatty acid biosynthesis in mitochondria, animals [PATH:map01100]\n            M00874  Fatty acid biosynthesis in mitochondria, fungi [PATH:map01100]\n            M00875  Staphyloferrin B biosynthesis, L-serine => staphyloferrin B [PATH:map01100]\n            M00876  Staphyloferrin A biosynthesis, L-ornithine => staphyloferrin A [PATH:map01100]\n            M00877  Kanosamine biosynthesis, glucose 6-phosphate => kanosamine [PATH:map01100]\n            M00878  Phenylacetate degradation, phenylaxetate => acetyl-CoA/succinyl-CoA [PATH:map01100]\n            M00879  Arginine succinyltransferase pathway, arginine => glutamate [PATH:map01100]\n            M00880  Molybdenum cofactor biosynthesis, GTP => molybdenum cofactor [PATH:map01100]\n            M00881  Lipoic acid biosynthesis, plants and bacteria, octanoyl-ACP => dihydrolipoyl-E2/H [PATH:map01100]\n            M00882  Lipoic acid biosynthesis, eukaryotes, octanoyl-ACP => dihydrolipoyl-H [PATH:map01100]\n            M00883  Lipoic acid biosynthesis, animals and bacteria, octanoyl-ACP => dihydrolipoyl-H => dihydrolipoyl-E2 [PATH:map01100]\n            M00884  Lipoic acid biosynthesis, octanoyl-CoA => dihydrolipoyl-E2 [PATH:map01100]\n            M00889  Puromycin biosynthesis, ATP => puromycin [PATH:map01100]\n            M00890  Roseoflavin biosynthesis, FMN => roseoflavin [PATH:map01100]\n            M00891  Ditryptophenaline biosynthesis, tryptophan + phenylalanine => ditryptophenaline [PATH:map01100]\n            M00892  UDP-N-acetyl-D-glucosamine biosynthesis, eukaryotes, glucose => UDP-GlcNAc [PATH:map01100]\n            M00893  Lovastatin biosynthesis, malonyl-CoA => lovastatin acid [PATH:map01100]\n            M00894  Cannabidiol biosynthesis, malonyl-CoA => cannabidiol/dronabinol [PATH:map01100]\n            M00895  Thiamine biosynthesis, prokaryotes, AIR (+ DXP/glycine) => TMP/TPP [PATH:map01100]\n            M00896  Thiamine biosynthesis, archaea, AIR (+ NAD+) => TMP/TPP [PATH:map01100]\n            M00897  Thiamine biosynthesis, plants, AIR (+ NAD+) => TMP/thiamine/TPP [PATH:map01100]\n            M00898  Thiamine biosynthesis, pyridoxal-5P => TMP/thiamine/TPP [PATH:map01100]\n            M00899  Thiamine salvage pathway, HMP/HET => TMP [PATH:map01100]\n            M00900  Crocin biosynthesis, crocetin => crocin [PATH:map01100]\n            M00901  Fumiquinazoline biosynthesis, tryptophan + alanine + anthranilate => fumiquinazoline [PATH:map01100]\n            M00902  Podophyllotoxin biosynthesis, coniferyl alcohol => podophyllotoxin [PATH:map01100]\n            M00903  Fosfomycin biosynthesis, phosphoenolpyruvate => fosfomycin [PATH:map01100]\n            M00904  Dapdiamides biosynthesis, L-2,3-diaminopropanoate => dapdiamide A/B/C [PATH:map01100]\n            M00905  Grixazone biosynthesis, aspartate 4-semialdehyde => grixazone B [PATH:map01100]\n            M00906  Ethynylserine biosynthesis, lysine => ethynylserine [PATH:map01100]\n            M00909  UDP-N-acetyl-D-glucosamine biosynthesis, prokaryotes, glucose => UDP-GlcNAc [PATH:map01100]\n            M00910  Phenylalanine biosynthesis, chorismate => arogenate => phenylalanine [PATH:map01100]\n            M00911  Riboflavin biosynthesis, fungi, GTP => riboflavin/FMN/FAD [PATH:map01100]\n            M00912  NAD biosynthesis, tryptophan => quinolinate => NAD [PATH:map01100]\n            M00913  Pantothenate biosynthesis, 2-oxoisovalerate/spermine => pantothenate [PATH:map01100]\n            M00914  Coenzyme A biosynthesis, archaea, 2-oxoisovalerate => 4-phosphopantoate => CoA [PATH:map01100]\n            M00915  Caffeine degradation, caffeine => xanthine [PATH:map01100]\n            M00916  Pyridoxal-P biosynthesis, R5P + glyceraldehyde-3P + glutamine => pyridoxal-P [PATH:map01100]\n            M00917  Phytosterol biosynthesis, squalene 2,3-epoxide => campesterol/sitosterol [PATH:map01100]\n            M00918  Aerobactin biosynthesis, lysine => aerobactin [PATH:map01100]\n            M00919  Ectoine degradation, ectoine => aspartate [PATH:map01100]\n            M00921  Cyclooctatin biosynthesis, dimethylallyl-PP + isopentenyl-PP => cyclooctatin [PATH:map01100]\n            M00922  CMP-Neu5Ac biosynthesis [PATH:map01100]\n            M00923  UDP-L-FucNAm biosynthesis [PATH:map01100]\n            M00924  Cobalamin biosynthesis, anaerobic, uroporphyrinogen III => sirohydrochlorin => cobyrinate a,c-diamide [PATH:map01100]\n            M00925  Cobalamin biosynthesis, aerobic, uroporphyrinogen III => precorrin 2 => cobyrinate a,c-diamide [PATH:map01100]\n            M00926  Heme biosynthesis, bacteria, glutamyl-tRNA => coproporphyrin III => heme [PATH:map01100]\n            M00927  Gibberellin A12 biosynthesis, GAPP => GA12 [PATH:map01100]\n            M00928  Gibberellin A4/A1 biosynthesis, GA12/GA53 => GA4/GA1 [PATH:map01100]\n            M00929  Gibberellin A1 biosynthesis, GGPP => GA1 [PATH:map01100]\n            M00930  Menaquinone biosynthesis, futalosine pathway [PATH:map01100]\n            M00931  Menaquinone biosynthesis, modified futalosine pathway [PATH:map01100]\n            M00932  Phylloquinone biosynthesis, chorismate (+ phytyl-PP) => phylloquinol [PATH:map01100]\n            M00933  Plastoquinone biosynthesis, homogentisate + solanesyl-PP => plastoquinol [PATH:map01100]\n            M00934  Mycinamicin biosynthesis, malonyl-CoA + methylmalonyl-CoA => protomycinolide IV => mycinamicin II [PATH:map01100]\n            M00935  Methanofuran biosynthesis [PATH:map01100]\n            M00936  Melatonin biosynthesis, plants, tryptophan => serotonin => melatonin [PATH:map01100]\n            M00937  Aflatoxin biosynthesis, malonyl-CoA => aflatoxin B1 [PATH:map01100]\n            M00938  Pyrimidine deoxyribonucleotide biosynthesis, UDP => dTTP [PATH:map01100]\n            M00939  Pyrimidine degradation, uracil => 3-hydroxypropanoate [PATH:map01100]\n            M00940  Flavanone biosynthesis, p-coumaroyl-CoA => liquiritigenin [PATH:map01100]\n            M00941  Isoflavone biosynthesis, liquiritigenin/naringenin => daidzein/genistein [PATH:map01100]\n            M00942  Pterocarpan biosynthesis, daidzein => medicarpin [PATH:map01100]\n            M00943  Reticuline biosynthesis, dopamine + 4HPAA => (S)-reticuline [PATH:map01100]\n            M00944  Morphine biosynthesis, (S)-reticuline => morphine [PATH:map01100]\n            M00945  Sanguinarine biosynthesis, (S)-reticuline => sanguinarine [PATH:map01100]\n            M00946  Noscapine biosynthesis, (S)-reticuline => noscapine [PATH:map01100]\n            M00947  D-Arginine racemization, D-arginine => L-arginine [PATH:map01100]\n            M00948  Hydroxyproline degradation, trans-4-hydroxy-L-proline => 2-oxoglutarate [PATH:map01100]\n            M00949  Staphylopine biosynthesis, L-histidine => staphylopine [PATH:map01100]\n            M00950  Biotin biosynthesis, BioU pathway, pimeloyl-ACP/CoA => biotin [PATH:map01100]\nREL_PATHWAY map00010  Glycolysis / Gluconeogenesis\n            map00020  Citrate cycle (TCA cycle)\n            map00030  Pentose phosphate pathway\n            map00040  Pentose and glucuronate interconversions\n            map00051  Fructose and mannose metabolism\n            map00052  Galactose metabolism\n            map00053  Ascorbate and aldarate metabolism\n            map00061  Fatty acid biosynthesis\n            map00062  Fatty acid elongation\n            map00071  Fatty acid degradation\n            map00073  Cutin, suberine and wax biosynthesis\n            map00100  Steroid biosynthesis\n            map00120  Primary bile acid biosynthesis\n            map00121  Secondary bile acid biosynthesis\n            map00130  Ubiquinone and other terpenoid-quinone biosynthesis\n            map00140  Steroid hormone biosynthesis\n            map00190  Oxidative phosphorylation\n            map00195  Photosynthesis\n            map00196  Photosynthesis - antenna proteins\n            map00220  Arginine biosynthesis\n            map00230  Purine metabolism\n            map00232  Caffeine metabolism\n            map00240  Pyrimidine metabolism\n            map00250  Alanine, aspartate and glutamate metabolism\n            map00253  Tetracycline biosynthesis\n            map00254  Aflatoxin biosynthesis\n            map00260  Glycine, serine and threonine metabolism\n            map00261  Monobactam biosynthesis\n            map00270  Cysteine and methionine metabolism\n            map00280  Valine, leucine and isoleucine degradation\n            map00290  Valine, leucine and isoleucine biosynthesis\n            map00300  Lysine biosynthesis\n            map00310  Lysine degradation\n            map00311  Penicillin and cephalosporin biosynthesis\n            map00330  Arginine and proline metabolism\n            map00331  Clavulanic acid biosynthesis\n            map00332  Carbapenem biosynthesis\n            map00333  Prodigiosin biosynthesis\n            map00340  Histidine metabolism\n            map00350  Tyrosine metabolism\n            map00360  Phenylalanine metabolism\n            map00361  Chlorocyclohexane and chlorobenzene degradation\n            map00362  Benzoate degradation\n            map00363  Bisphenol degradation\n            map00364  Fluorobenzoate degradation\n            map00365  Furfural degradation\n            map00380  Tryptophan metabolism\n            map00400  Phenylalanine, tyrosine and tryptophan biosynthesis\n            map00401  Novobiocin biosynthesis\n            map00402  Benzoxazinoid biosynthesis\n            map00403  Indole diterpene alkaloid biosynthesis\n            map00404  Staurosporine biosynthesis\n            map00405  Phenazine biosynthesis\n            map00410  beta-Alanine metabolism\n            map00430  Taurine and hypotaurine metabolism\n            map00440  Phosphonate and phosphinate metabolism\n            map00450  Selenocompound metabolism\n            map00460  Cyanoamino acid metabolism\n            map00470  D-Amino acid metabolism\n            map00480  Glutathione metabolism\n            map00500  Starch and sucrose metabolism\n            map00510  N-Glycan biosynthesis\n            map00511  Other glycan degradation\n            map00512  Mucin type O-glycan biosynthesis\n            map00513  Various types of N-glycan biosynthesis\n            map00514  Other types of O-glycan biosynthesis\n            map00515  Mannose type O-glycan biosynthesis\n            map00520  Amino sugar and nucleotide sugar metabolism\n            map00521  Streptomycin biosynthesis\n            map00522  Biosynthesis of 12-, 14- and 16-membered macrolides\n            map00523  Polyketide sugar unit biosynthesis\n            map00524  Neomycin, kanamycin and gentamicin biosynthesis\n            map00525  Acarbose and validamycin biosynthesis\n            map00531  Glycosaminoglycan degradation\n            map00532  Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate\n            map00533  Glycosaminoglycan biosynthesis - keratan sulfate\n            map00534  Glycosaminoglycan biosynthesis - heparan sulfate / heparin\n            map00540  Lipopolysaccharide biosynthesis\n            map00541  O-Antigen nucleotide sugar biosynthesis\n            map00542  O-Antigen repeat unit biosynthesis\n            map00550  Peptidoglycan biosynthesis\n            map00552  Teichoic acid biosynthesis\n            map00561  Glycerolipid metabolism\n            map00562  Inositol phosphate metabolism\n            map00563  Glycosylphosphatidylinositol (GPI)-anchor biosynthesis\n            map00564  Glycerophospholipid metabolism\n            map00565  Ether lipid metabolism\n            map00571  Lipoarabinomannan (LAM) biosynthesis\n            map00572  Arabinogalactan biosynthesis - Mycobacterium\n            map00590  Arachidonic acid metabolism\n            map00591  Linoleic acid metabolism\n            map00592  alpha-Linolenic acid metabolism\n            map00600  Sphingolipid metabolism\n            map00601  Glycosphingolipid biosynthesis - lacto and neolacto series\n            map00603  Glycosphingolipid biosynthesis - globo and isoglobo series\n            map00604  Glycosphingolipid biosynthesis - ganglio series\n            map00620  Pyruvate metabolism\n            map00621  Dioxin degradation\n            map00622  Xylene degradation\n            map00623  Toluene degradation\n            map00624  Polycyclic aromatic hydrocarbon degradation\n            map00625  Chloroalkane and chloroalkene degradation\n            map00626  Naphthalene degradation\n            map00627  Aminobenzoate degradation\n            map00630  Glyoxylate and dicarboxylate metabolism\n            map00633  Nitrotoluene degradation\n            map00640  Propanoate metabolism\n            map00642  Ethylbenzene degradation\n            map00643  Styrene degradation\n            map00650  Butanoate metabolism\n            map00660  C5-Branched dibasic acid metabolism\n            map00670  One carbon pool by folate\n            map00680  Methane metabolism\n            map00710  Carbon fixation in photosynthetic organisms\n            map00720  Carbon fixation pathways in prokaryotes\n            map00730  Thiamine metabolism\n            map00740  Riboflavin metabolism\n            map00750  Vitamin B6 metabolism\n            map00760  Nicotinate and nicotinamide metabolism\n            map00770  Pantothenate and CoA biosynthesis\n            map00780  Biotin metabolism\n            map00785  Lipoic acid metabolism\n            map00790  Folate biosynthesis\n            map00791  Atrazine degradation\n            map00830  Retinol metabolism\n            map00860  Porphyrin metabolism\n            map00900  Terpenoid backbone biosynthesis\n            map00901  Indole alkaloid biosynthesis\n            map00902  Monoterpenoid biosynthesis\n            map00903  Limonene and pinene degradation\n            map00904  Diterpenoid biosynthesis\n            map00905  Brassinosteroid biosynthesis\n            map00906  Carotenoid biosynthesis\n            map00908  Zeatin biosynthesis\n            map00909  Sesquiterpenoid and triterpenoid biosynthesis\n            map00910  Nitrogen metabolism\n            map00920  Sulfur metabolism\n            map00930  Caprolactam degradation\n            map00940  Phenylpropanoid biosynthesis\n            map00941  Flavonoid biosynthesis\n            map00942  Anthocyanin biosynthesis\n            map00943  Isoflavonoid biosynthesis\n            map00944  Flavone and flavonol biosynthesis\n            map00950  Isoquinoline alkaloid biosynthesis\n            map00960  Tropane, piperidine and pyridine alkaloid biosynthesis\n            map00965  Betalain biosynthesis\n            map00966  Glucosinolate biosynthesis\n            map00980  Metabolism of xenobiotics by cytochrome P450\n            map00981  Insect hormone biosynthesis\n            map00982  Drug metabolism - cytochrome P450\n            map00983  Drug metabolism - other enzymes\n            map00984  Steroid degradation\n            map00996  Biosynthesis of various alkaloids\n            map00997  Biosynthesis of various other secondary metabolites\n            map00998  Biosynthesis of various antibiotics\n            map00999  Biosynthesis of various plant secondary metabolites\n            map01040  Biosynthesis of unsaturated fatty acids\n            map01051  Biosynthesis of ansamycins\n            map01053  Biosynthesis of siderophore group nonribosomal peptides\n            map01055  Biosynthesis of vancomycin group antibiotics\n            map01056  Biosynthesis of type II polyketide backbone\n            map01057  Biosynthesis of type II polyketide products\n            map01059  Biosynthesis of enediyne antibiotics\nKO_PATHWAY  ko01100\n///\n","added":1656608384712},{"name":"map00997","response":"ENTRY       map00997                    Pathway\nNAME        Biosynthesis of various other secondary metabolites\nCLASS       Metabolism; Biosynthesis of other secondary metabolites\nPATHWAY_MAP map00997  Biosynthesis of various other secondary metabolites\nMODULE      M00875  Staphyloferrin B biosynthesis, L-serine => staphyloferrin B [PATH:map00997]\n            M00876  Staphyloferrin A biosynthesis, L-ornithine => staphyloferrin A [PATH:map00997]\n            M00891  Ditryptophenaline biosynthesis, tryptophan + phenylalanine => ditryptophenaline [PATH:map00997]\n            M00893  Lovastatin biosynthesis, malonyl-CoA => lovastatin acid [PATH:map00997]\n            M00901  Fumiquinazoline biosynthesis, tryptophan + alanine + anthranilate => fumiquinazoline [PATH:map00997]\n            M00905  Grixazone biosynthesis, aspartate 4-semialdehyde => grixazone B [PATH:map00997]\n            M00906  Ethynylserine biosynthesis, lysine => ethynylserine [PATH:map00997]\n            M00918  Aerobactin biosynthesis, lysine => aerobactin [PATH:map00997]\n            M00921  Cyclooctatin biosynthesis, dimethylallyl-PP + isopentenyl-PP => cyclooctatin [PATH:map00997]\nREFERENCE   PMID:24677498\n  AUTHORS   Saruwatari T, Yagishita F, Mino T, Noguchi H, Hotta K, Watanabe K\n  TITLE     Cytochrome P450 as dimerization catalyst in diketopiperazine alkaloid biosynthesis.\n  JOURNAL   Chembiochem 15:656-9 (2014)\n            DOI:10.1002/cbic.201300751\nREFERENCE   PMID:24612080\n  AUTHORS   Lim FY, Ames B, Walsh CT, Keller NP\n  TITLE     Co-ordination between BrlA regulation and secretion of the oxidoreductase FmqD directs selective accumulation of fumiquinazoline C to conidial tissues in Aspergillus fumigatus.\n  JOURNAL   Cell Microbiol 16:1267-83 (2014)\n            DOI:10.1111/cmi.12284\nREFERENCE   PMID:18689486\n  AUTHORS   Clarke-Pearson MF, Brady SF\n  TITLE     Paerucumarin, a new metabolite produced by the pvc gene cluster from Pseudomonas  aeruginosa.\n  JOURNAL   J Bacteriol 190:6927-30 (2008)\n            DOI:10.1128/JB.00801-08\nREFERENCE   PMID:19775248\n  AUTHORS   Cheung J, Beasley FC, Liu S, Lajoie GA, Heinrichs DE\n  TITLE     Molecular characterization of staphyloferrin B biosynthesis in Staphylococcus aureus.\n  JOURNAL   Mol Microbiol 74:594-608 (2009)\n            DOI:10.1111/j.1365-2958.2009.06880.x\nREFERENCE   PMID:19635410\n  AUTHORS   Kim SY, Zhao P, Igarashi M, Sawa R, Tomita T, Nishiyama M, Kuzuyama T\n  TITLE     Cloning and heterologous expression of the cyclooctatin biosynthetic gene cluster afford a diterpene cyclase and two p450 hydroxylases.\n  JOURNAL   Chem Biol 16:736-43 (2009)\n            DOI:10.1016/j.chembiol.2009.06.007\nREFERENCE   PMID:23653178\n  AUTHORS   Xu W, Chooi YH, Choi JW, Li S, Vederas JC, Da Silva NA, Tang Y\n  TITLE     LovG: the thioesterase required for dihydromonacolin L release and lovastatin nonaketide synthase turnover in lovastatin biosynthesis.\n  JOURNAL   Angew Chem Int Ed Engl 52:6472-5 (2013)\n            DOI:10.1002/anie.201302406\nREFERENCE   PMID:17003031\n  AUTHORS   Suzuki H, Ohnishi Y, Furusho Y, Sakuda S, Horinouchi S\n  TITLE     Novel benzene ring biosynthesis from C(3) and C(4) primary metabolites by two enzymes.\n  JOURNAL   J Biol Chem 281:36944-51 (2006)\n            DOI:10.1074/jbc.M608103200\nREFERENCE   PMID:19138128\n  AUTHORS   Cotton JL, Tao J, Balibar CJ\n  TITLE     Identification and characterization of the Staphylococcus aureus gene cluster coding for staphyloferrin A.\n  JOURNAL   Biochemistry 48:1025-35 (2009)\n            DOI:10.1021/bi801844c\nREFERENCE   PMID:30867596\n  AUTHORS   Marchand JA, Neugebauer ME, Ing MC, Lin CI, Pelton JG, Chang MCY\n  TITLE     Discovery of a pathway for terminal-alkyne amino acid biosynthesis.\n  JOURNAL   Nature 567:420-424 (2019)\n            DOI:10.1038/s41586-019-1020-y\nREFERENCE   PMID:1393837\n  AUTHORS   Neilands JB\n  TITLE     Mechanism and regulation of synthesis of aerobactin in Escherichia coli K12 (pColV-K30).\n  JOURNAL   Can J Microbiol 38:728-33 (1992)\n            DOI:10.1139/m92-119\nREL_PATHWAY map00010  Glycolysis / Gluconeogenesis\n            map00020  Citrate cycle (TCA cycle)\n            map00250  Alanine, aspartate and glutamate metabolism\n            map00260  Glycine, serine and threonine metabolism\n            map00400  Phenylalanine, tyrosine and tryptophan biosynthesis\n            map00900  Terpenoid backbone biosynthesis\nKO_PATHWAY  ko00997\n///\n","added":1656608385570},{"name":"map02020","response":"ENTRY       map02020                    Pathway\nNAME        Two-component system\nDESCRIPTION Two-component signal transduction systems enable bacteria to sense, respond, and adapt to changes in their environment or in their intracellular state. Each two-component system consists of a sensor protein-histidine kinase (HK) and a response regulator (RR). In the prototypical two-component pathway, the sensor HK phosphorylates its own conserved His residue in response to a signal(s) in the environment. Subsequently, the phosphoryl group of HK is transferred onto a specific Asp residue on the RR. The activated RR can then effect changes in cellular physiology, often by regulating gene expression. Two-component pathways thus often enable cells to sense and respond to stimuli by inducing changes in transcription.\nCLASS       Environmental Information Processing; Signal transduction\nPATHWAY_MAP map02020  Two-component system\nMODULE      M00651  Vancomycin resistance, D-Ala-D-Lac type [PATH:map02020]\n            M00652  Vancomycin resistance, D-Ala-D-Ser type [PATH:map02020]\nDBLINKS     GO: 0000160\nREFERENCE   PMID:15522865\n  AUTHORS   Yamamoto K, Hirao K, Oshima T, Aiba H, Utsumi R, Ishihama A.\n  TITLE     Functional characterization in vitro of all two-component signal transduction systems from Escherichia coli.\n  JOURNAL   J Biol Chem 280:1448-56 (2005)\n            DOI:10.1074/jbc.M410104200\nREFERENCE   PMID:16030210\n  AUTHORS   Abdel-Fattah WR, Chen Y, Eldakak A, Hulett FM.\n  TITLE     Bacillus subtilis phosphorylated PhoP: direct activation of the E(sigma)A- and repression of the E(sigma)E-responsive phoB-PS+V promoters during pho response.\n  JOURNAL   J Bacteriol 187:5166-78 (2005)\n            DOI:10.1128/JB.187.15.5166-5178.2005\nREFERENCE   PMID:15813739\n  AUTHORS   Navarre WW, Halsey TA, Walthers D, Frye J, McClelland M, Potter JL, Kenney LJ, Gunn JS, Fang FC, Libby SJ.\n  TITLE     Co-regulation of Salmonella enterica genes required for virulence and resistance to antimicrobial peptides by SlyA and PhoP/PhoQ.\n  JOURNAL   Mol Microbiol 56:492-508 (2005)\n            DOI:10.1111/j.1365-2958.2005.04553.x\nREFERENCE   PMID:11973328\n  AUTHORS   Cai SJ, Inouye M.\n  TITLE     EnvZ-OmpR interaction and osmoregulation in Escherichia coli.\n  JOURNAL   J Biol Chem 277:24155-61 (2002)\n            DOI:10.1074/jbc.M110715200\nREFERENCE   PMID:16077119\n  AUTHORS   Batchelor E, Walthers D, Kenney LJ, Goulian M.\n  TITLE     The Escherichia coli CpxA-CpxR envelope stress response system regulates expression of the porins ompF and ompC.\n  JOURNAL   J Bacteriol 187:5723-31 (2005)\n            DOI:10.1128/JB.187.16.5723-5731.2005\nREFERENCE   PMID:12107133\n  AUTHORS   Nagakubo S, Nishino K, Hirata T, Yamaguchi A.\n  TITLE     The putative response regulator BaeR stimulates multidrug resistance of Escherichia coli via a novel multidrug exporter system, MdtABC.\n  JOURNAL   J Bacteriol 184:4161-7 (2002)\n            DOI:10.1128/JB.184.15.4161-4167.2002\nREFERENCE   PMID:15322361\n  AUTHORS   Hagiwara D, Yamashino T, Mizuno T.\n  TITLE     A Genome-wide view of the Escherichia coli BasS-BasR two-component system implicated in iron-responses.\n  JOURNAL   Biosci Biotechnol Biochem 68:1758-67 (2004)\n            DOI:10.1271/bbb.68.1758\nREFERENCE   PMID:11004187\n  AUTHORS   Munson GP, Lam DL, Outten FW, O'Halloran TV.\n  TITLE     Identification of a copper-responsive two-component system on the chromosome of Escherichia coli K-12.\n  JOURNAL   J Bacteriol 182:5864-71 (2000)\n            DOI:10.1128/JB.182.20.5864-5871.2000\nREFERENCE   PMID:11929534\n  AUTHORS   Sperandio V, Torres AG, Kaper JB.\n  TITLE     Quorum sensing Escherichia coli regulators B and C (QseBC): a novel two-component regulatory system involved in the regulation of flagella and motility by quorum sensing in E. coli.\n  JOURNAL   Mol Microbiol 43:809-21 (2002)\n            DOI:10.1046/j.1365-2958.2002.02803.x\nREFERENCE   PMID:14604015\n  AUTHORS   Epstein W.\n  TITLE     The roles and regulation of potassium in bacteria.\n  JOURNAL   Prog Nucleic Acid Res Mol Biol 75:293-320 (2003)\n            DOI:10.1016/S0079-6603(03)75008-9\nREFERENCE   PMID:10648521\n  AUTHORS   Ansaldi M, Simon G, Lepelletier M, Mejean V.\n  TITLE     The TorR high-affinity binding site plays a key role in both torR autoregulation and torCAD operon expression in Escherichia coli.\n  JOURNAL   J Bacteriol 182:961-6 (2000)\n            DOI:10.1128/JB.182.4.961-966.2000\nREFERENCE   PMID:15326287\n  AUTHORS   Malpica R, Franco B, Rodriguez C, Kwon O, Georgellis D.\n  TITLE     Identification of a quinone-sensitive redox switch in the ArcB sensor kinase.\n  JOURNAL   Proc Natl Acad Sci U S A 101:13318-23 (2004)\n            DOI:10.1073/pnas.0403064101\nREFERENCE   PMID:2666399\n  AUTHORS   Widenhorn KA, Somers JM, Kay WW.\n  TITLE     Genetic regulation of the tricarboxylate transport operon (tctI) of Salmonella typhimurium.\n  JOURNAL   J Bacteriol 171:4436-41 (1989)\n            DOI:10.1128/JB.171.8.4436-4441.1989\nREFERENCE   PMID:11555295\n  AUTHORS   Hyyrylainen HL, Bolhuis A, Darmon E, Muukkonen L, Koski P, Vitikainen M, Sarvas M, Pragai Z, Bron S, van Dijl JM, Kontinen VP.\n  TITLE     A novel two-component regulatory system in Bacillus subtilis for the survival of severe secretion stress.\n  JOURNAL   Mol Microbiol 41:1159-72 (2001)\n            DOI:10.1046/j.1365-2958.2001.02576.x\nREFERENCE   PMID:10972837\n  AUTHORS   Zhang X, Hulett FM.\n  TITLE     ResD signal transduction regulator of aerobic respiration in Bacillus subtilis: ctaA promoter regulation.\n  JOURNAL   Mol Microbiol 37:1208-19 (2000)\n            DOI:10.1046/j.1365-2958.2000.02076.x\nREFERENCE   PMID:15937169\n  AUTHORS   Senadheera MD, Guggenheim B, Spatafora GA, Huang YC, Choi J, Hung DC, Treglown JS, Goodman SD, Ellen RP, Cvitkovitch DG.\n  TITLE     A VicRK signal transduction system in Streptococcus mutans affects gtfBCD, gbpB, and ftf expression, biofilm formation, and genetic competence development.\n  JOURNAL   J Bacteriol 187:4064-76 (2005)\n            DOI:10.1128/JB.187.12.4064-4076.2005\nREFERENCE   PMID:15601704\n  AUTHORS   He H, Zahrt TC.\n  TITLE     Identification and characterization of a regulatory sequence recognized by Mycobacterium tuberculosis persistence regulator MprA.\n  JOURNAL   J Bacteriol 187:202-12 (2005)\n            DOI:10.1128/JB.187.1.202-212.2005\nREFERENCE   PMID:17448786\n  AUTHORS   Hutchings MI\n  TITLE     Unusual two-component signal transduction pathways in the actinobacteria.\n  JOURNAL   Adv Appl Microbiol 61:1-26 (2007)\n            DOI:10.1016/S0065-2164(06)61001-0\nREFERENCE   PMID:19308662\n  AUTHORS   Kramer R\n  TITLE     Osmosensing and osmosignaling in Corynebacterium glutamicum.\n  JOURNAL   Amino Acids 37:487-97 (2009)\n            DOI:10.1007/s00726-009-0271-6\nREFERENCE   PMID:7751278\n  AUTHORS   Eraso JM, Kaplan S.\n  TITLE     Oxygen-insensitive synthesis of the photosynthetic membranes of Rhodobacter sphaeroides: a mutant histidine kinase.\n  JOURNAL   J Bacteriol 177:2695-706 (1995)\n            DOI:10.1128/JB.177.10.2695-2706.1995\nREFERENCE   PMID:10089160\n  AUTHORS   Haydel SE, Dunlap NE, Benjamin WH Jr.\n  TITLE     In vitro evidence of two-component system phosphorylation between the Mycobacterium tuberculosis TrcR/TrcS proteins.\n  JOURNAL   Microb Pathog 26:195-206 (1999)\n            DOI:10.1006/mpat.1998.0265\nREFERENCE   PMID:11673427\n  AUTHORS   Quisel JD, Burkholder WF, Grossman AD.\n  TITLE     In vivo effects of sporulation kinases on mutant Spo0A proteins in Bacillus subtilis.\n  JOURNAL   J Bacteriol 183:6573-8 (2001)\n            DOI:10.1128/JB.183.22.6573-6578.2001\nREFERENCE   PMID:11889485\n  AUTHORS   Kaspar S, Bott M.\n  TITLE     The sensor kinase CitA (DpiB) of Escherichia coli functions as a high-affinity citrate receptor.\n  JOURNAL   Arch Microbiol 177:313-21 (2002)\n            DOI:10.1007/s00203-001-0393-z\nREFERENCE   PMID:12167640\n  AUTHORS   Janausch IG, Garcia-Moreno I, Unden G.\n  TITLE     Function of DcuS from Escherichia coli as a fumarate-stimulated histidine protein kinase in vitro.\n  JOURNAL   J Biol Chem 277:39809-14 (2002)\n            DOI:10.1074/jbc.M204482200\nREFERENCE   PMID:8550490\n  AUTHORS   Brunskill EW, Bayles KW.\n  TITLE     Identification and molecular characterization of a putative regulatory locus that affects autolysis in Staphylococcus aureus.\n  JOURNAL   J Bacteriol 178:611-8 (1996)\n            DOI:10.1128/JB.178.3.611-618.1996\nREFERENCE   PMID:10940023\n  AUTHORS   Fujimoto DF, Brunskill EW, Bayles KW.\n  TITLE     Analysis of genetic elements controlling Staphylococcus aureus lrgAB expression: potential role of DNA topology in SarA regulation.\n  JOURNAL   J Bacteriol 182:4822-8 (2000)\n            DOI:10.1128/JB.182.17.4822-4828.2000\nREFERENCE   PMID:11807079\n  AUTHORS   Dufour P, Jarraud S, Vandenesch F, Greenland T, Novick RP, Bes M, Etienne J, Lina G.\n  TITLE     High genetic variability of the agr locus in Staphylococcus species.\n  JOURNAL   J Bacteriol 184:1180-6 (2002)\n            DOI:10.1128/JB.184.4.1180-1186.2002\nREFERENCE   PMID:8501030\n  AUTHORS   Rabin RS, Stewart V.\n  TITLE     Dual response regulators (NarL and NarP) interact with dual sensors (NarX and NarQ) to control nitrate- and nitrite-regulated gene expression in Escherichia coli K-12.\n  JOURNAL   J Bacteriol 175:3259-68 (1993)\n            DOI:10.1128/JB.175.11.3259-3268.1993\nREFERENCE   PMID:9220011\n  AUTHORS   Chiang RC, Cavicchioli R, Gunsalus RP.\n  TITLE     'Locked-on' and 'locked-off' signal transduction mutations in the periplasmic domain of the Escherichia coli NarQ and NarX sensors affect nitrate- and nitrite-dependent regulation by NarL and NarP.\n  JOURNAL   Mol Microbiol 24:1049-60 (1997)\n            DOI:10.1046/j.1365-2958.1997.4131779.x\nREFERENCE   PMID:12107138\n  AUTHORS   Verhamme DT, Postma PW, Crielaard W, Hellingwerf KJ.\n  TITLE     Cooperativity in signal transfer through the Uhp system of Escherichia coli.\n  JOURNAL   J Bacteriol 184:4205-10 (2002)\n            DOI:10.1128/JB.184.15.4205-4210.2002\nREFERENCE   PMID:13129944\n  AUTHORS   Hagiwara D, Sugiura M, Oshima T, Mori H, Aiba H, Yamashino T, Mizuno T.\n  TITLE     Genome-wide analyses revealing a signaling network of the RcsC-YojN-RcsB phosphorelay system in Escherichia coli.\n  JOURNAL   J Bacteriol 185:5735-46 (2003)\n            DOI:10.1128/JB.185.19.5735-5746.2003\nREFERENCE   PMID:12951338\n  AUTHORS   Hirakawa H, Nishino K, Yamada J, Hirata T, Yamaguchi A.\n  TITLE     Beta-lactam resistance modulated by the overexpression of response regulators of two-component signal transduction systems in Escherichia coli.\n  JOURNAL   J Antimicrob Chemother 52:576-82 (2003)\n            DOI:10.1093/jac/dkg406\nREFERENCE   PMID:12193630\n  AUTHORS   Suzuki K, Wang X, Weilbacher T, Pernestig AK, Melefors O, Georgellis D, Babitzke P, Romeo T.\n  TITLE     Regulatory circuitry of the CsrA/CsrB and BarA/UvrY systems of Escherichia coli.\n  JOURNAL   J Bacteriol 184:5130-40 (2002)\n            DOI:10.1128/JB.184.18.5130-5140.2002\nREFERENCE   PMID:10923791\n  AUTHORS   Kato A, Ohnishi H, Yamamoto K, Furuta E, Tanabe H, Utsumi R.\n  TITLE     Transcription of emrKY is regulated by the EvgA-EvgS two-component system in Escherichia coli K-12.\n  JOURNAL   Biosci Biotechnol Biochem 64:1203-9 (2000)\n            DOI:10.1271/bbb.64.1203\nREFERENCE   PMID:14679219\n  AUTHORS   Ansaldi M, Dubnau D.\n  TITLE     Diversifying selection at the Bacillus quorum-sensing locus and determinants of modification specificity during synthesis of the ComX pheromone.\n  JOURNAL   J Bacteriol 186:15-21 (2004)\n            DOI:10.1128/JB.186.1.15-21.2004\nREFERENCE   PMID:16035234\n  AUTHORS   Gabdrakhmanova L, Vishniakov I, Sharipova M, Balaban N, Kostrov S, Leshchinskaya I.\n  TITLE     Salt stress induction of glutamyl endopeptidase biosynthesis in Bacillus intermedius.\n  JOURNAL   Microbiol Res 160:233-42 (2005)\n            DOI:10.1016/j.micres.2004.05.005\nREFERENCE   PMID:11285232\n  AUTHORS   Aguilar PS, Hernandez-Arriaga AM, Cybulski LE, Erazo AC, de Mendoza D.\n  TITLE     Molecular basis of thermosensing: a two-component signal transduction thermometer in Bacillus subtilis.\n  JOURNAL   EMBO J 20:1681-91 (2001)\n            DOI:10.1093/emboj/20.7.1681\nREFERENCE   PMID:12864861\n  AUTHORS   Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K.\n  TITLE     Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus.\n  JOURNAL   Mol Microbiol 49:807-21 (2003)\n            DOI:10.1046/j.1365-2958.2003.03599.x\nREFERENCE   PMID:15073296\n  AUTHORS   Saini DK, Malhotra V, Dey D, Pant N, Das TK, Tyagi JS.\n  TITLE     DevR-DevS is a bona fide two-component system of Mycobacterium tuberculosis that is hypoxia-responsive in the absence of the DNA-binding domain of DevR.\n  JOURNAL   Microbiology 150:865-75 (2004)\n            DOI:10.1099/mic.0.26218-0\nREFERENCE   PMID:12426351\n  AUTHORS   Fedtke I, Kamps A, Krismer B, Gotz F.\n  TITLE     The nitrate reductase and nitrite reductase operons and the narT gene of Staphylococcus carnosus are positively controlled by the novel two-component system NreBC.\n  JOURNAL   J Bacteriol 184:6624-34 (2002)\n            DOI:10.1128/JB.184.23.6624-6634.2002\nREFERENCE   PMID:8416895\n  AUTHORS   Shiau SP, Chen P, Reitzer LJ.\n  TITLE     Effects of insertions and deletions in glnG (ntrC) of Escherichia coli on nitrogen regulator I-dependent DNA binding and transcriptional activation.\n  JOURNAL   J Bacteriol 175:190-9 (1993)\n            DOI:10.1128/JB.175.1.190-199.1993\nREFERENCE   PMID:11243806\n  AUTHORS   Leonhartsberger S, Huber A, Lottspeich F, Bock A.\n  TITLE     The hydH/G Genes from Escherichia coli code for a zinc and lead responsive two-component regulatory system.\n  JOURNAL   J Mol Biol 307:93-105 (2001)\n            DOI:10.1006/jmbi.2000.4451\nREFERENCE   PMID:15200682\n  AUTHORS   Lioliou EE, Kyriakidis DA.\n  TITLE     The role of bacterial antizyme: From an inhibitory protein to AtoC transcriptional regulator.\n  JOURNAL   Microb Cell Fact 3:8 (2004)\n            DOI:10.1186/1475-2859-3-8\nREFERENCE   PMID:15773991\n  AUTHORS   Yamamoto K, Ishihama A\n  TITLE     Transcriptional response of Escherichia coli to external copper.\n  JOURNAL   Mol Microbiol 56:215-27 (2005)\n            DOI:10.1111/j.1365-2958.2005.04532.x\nREFERENCE   PMID:10585546\n  AUTHORS   Ashby MK, Mullineaux CW\n  TITLE     Cyanobacterial ycf27 gene products regulate energy transfer from phycobilisomes to photosystems I and II.\n  JOURNAL   FEMS Microbiol Lett 181:253-60 (1999)\n            DOI:10.1111/j.1574-6968.1999.tb08852.x\nREFERENCE   PMID:11849552\n  AUTHORS   Lopez-Maury L, Garcia-Dominguez M, Florencio FJ, Reyes JC\n  TITLE     A two-component signal transduction system involved in nickel sensing in the cyanobacterium Synechocystis sp. PCC 6803.\n  JOURNAL   Mol Microbiol 43:247-56 (2002)\n            DOI:10.1046/j.1365-2958.2002.02741.x\nREFERENCE   PMID:17526710\n  AUTHORS   Glover RT, Kriakov J, Garforth SJ, Baughn AD, Jacobs WR Jr\n  TITLE     The two-component regulatory system senX3-regX3 regulates phosphate-dependent gene expression in Mycobacterium smegmatis.\n  JOURNAL   J Bacteriol 189:5495-503 (2007)\n            DOI:10.1128/JB.00190-07\nREFERENCE   PMID:15175302\n  AUTHORS   Hsiao HY, He Q, Van Waasbergen LG, Grossman AR\n  TITLE     Control of photosynthetic and high-light-responsive genes by the histidine kinase DspA: negative and positive regulation and interactions between signal transduction pathways.\n  JOURNAL   J Bacteriol 186:3882-8 (2004)\n            DOI:10.1128/JB.186.12.3882-3888.2004\nREFERENCE   PMID:12626498\n  AUTHORS   Mutsuda M, Michel KP, Zhang X, Montgomery BL, Golden SS\n  TITLE     Biochemical properties of CikA, an unusual phytochrome-like histidine protein kinase that resets the circadian clock in Synechococcus elongatus PCC 7942.\n  JOURNAL   J Biol Chem 278:19102-10 (2003)\n            DOI:10.1074/jbc.M213255200\nREFERENCE   PMID:9278513\n  AUTHORS   Yeh KC, Wu SH, Murphy JT, Lagarias JC\n  TITLE     A cyanobacterial phytochrome two-component light sensory system.\n  JOURNAL   Science 277:1505-8 (1997)\n            DOI:10.1126/science.277.5331.1505\nREFERENCE   PMID:7635815\n  AUTHORS   Niu S, Jiang SQ, Hong J\n  TITLE     Salmonella typhimurium pgtB mutants conferring constitutive expression of phosphoglycerate transporter pgtP independent of pgtC.\n  JOURNAL   J Bacteriol 177:4297-302 (1995)\n            DOI:10.1128/JB.177.15.4297-4302.1995\nREFERENCE   PMID:16882723\n  AUTHORS   Takai N, Nakajima M, Oyama T, Kito R, Sugita C, Sugita M, Kondo T, Iwasaki H\n  TITLE     A KaiC-associating SasA-RpaA two-component regulatory system as a major circadian timing mediator in cyanobacteria.\n  JOURNAL   Proc Natl Acad Sci U S A 103:12109-14 (2006)\n            DOI:10.1073/pnas.0602955103\nREFERENCE   PMID:11803016\n  AUTHORS   Janausch IG, Zientz E, Tran QH, Kroger A, Unden G\n  TITLE     C4-dicarboxylate carriers and sensors in bacteria.\n  JOURNAL   Biochim Biophys Acta 1553:39-56 (2002)\n            DOI:10.1016/S0005-2728(01)00233-X\nREFERENCE   PMID:18725229\n  AUTHORS   Zhou YF, Nan B, Nan J, Ma Q, Panjikar S, Liang YH, Wang Y, Su XD\n  TITLE     C4-dicarboxylates sensing mechanism revealed by the crystal structures of DctB sensor domain.\n  JOURNAL   J Mol Biol 383:49-61 (2008)\n            DOI:10.1016/j.jmb.2008.08.010\nREFERENCE   PMID:14523104\n  AUTHORS   Novick RP, Jiang D\n  TITLE     The staphylococcal saeRS system coordinates environmental signals with agr quorum sensing.\n  JOURNAL   Microbiology 149:2709-17 (2003)\n            DOI:10.1099/mic.0.26575-0\nREFERENCE   PMID:17981963\n  AUTHORS   Leech AJ, Sprinkle A, Wood L, Wozniak DJ, Ohman DE\n  TITLE     The NtrC family regulator AlgB, which controls alginate biosynthesis in mucoid Pseudomonas aeruginosa, binds directly to the algD promoter.\n  JOURNAL   J Bacteriol 190:581-9 (2008)\n            DOI:10.1128/JB.01307-07\nREFERENCE   PMID:18455986\n  AUTHORS   Paul R, Jaeger T, Abel S, Wiederkehr I, Folcher M, Biondi EG, Laub MT, Jenal U\n  TITLE     Allosteric regulation of histidine kinases by their cognate response regulator determines cell fate.\n  JOURNAL   Cell 133:452-61 (2008)\n            DOI:10.1016/j.cell.2008.02.045\nREFERENCE   PMID:15101991\n  AUTHORS   Whitchurch CB, Leech AJ, Young MD, Kennedy D, Sargent JL, Bertrand JJ, Semmler AB, Mellick AS, Martin PR, Alm RA, Hobbs M, Beatson SA, Huang B, Nguyen L, Commolli JC, Engel JN, Darzins A, Mattick JS.\n  TITLE     Characterization of a complex chemosensory signal transduction system which controls twitching motility in Pseudomonas aeruginosa.\n  JOURNAL   Mol Microbiol 52:873-93 (2004)\n            DOI:10.1111/j.1365-2958.2004.04026.x\nREFERENCE   PMID:15170479\n  AUTHORS   Yoshihara S, Ikeuchi M.\n  TITLE     Phototactic motility in the unicellular cyanobacterium Synechocystis sp. PCC 6803.\n  JOURNAL   Photochem Photobiol Sci 3:512-8 (2004)\n            DOI:10.1039/b402320j\nREFERENCE   PMID:12039966\n  AUTHORS   Ogawa T, Bao DH, Katoh H, Shibata M, Pakrasi HB, Bhattacharyya-Pakrasi M\n  TITLE     A two-component signal transduction pathway regulates manganese homeostasis in Synechocystis 6803, a photosynthetic organism.\n  JOURNAL   J Biol Chem 277:28981-6 (2002)\n            DOI:10.1074/jbc.M204175200\nREFERENCE   PMID:12417709\n  AUTHORS   Yamaguchi K, Suzuki I, Yamamoto H, Lyukevich A, Bodrova I, Los DA, Piven I, Zinchenko V, Kanehisa M, Murata N\n  TITLE     A two-component Mn2+-sensing system negatively regulates expression of the mntCAB operon in Synechocystis.\n  JOURNAL   Plant Cell 14:2901-13 (2002)\n            DOI:10.1105/tpc.006262\nREFERENCE   PMID:15273097\n  AUTHORS   Mascher T, Zimmer SL, Smith TA, Helmann JD\n  TITLE     Antibiotic-inducible promoter regulated by the cell envelope stress-sensing two-component system LiaRS of Bacillus subtilis.\n  JOURNAL   Antimicrob Agents Chemother 48:2888-96 (2004)\n            DOI:10.1128/AAC.48.8.2888-2896.2004\nREFERENCE   PMID:15856219\n  AUTHORS   Hyyrylainen HL, Sarvas M, Kontinen VP\n  TITLE     Transcriptome analysis of the secretion stress response of Bacillus subtilis.\n  JOURNAL   Appl Microbiol Biotechnol 67:389-96 (2005)\n            DOI:10.1007/s00253-005-1898-1\nREFERENCE   PMID:15941986\n  AUTHORS   Serizawa M, Sekiguchi J\n  TITLE     The Bacillus subtilis YdfHI two-component system regulates the transcription of ydfJ, a member of the RND superfamily.\n  JOURNAL   Microbiology 151:1769-78 (2005)\n            DOI:10.1099/mic.0.27619-0\nREFERENCE   PMID:12890034\n  AUTHORS   Ohki R, Giyanto, Tateno K, Masuyama W, Moriya S, Kobayashi K, Ogasawara N\n  TITLE     The BceRS two-component regulatory system induces expression of the bacitracin transporter, BceAB, in Bacillus subtilis.\n  JOURNAL   Mol Microbiol 49:1135-44 (2003)\n            DOI:10.1046/j.1365-2958.2003.03653.x\nREFERENCE   PMID:17322186\n  AUTHORS   Ogura M, Tsukahara K, Hayashi K, Tanaka T\n  TITLE     The Bacillus subtilis NatK-NatR two-component system regulates expression of the natAB operon encoding an ABC transporter for sodium ion extrusion.\n  JOURNAL   Microbiology 153:667-75 (2007)\n            DOI:10.1099/mic.0.2006/003673-0\nREFERENCE   PMID:10972810\n  AUTHORS   Yamamoto H, Murata M, Sekiguchi J\n  TITLE     The CitST two-component system regulates the expression of the Mg-citrate transporter in Bacillus subtilis.\n  JOURNAL   Mol Microbiol 37:898-912 (2000)\n            DOI:10.1046/j.1365-2958.2000.02055.x\nREFERENCE   PMID:15995196\n  AUTHORS   Satomura T, Shimura D, Asai K, Sadaie Y, Hirooka K, Fujita Y\n  TITLE     Enhancement of glutamine utilization in Bacillus subtilis through the GlnK-GlnL two-component regulatory system.\n  JOURNAL   J Bacteriol 187:4813-21 (2005)\n            DOI:10.1128/JB.187.14.4813-4821.2005\nREFERENCE   PMID:12949160\n  AUTHORS   Doan T, Servant P, Tojo S, Yamaguchi H, Lerondel G, Yoshida K, Fujita Y, Aymerich S\n  TITLE     The Bacillus subtilis ywkA gene encodes a malic enzyme and its transcription is activated by the YufL/YufM two-component system in response to malate.\n  JOURNAL   Microbiology 149:2331-43 (2003)\n            DOI:10.1099/mic.0.26256-0\nREFERENCE   PMID:12949159\n  AUTHORS   Tanaka K, Kobayashi K, Ogasawara N\n  TITLE     The Bacillus subtilis YufLM two-component system regulates the expression of the malate transporters MaeN (YufR) and YflS, and is essential for utilization of malate in minimal medium.\n  JOURNAL   Microbiology 149:2317-29 (2003)\n            DOI:10.1099/mic.0.26257-0\nREFERENCE   PMID:10708364\n  AUTHORS   Asai K, Baik SH, Kasahara Y, Moriya S, Ogasawara N\n  TITLE     Regulation of the transport system for C4-dicarboxylic acids in Bacillus subtilis.\n  JOURNAL   Microbiology 146 ( Pt 2):263-71 (2000)\n            DOI:10.1099/00221287-146-2-263\nREFERENCE   PMID:8455557\n  AUTHORS   Hamblin MJ, Shaw JG, Kelly DJ\n  TITLE     Sequence analysis and interposon mutagenesis of a sensor-kinase (DctS) and response-regulator (DctR) controlling synthesis of the high-affinity C4-dicarboxylate transport system in Rhodobacter capsulatus.\n  JOURNAL   Mol Gen Genet 237:215-24 (1993)\n            DOI:10.1007/BF00282803\nREFERENCE   PMID:9287004\n  AUTHORS   Forward JA, Behrendt MC, Wyborn NR, Cross R, Kelly DJ\n  TITLE     TRAP transporters: a new family of periplasmic solute transport systems encoded by the dctPQM genes of Rhodobacter capsulatus and by homologs in diverse gram-negative bacteria.\n  JOURNAL   J Bacteriol 179:5482-93 (1997)\n            DOI:10.1128/JB.179.17.5482-5493.1997\nREFERENCE   PMID:16820295\n  AUTHORS   Martin B, Quentin Y, Fichant G, Claverys JP\n  TITLE     Independent evolution of competence regulatory cascades in streptococci?\n  JOURNAL   Trends Microbiol 14:339-45 (2006)\n            DOI:10.1016/j.tim.2006.06.007\nREFERENCE   PMID:10231485\n  AUTHORS   Hensel M, Hinsley AP, Nikolaus T, Sawers G, Berks BC\n  TITLE     The genetic basis of tetrathionate respiration in Salmonella typhimurium.\n  JOURNAL   Mol Microbiol 32:275-87 (1999)\n            DOI:10.1046/j.1365-2958.1999.01345.x\nREFERENCE   PMID:18028314\n  AUTHORS   Guvener ZT, Harwood CS\n  TITLE     Subcellular location characteristics of the Pseudomonas aeruginosa GGDEF protein, WspR, indicate that it produces cyclic-di-GMP in response to growth on surfaces.\n  JOURNAL   Mol Microbiol 66:1459-73 (2007)\n            DOI:10.1111/j.1365-2958.2007.06008.x\nREFERENCE   PMID:17339222\n  AUTHORS   Bantinaki E, Kassen R, Knight CG, Robinson Z, Spiers AJ, Rainey PB\n  TITLE     Adaptive divergence in experimental populations of Pseudomonas fluorescens. III. Mutational origins of wrinkly spreader diversity.\n  JOURNAL   Genetics 176:441-53 (2007)\n            DOI:10.1534/genetics.106.069906\nREFERENCE   PMID:11069677\n  AUTHORS   Jiang M, Shao W, Perego M, Hoch JA\n  TITLE     Multiple histidine kinases regulate entry into stationary phase and sporulation in Bacillus subtilis.\n  JOURNAL   Mol Microbiol 38:535-42 (2000)\n            DOI:10.1046/j.1365-2958.2000.02148.x\nREFERENCE   PMID:19781638\n  AUTHORS   Jenal U\n  TITLE     The role of proteolysis in the Caulobacter crescentus cell cycle and development.\n  JOURNAL   Res Microbiol 160:687-95 (2009)\n            DOI:10.1016/j.resmic.2009.09.006\nREFERENCE   PMID:19246239\n  AUTHORS   Jenal U, Galperin MY\n  TITLE     Single domain response regulators: molecular switches with emerging roles in cell organization and dynamics.\n  JOURNAL   Curr Opin Microbiol 12:152-60 (2009)\n            DOI:10.1016/j.mib.2009.01.010\nREFERENCE   PMID:16640581\n  AUTHORS   Drepper T, Wiethaus J, Giaourakis D, Gross S, Schubert B, Vogt M, Wiencek Y, McEwan AG, Masepohl B\n  TITLE     Cross-talk towards the response regulator NtrC controlling nitrogen metabolism in Rhodobacter capsulatus.\n  JOURNAL   FEMS Microbiol Lett 258:250-6 (2006)\n            DOI:10.1111/j.1574-6968.2006.00228.x\nREFERENCE   PMID:1661370\n  AUTHORS   Pawlowski K, Klosse U, de Bruijn FJ\n  TITLE     Characterization of a novel Azorhizobium caulinodans ORS571 two-component regulatory system, NtrY/NtrX, involved in nitrogen fixation and metabolism.\n  JOURNAL   Mol Gen Genet 231:124-38 (1991)\n            DOI:10.1007/BF00293830\nREFERENCE   PMID:18422428\n  AUTHORS   Chatterjee S, Almeida RP, Lindow S\n  TITLE     Living in two worlds: the plant and insect lifestyles of Xylella fastidiosa.\n  JOURNAL   Annu Rev Phytopathol 46:243-71 (2008)\n            DOI:10.1146/annurev.phyto.45.062806.094342\nREFERENCE   PMID:18506032\n  AUTHORS   Dow M\n  TITLE     Diversification of the function of cell-to-cell signaling in regulation of virulence within plant pathogenic xanthomonads.\n  JOURNAL   Sci Signal 1:pe23 (2008)\n            DOI:10.1126/stke.121pe23\nREFERENCE   PMID:17902112\n  AUTHORS   Colnaghi Simionato AV, da Silva DS, Lambais MR, Carrilho E\n  TITLE     Characterization of a putative Xylella fastidiosa diffusible signal factor by HRGC-EI-MS.\n  JOURNAL   J Mass Spectrom 42:1375-81 (2007)\n            DOI:10.1002/jms.1325\nREFERENCE   PMID:19203648\n  AUTHORS   Miller LD, Russell MH, Alexandre G\n  TITLE     Diversity in bacterial chemotactic responses and niche adaptation.\n  JOURNAL   Adv Appl Microbiol 66:53-75 (2009)\n            DOI:10.1016/S0065-2164(08)00803-4\nREFERENCE   PMID:8760916\n  AUTHORS   Eder S, Shi L, Jensen K, Yamane K, Hulett FM\n  TITLE     A Bacillus subtilis secreted phosphodiesterase/alkaline phosphatase is the product of a Pho regulon gene, phoD.\n  JOURNAL   Microbiology 142 ( Pt 8):2041-7 (1996)\n            DOI:10.1099/13500872-142-8-2041\nREL_PATHWAY map00190  Oxidative phosphorylation\n            map00195  Photosynthesis\n            map00550  Peptidoglycan biosynthesis\n            map00910  Nitrogen metabolism\n            map02030  Bacterial chemotaxis\n            map02040  Flagellar assembly\n            map03070  Bacterial secretion system\n            map04011  MAPK signaling pathway - yeast\n            map04112  Cell cycle - Caulobacter\nKO_PATHWAY  ko02020\n///\n","added":1656608386716},{"name":"map02060","response":"ENTRY       map02060                    Pathway\nNAME        Phosphotransferase system (PTS)\nDESCRIPTION The phosphoenolpyruvate (PEP)-dependent phosphotransferase system (PTS) is a major mechanism used by bacteria for uptake of carbohydrates, particularly hexoses, hexitols, and disaccharides, where the source of energy is from PEP. The PTS consists of two general components, enzyme I (EI) and histidine phosphocarrier protein (HPr), and of membrane-bound sugar specific permeases (enzymes II). Each enzyme II (EII) complex consists of one or two hydrophobic integral membrane domains (domains C and D) and two hydrophilic domains (domains A and B). EII complexes may exist as distinct proteins or as a single multidomain protein. The PTS catalyzes the uptake of carbohydrates and their conversion into their respective phosphoesters during transport. There are four successive phosphoryl transfers in the PTS. Initial autophosphorylation of EI, using PEP as a substrate, is followed by transfer of the phosphoryl group from EI to HPr. EIIA catalyzes the self-phosphoryl transfer from HPr after which the phosphoryl group is transferred to histidine or cysteine residues of EIIB. The sugar is transported through the membrane-bound EIIC and is phosphorylated by the appropriate sugar-specific EIIB.\nCLASS       Environmental Information Processing; Membrane transport\nPATHWAY_MAP map02060  Phosphotransferase system (PTS)\nDBLINKS     GO: 0009401\n            TC: 4.A\nREFERENCE   PMID:11361076\n  AUTHORS   Darbon E, Galinier A, Le Coq D, Deutscher J.\n  TITLE     Phosphotransfer functions mutated Bacillus subtilis HPr-like protein Crh carrying a histidine in the active site.\n  JOURNAL   J Mol Microbiol Biotechnol 3:439-44 (2001)\nREFERENCE   PMID:15060041\n  AUTHORS   Dahl U, Jaeger T, Nguyen BT, Sattler JM, Mayer C.\n  TITLE     Identification of a phosphotransferase system of Escherichia coli required for growth on N-acetylmuramic acid.\n  JOURNAL   J Bacteriol 186:2385-92 (2004)\n            DOI:10.1128/JB.186.8.2385-2392.2004\nREFERENCE   PMID:2117666\n  AUTHORS   Martin-Verstraete I, Debarbouille M, Klier A, Rapoport G\n  TITLE     Levanase operon of Bacillus subtilis includes a fructose-specific phosphotransferase system regulating the expression of the operon.\n  JOURNAL   J Mol Biol 214:657-71 (1990)\n            DOI:10.1016/0022-2836(90)90284-S\nREFERENCE   PMID:12603740\n  AUTHORS   Kristich CJ, Glekas GD, Ordal GW.\n  TITLE     The conserved cytoplasmic module of the transmembrane chemoreceptor McpC mediates carbohydrate chemotaxis in Bacillus subtilis.\n  JOURNAL   Mol Microbiol 47:1353-66 (2003)\n            DOI:10.1046/j.1365-2958.2003.03375.x\nREFERENCE   PMID:14645248\n  AUTHORS   Sampaio MM, Chevance F, Dippel R, Eppler T, Schlegel A, Boos W, Lu YJ, Rock CO.\n  TITLE     Phosphotransferase-mediated transport of the osmolyte 2-O-alpha-mannosyl-D-glycerate in Escherichia coli occurs by the product of the mngA (hrsA) gene and is regulated by the mngR (farR) gene product acting as repressor.\n  JOURNAL   J Biol Chem 279:5537-48 (2004)\n            DOI:10.1074/jbc.M310980200\nREFERENCE   PMID:15608210\n  AUTHORS   Keseler IM, Collado-Vides J, Gama-Castro S, Ingraham J, Paley S, Paulsen IT, Peralta-Gil M, Karp PD.\n  TITLE     EcoCyc: a comprehensive database resource for Escherichia coli.\n  JOURNAL   Nucleic Acids Res 33:D334-7 (2005)\n            DOI:10.1093/nar/gki108\nREFERENCE   PMID:18156259\n  AUTHORS   Mukherjee A, Mammel MK, LeClerc JE, Cebula TA.\n  TITLE     Altered utilization of N-acetyl-D-galactosamine by Escherichia coli O157:H7 from the 2006 spinach outbreak.\n  JOURNAL   J Bacteriol 190:1710-7 (2008)\n            DOI:10.1128/JB.01737-07\nREFERENCE   PMID:10931310\n  AUTHORS   Brinkkotter A, Kloss H, Alpert C, Lengeler JW.\n  TITLE     Pathways for the utilization of N-acetyl-galactosamine and galactosamine in Escherichia coli.\n  JOURNAL   Mol Microbiol 37:125-35 (2000)\n            DOI:10.1046/j.1365-2958.2000.01969.x\nREFERENCE   PMID:11361063\n  AUTHORS   Tchieu JH, Norris V, Edwards JS, Saier MH Jr.\n  TITLE     The complete phosphotranferase system in Escherichia coli.\n  JOURNAL   J Mol Microbiol Biotechnol 3:329-46 (2001)\nREFERENCE   PMID:16233138\n  AUTHORS   Kotrba P, Inui M, Yukawa H.\n  TITLE     Bacterial phosphotransferase system (PTS) in carbohydrate uptake and control of carbon metabolism.\n  JOURNAL   J Biosci Bioeng 92:502-17 (2001)\n            DOI:10.1016/S1389-1723(01)80308-X\nREL_PATHWAY map00051  Fructose and mannose metabolism\nKO_PATHWAY  ko02060\n///\n","added":1656608387548},{"name":"map04911","response":"ENTRY       map04911                    Pathway\nNAME        Insulin secretion\nDESCRIPTION Pancreatic beta cells are specialised endocrine cells that continuously sense the levels of blood sugar and other fuels and, in response, secrete insulin to maintain normal fuel homeostasis. Glucose-induced insulin secretion and its potentiation constitute the principal mechanism of insulin release. Glucose is transported by the glucose transporter (GLUT) into the pancreatic beta-cell. Metabolism of glucose generates ATP, which inhibits ATP-sensitive K+ channels and causes voltage-dependent Ca2+ influx. Elevation of [Ca2+]i triggers exocytotic release of insulin granules. Insulin secretion is further regulated by several hormones and neurotransmitters. Peptide hormones, such as glucagon-like peptide 1 (GLP-1), increase cAMP levels and thereby potentiate insulin secretion via the combined action of PKA and Epac2. Achetylcholine (ACh), a major parasympathetic neurotransmitter, binds to Gq-coupled receptors and activates phospholipase C- (PLC-), and the stimulatory effects involve activation of protein kinase C (PKC), which stimulates exocytosis. In addition, ACh mobilizes intracellular Ca2+ by activation of IP3 receptors.\nCLASS       Organismal Systems; Endocrine system\nPATHWAY_MAP map04911  Insulin secretion\nDBLINKS     GO: 0030073\nREFERENCE   PMID:20551594\n  AUTHORS   Seino S, Shibasaki T, Minami K\n  TITLE     Pancreatic beta-cell signaling: toward better understanding of diabetes and its treatment.\n  JOURNAL   Proc Jpn Acad Ser B Phys Biol Sci 86:563-77 (2010)\n            DOI:10.2183/pjab.86.563\nREFERENCE   PMID:20225132\n  AUTHORS   Jitrapakdee S, Wutthisathapornchai A, Wallace JC, MacDonald MJ\n  TITLE     Regulation of insulin secretion: role of mitochondrial signalling.\n  JOURNAL   Diabetologia 53:1019-32 (2010)\n            DOI:10.1007/s00125-010-1685-0\nREFERENCE   PMID:22974438\n  AUTHORS   Rorsman P, Braun M\n  TITLE     Regulation of insulin secretion in human pancreatic islets.\n  JOURNAL   Annu Rev Physiol 75:155-79 (2013)\n            DOI:10.1146/annurev-physiol-030212-183754\nREFERENCE   PMID:9715374\n  AUTHORS   Jones PM, Persaud SJ\n  TITLE     Protein kinases, protein phosphorylation, and the regulation of insulin secretion from pancreatic beta-cells.\n  JOURNAL   Endocr Rev 19:429-61 (1998)\n            DOI:10.1210/edrv.19.4.0339\nREFERENCE   PMID:21934040\n  AUTHORS   MacDonald PE\n  TITLE     Signal integration at the level of ion channel and exocytotic function in pancreatic beta-cells.\n  JOURNAL   Am J Physiol Endocrinol Metab 301:E1065-9 (2011)\n            DOI:10.1152/ajpendo.00426.2011\nREFERENCE   PMID:9914469\n  AUTHORS   Lang J\n  TITLE     Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion.\n  JOURNAL   Eur J Biochem 259:3-17 (1999)\n            DOI:10.1046/j.1432-1327.1999.00043.x\nREFERENCE   PMID:10605628\n  AUTHORS   Kieffer TJ, Habener JF\n  TITLE     The glucagon-like peptides.\n  JOURNAL   Endocr Rev 20:876-913 (1999)\n            DOI:10.1210/edrv.20.6.0385\nREFERENCE   PMID:19036624\n  AUTHORS   Girard J\n  TITLE     The incretins: from the concept to their use in the treatment of type 2 diabetes. Part A: incretins: concept and physiological functions.\n  JOURNAL   Diabetes Metab 34:550-9 (2008)\n            DOI:10.1016/j.diabet.2008.09.001\nREFERENCE   PMID:15655710\n  AUTHORS   Holz GG\n  TITLE     New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.\n  JOURNAL   Horm Metab Res 36:787-94 (2004)\n            DOI:10.1055/s-2004-826165\nREFERENCE   PMID:15271645\n  AUTHORS   Holst JJ, Gromada J\n  TITLE     Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans.\n  JOURNAL   Am J Physiol Endocrinol Metab 287:E199-206 (2004)\n            DOI:10.1152/ajpendo.00545.2003\nREFERENCE   PMID:17306374\n  AUTHORS   Doyle ME, Egan JM\n  TITLE     Mechanisms of action of glucagon-like peptide 1 in the pancreas.\n  JOURNAL   Pharmacol Ther 113:546-93 (2007)\n            DOI:10.1016/j.pharmthera.2006.11.007\nREFERENCE   PMID:19074620\n  AUTHORS   Kim W, Egan JM\n  TITLE     The role of incretins in glucose homeostasis and diabetes treatment.\n  JOURNAL   Pharmacol Rev 60:470-512 (2008)\n            DOI:10.1124/pr.108.000604\nREFERENCE   PMID:19817800\n  AUTHORS   Seino S, Takahashi H, Fujimoto W, Shibasaki T\n  TITLE     Roles of cAMP signalling in insulin granule exocytosis.\n  JOURNAL   Diabetes Obes Metab 11 Suppl 4:180-8 (2009)\n            DOI:10.1111/j.1463-1326.2009.01108.x\nREFERENCE   PMID:22970724\n  AUTHORS   Tengholm A\n  TITLE     Cyclic AMP dynamics in the pancreatic beta-cell.\n  JOURNAL   Ups J Med Sci 117:355-69 (2012)\n            DOI:10.3109/03009734.2012.724732\nREFERENCE   PMID:14693691\n  AUTHORS   Holz GG\n  TITLE     Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell.\n  JOURNAL   Diabetes 53:5-13 (2004)\n            DOI:10.2337/diabetes.53.1.5\nREFERENCE   PMID:20055708\n  AUTHORS   Gloerich M, Bos JL\n  TITLE     Epac: defining a new mechanism for cAMP action.\n  JOURNAL   Annu Rev Pharmacol Toxicol 50:355-75 (2010)\n            DOI:10.1146/annurev.pharmtox.010909.105714\nREFERENCE   PMID:17084085\n  AUTHORS   Bos JL\n  TITLE     Epac proteins: multi-purpose cAMP targets.\n  JOURNAL   Trends Biochem Sci 31:680-6 (2006)\n            DOI:10.1016/j.tibs.2006.10.002\nREFERENCE   PMID:11522660\n  AUTHORS   Filipsson K, Kvist-Reimer M, Ahren B\n  TITLE     The neuropeptide pituitary adenylate cyclase-activating polypeptide and islet function.\n  JOURNAL   Diabetes 50:1959-69 (2001)\n            DOI:10.2337/diabetes.50.9.1959\nREFERENCE   PMID:19817784\n  AUTHORS   Kebede MA, Alquier T, Latour MG, Poitout V\n  TITLE     Lipid receptors and islet function: therapeutic implications?\n  JOURNAL   Diabetes Obes Metab 11 Suppl 4:10-20 (2009)\n            DOI:10.1111/j.1463-1326.2009.01114.x\nREFERENCE   PMID:19660440\n  AUTHORS   Morgan NG, Dhayal S\n  TITLE     G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell.\n  JOURNAL   Biochem Pharmacol 78:1419-27 (2009)\n            DOI:10.1016/j.bcp.2009.07.020\nREL_PATHWAY map00020  Citrate cycle (TCA cycle)\n            map04020  Calcium signaling pathway\nKO_PATHWAY  ko04911\n///\n","added":1656608388375},{"name":"map04917","response":"ENTRY       map04917                    Pathway\nNAME        Prolactin signaling pathway\nDESCRIPTION Prolactin (PRL) is a polypeptide hormone known to be involved in a wide range of biological functions including osmoregulation, lactation, reproduction, growth and development, endocrinology and metabolism, brain and behavior, and immunomodulation. PRL mediates its action through PRLR, a transmembrane protein of the hematopoietin cytokine receptor superfamily. At the protein level, the long PRLR isoform (long-R) and several short PRLR isoforms (short-R) have been detected. Acting through the long-R, PRL activates many signaling cascades including Jak2/Stat, the major cascade, Src kinase, phosphatidylinositol-3-kinase (PI3K)/AKT, and mitogen-activated protein kinase (MAPK) pathways. PRL cannot activate Jak2/Stat5 through the short-R, but can activate pathways including MAPK and PI3K pathways.\nCLASS       Organismal Systems; Endocrine system\nPATHWAY_MAP map04917  Prolactin signaling pathway\nDBLINKS     GO: 0038161\nREFERENCE   PMID:20149678\n  AUTHORS   Binart N, Bachelot A, Bouilly J\n  TITLE     Impact of prolactin receptor isoforms on reproduction.\n  JOURNAL   Trends Endocrinol Metab 21:362-8 (2010)\n            DOI:10.1016/j.tem.2010.01.008\nREFERENCE   PMID:17307904\n  AUTHORS   Bachelot A, Binart N\n  TITLE     Reproductive role of prolactin.\n  JOURNAL   Reproduction 133:361-9 (2007)\n            DOI:10.1530/REP-06-0299\nREFERENCE   PMID:16231422\n  AUTHORS   Hennighausen L, Robinson GW\n  TITLE     Information networks in the mammary gland.\n  JOURNAL   Nat Rev Mol Cell Biol 6:715-25 (2005)\n            DOI:10.1038/nrm1714\nREFERENCE   PMID:21664429\n  AUTHORS   Bouilly J, Sonigo C, Auffret J, Gibori G, Binart N\n  TITLE     Prolactin signaling mechanisms in ovary.\n  JOURNAL   Mol Cell Endocrinol 356:80-7 (2012)\n            DOI:10.1016/j.mce.2011.05.004\nREFERENCE   PMID:18219564\n  AUTHORS   Oakes SR, Rogers RL, Naylor MJ, Ormandy CJ\n  TITLE     Prolactin regulation of mammary gland development.\n  JOURNAL   J Mammary Gland Biol Neoplasia 13:13-28 (2008)\n            DOI:10.1007/s10911-008-9069-5\nREFERENCE   PMID:12670737\n  AUTHORS   Frasor J, Gibori G\n  TITLE     Prolactin regulation of estrogen receptor expression.\n  JOURNAL   Trends Endocrinol Metab 14:118-23 (2003)\n            DOI:10.1016/S1043-2760(03)00030-4\nREFERENCE   PMID:9626554\n  AUTHORS   Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA\n  TITLE     Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.\n  JOURNAL   Endocr Rev 19:225-68 (1998)\n            DOI:10.1210/edrv.19.3.0334\nREFERENCE   PMID:17535875\n  AUTHORS   Weinhaus AJ, Stout LE, Bhagroo NV, Brelje TC, Sorenson RL\n  TITLE     Regulation of glucokinase in pancreatic islets by prolactin: a mechanism for increasing glucose-stimulated insulin secretion during pregnancy.\n  JOURNAL   J Endocrinol 193:367-81 (2007)\n            DOI:10.1677/JOE-07-0043\nREFERENCE   PMID:18601698\n  AUTHORS   Grattan DR, Kokay IC\n  TITLE     Prolactin: a pleiotropic neuroendocrine hormone.\n  JOURNAL   J Neuroendocrinol 20:752-63 (2008)\n            DOI:10.1111/j.1365-2826.2008.01736.x\nREFERENCE   PMID:9475379\n  AUTHORS   Yu-Lee LY, Luo G, Book ML, Morris SM\n  TITLE     Lactogenic hormone signal transduction.\n  JOURNAL   Biol Reprod 58:295-301 (1998)\n            DOI:10.1095/biolreprod58.2.295\nREFERENCE   PMID:11606470\n  AUTHORS   Tam SP, Lau P, Djiane J, Hilton DJ, Waters MJ\n  TITLE     Tissue-specific induction of SOCS gene expression by PRL.\n  JOURNAL   Endocrinology 142:5015-26 (2001)\n            DOI:10.1210/endo.142.11.8466\nREFERENCE   PMID:17975019\n  AUTHORS   Halperin J, Devi SY, Elizur S, Stocco C, Shehu A, Rebourcet D, Unterman TG, Leslie ND, Le J, Binart N, Gibori G\n  TITLE     Prolactin signaling through the short form of its receptor represses forkhead transcription factor FOXO3 and its target gene galt causing a severe ovarian defect.\n  JOURNAL   Mol Endocrinol 22:513-22 (2008)\n            DOI:10.1210/me.2007-0399\nREFERENCE   PMID:17519353\n  AUTHORS   Sakamoto K, Creamer BA, Triplett AA, Wagner KU\n  TITLE     The Janus kinase 2 is required for expression and nuclear accumulation of cyclin D1 in proliferating mammary epithelial cells.\n  JOURNAL   Mol Endocrinol 21:1877-92 (2007)\n            DOI:10.1210/me.2006-0316\nREFERENCE   PMID:16677418\n  AUTHORS   Oakes SR, Hilton HN, Ormandy CJ\n  TITLE     The alveolar switch: coordinating the proliferative cues and cell fate decisions that drive the formation of lobuloalveoli from ductal epithelium.\n  JOURNAL   Breast Cancer Res 8:207 (2006)\n            DOI:10.1186/bcr1411\nREL_PATHWAY map04010  MAPK signaling pathway\n            map04151  PI3K-Akt signaling pathway\n            map04630  JAK-STAT signaling pathway\n            map04728  Dopaminergic synapse\n            map04911  Insulin secretion\n            map04913  Ovarian steroidogenesis\n            map04915  Estrogen signaling pathway\nKO_PATHWAY  ko04917\n///\n","added":1656608389210},{"name":"map04918","response":"ENTRY       map04918                    Pathway\nNAME        Thyroid hormone synthesis\nDESCRIPTION Thyroid hormones triiodothyronine (T3) and thyroxine (T4) are essential for normal development, growth and metabolic homeostasis in all vertebrates, and synthesized in the thyroid gland. The functional unit of the thyroid gland is the follicle, delimited by a monolayer of thyrocytes. Polarized thyrocytes surround the follicular lumen; with their basal and apical surfaces facing the bloodstream and the lumen, respectively. To synthesize thyroid hormones, thyrocytes take up iodide at their basal side and concentrate it into the lumen. They also secrete in this lumen the specialized protein thyroglobulin (TG) which serves as a store for the hormones. In the follicular lumen oxidation of iodine, iodination of tyrosines (MIT, 3-monoiodotyrosine; DIT, 3,5-diiodotyrosine) and coupling of iodotyrosines takes place on tyrosine residues in TG, resulting in T3 and T4 synthesis. Iodinated TG is resorbed through the apical membrane and degraded to form T3/T4 in lysosomes; the T3/T4 is then secreted through the basal membrane.\nCLASS       Organismal Systems; Endocrine system\nPATHWAY_MAP map04918  Thyroid hormone synthesis\nDBLINKS     GO: 0006590\nREFERENCE   PMID:21448409\n  AUTHORS   Ahad F, Ganie SA\n  TITLE     Iodine, Iodine metabolism and Iodine deficiency disorders revisited.\n  JOURNAL   Indian J Endocrinol Metab 14:13-7 (2010)\nREFERENCE   PMID:11717564\n  AUTHORS   Gillam MP, Kopp P\n  TITLE     Genetic defects in thyroid hormone synthesis.\n  JOURNAL   Curr Opin Pediatr 13:364-72 (2001)\n            DOI:10.1097/00008480-200108000-00014\nREFERENCE   PMID:20167242\n  AUTHORS   Rokita SE, Adler JM, McTamney PM, Watson JA Jr\n  TITLE     Efficient use and recycling of the micronutrient iodide in mammals.\n  JOURNAL   Biochimie 92:1227-35 (2010)\n            DOI:10.1016/j.biochi.2010.02.013\nREFERENCE   PMID:21683758\n  AUTHORS   Massart C, Hoste C, Virion A, Ruf J, Dumont JE, Van Sande J\n  TITLE     Cell biology of H2O2 generation in the thyroid: investigation of the control of dual oxidases (DUOX) activity in intact ex vivo thyroid tissue and cell lines.\n  JOURNAL   Mol Cell Endocrinol 343:32-44 (2011)\n            DOI:10.1016/j.mce.2011.05.047\nREFERENCE   PMID:19196800\n  AUTHORS   Bizhanova A, Kopp P\n  TITLE     Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid.\n  JOURNAL   Endocrinology 150:1084-90 (2009)\n            DOI:10.1210/en.2008-1437\nREFERENCE   PMID:21986207\n  AUTHORS   Fong P\n  TITLE     Thyroid iodide efflux: a team effort?\n  JOURNAL   J Physiol 589:5929-39 (2011)\n            DOI:10.1113/jphysiol.2011.218594\nREFERENCE   PMID:17666482\n  AUTHORS   Song Y, Driessens N, Costa M, De Deken X, Detours V, Corvilain B, Maenhaut C, Miot F, Van Sande J, Many MC, Dumont JE\n  TITLE     Roles of hydrogen peroxide in thyroid physiology and disease.\n  JOURNAL   J Clin Endocrinol Metab 92:3764-73 (2007)\n            DOI:10.1210/jc.2007-0660\nREFERENCE   PMID:11137035\n  AUTHORS   Kohn LD, Suzuki K, Nakazato M, Royaux I, Green ED\n  TITLE     Effects of thyroglobulin and pendrin on iodide flux through the thyrocyte.\n  JOURNAL   Trends Endocrinol Metab 12:10-6 (2001)\n            DOI:10.1016/S1043-2760(00)00337-4\nREFERENCE   PMID:11029276\n  AUTHORS   Marino M, McCluskey RT\n  TITLE     Role of thyroglobulin endocytic pathways in the control of thyroid hormone release.\n  JOURNAL   Am J Physiol Cell Physiol 279:C1295-306 (2000)\n            DOI:10.1152/ajpcell.2000.279.5.C1295\nREFERENCE   PMID:16870170\n  AUTHORS   Rivolta CM, Targovnik HM\n  TITLE     Molecular advances in thyroglobulin disorders.\n  JOURNAL   Clin Chim Acta 374:8-24 (2006)\n            DOI:10.1016/j.cca.2006.05.043\nREFERENCE   PMID:10893432\n  AUTHORS   De La Vieja A, Dohan O, Levy O, Carrasco N\n  TITLE     Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology.\n  JOURNAL   Physiol Rev 80:1083-105 (2000)\n            DOI:10.1152/physrev.2000.80.3.1083\nREFERENCE   PMID:20407074\n  AUTHORS   Ohye H, Sugawara M\n  TITLE     Dual oxidase, hydrogen peroxide and thyroid diseases.\n  JOURNAL   Exp Biol Med (Maywood) 235:424-33 (2010)\n            DOI:10.1258/ebm.2009.009241\nREFERENCE   PMID:20093166\n  AUTHORS   Targovnik HM, Esperante SA, Rivolta CM\n  TITLE     Genetics and phenomics of hypothyroidism and goiter due to thyroglobulin mutations.\n  JOURNAL   Mol Cell Endocrinol 322:44-55 (2010)\n            DOI:10.1016/j.mce.2010.01.009\nREFERENCE   PMID:20122987\n  AUTHORS   Grasberger H\n  TITLE     Defects of thyroidal hydrogen peroxide generation in congenital hypothyroidism.\n  JOURNAL   Mol Cell Endocrinol 322:99-106 (2010)\n            DOI:10.1016/j.mce.2010.01.029\nREFERENCE   PMID:9086577\n  AUTHORS   Arvan P, Kim PS, Kuliawat R, Prabakaran D, Muresan Z, Yoo SE, Abu Hossain S\n  TITLE     Intracellular protein transport to the thyrocyte plasma membrane: potential implications for thyroid physiology.\n  JOURNAL   Thyroid 7:89-105 (1997)\n            DOI:10.1089/thy.1997.7.89\nREFERENCE   PMID:15611820\n  AUTHORS   Vono-Toniolo J, Kopp P\n  TITLE     Thyroglobulin gene mutations and other genetic defects associated with congenital hypothyroidism.\n  JOURNAL   Arq Bras Endocrinol Metabol 48:70-82 (2004)\n            DOI:10.1590/S0004-27302004000100009\nREFERENCE   PMID:23438835\n  AUTHORS   Vitale G, Salvioli S, Franceschi C\n  TITLE     Oxidative stress and the ageing endocrine system.\n  JOURNAL   Nat Rev Endocrinol 9:228-40 (2013)\n            DOI:10.1038/nrendo.2013.29\nREFERENCE   PMID:20378719\n  AUTHORS   Calebiro D, Nikolaev VO, Lohse MJ\n  TITLE     Imaging of persistent cAMP signaling by internalized G protein-coupled receptors.\n  JOURNAL   J Mol Endocrinol 45:1-8 (2010)\n            DOI:10.1677/JME-10-0014\nREFERENCE   PMID:9538302\n  AUTHORS   Newman CM, Price A, Davies DW, Gray TA, Weetman AP\n  TITLE     Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy.\n  JOURNAL   Heart 79:121-7 (1998)\n            DOI:10.1136/hrt.79.2.121\nREL_PATHWAY map00350  Tyrosine metabolism\n            map00480  Glutathione metabolism\n            map04020  Calcium signaling pathway\n            map04142  Lysosome\n            map04146  Peroxisome\n            map04530  Tight junction\nKO_PATHWAY  ko04918\n///\n","added":1656608390030},{"name":"map04931","response":"ENTRY       map04931                    Pathway\nNAME        Insulin resistance\nDESCRIPTION Insulin resistance is a condition where cells become resistant to the effects of insulin. It is often found in people with health disorders, including obesity, type 2 diabetes mellitus, non-alcoholic fatty liver disease, and cardiovascular diseases. In this diagram multiple mechanisms underlying insulin resistance are shown: (a) increased phosphorylation of IRS (insulin receptor substrate) protein through serine/threonine kinases, such as JNK1 and IKKB, and protein kinase C, (b) increased IRS-1 proteasome degradation via mTOR signaling pathway, (c) decreased activation of signaling molecules including PI3K and AKT, (d) increase in activity of phosphatases including PTPs, PTEN, and PP2A. Regulatory actions such as oxidative stress, mitochondrial dysfunction, accumulation of intracellular lipid derivatives (diacylglycrol and ceramides), and inflammation (via IL-6 and TNFA) contribute to these mechanisms. Consequently, insulin resistance causes reduced GLUT4 translocation, resulting in glucose takeup and glycogen synthesis in skeletal muscle as well as increased hepatic gluconeogenesis and decreased glycogen synthesis in liver. At the bottom of the diagram, interplay between O-GlcNAcylation and serine/threonine phosphorylation is shown. Studies suggested that elevated O-GlcNAc level was correlated to high glucose-induced insulin resistance. Donor UDP-GlcNAc is induced through hexosamine biosynthesis pathway and added to proteins by O-GlcNAc transferase. Elevation of O-GlcNAc modification alters phosphorylation and function of key insulin signaling proteins including IRS-1, PI3K, PDK1, Akt and other transcription factor and cofactors, resulting in the attenuation of insulin signaling cascade.\nCLASS       Human Diseases; Endocrine and metabolic disease\nPATHWAY_MAP map04931  Insulin resistance\nREFERENCE   PMID:22360800\n  AUTHORS   Martins AR, Nachbar RT, Gorjao R, Vinolo MA, Festuccia WT, Lambertucci RH, Cury-Boaventura MF, Silveira LR, Curi R, Hirabara SM\n  TITLE     Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function.\n  JOURNAL   Lipids Health Dis 11:30 (2012)\n            DOI:10.1186/1476-511X-11-30\nREFERENCE   PMID:12765939\n  AUTHORS   Bouzakri K, Roques M, Gual P, Espinosa S, Guebre-Egziabher F, Riou JP, Laville M, Le Marchand-Brustel Y, Tanti JF, Vidal H\n  TITLE     Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes.\n  JOURNAL   Diabetes 52:1319-25 (2003)\n            DOI:10.2337/diabetes.52.6.1319\nREFERENCE   PMID:20526383\n  AUTHORS   Choi K, Kim YB\n  TITLE     Molecular mechanism of insulin resistance in obesity and type 2 diabetes.\n  JOURNAL   Korean J Intern Med 25:119-29 (2010)\n            DOI:10.3904/kjim.2010.25.2.119\nREFERENCE   PMID:7666792\n  AUTHORS   Ahmad F, Goldstein BJ\n  TITLE     Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus.\n  JOURNAL   Metabolism 44:1175-84 (1995)\n            DOI:10.1016/0026-0495(95)90012-8\nREFERENCE   PMID:15166380\n  AUTHORS   George S, Rochford JJ, Wolfrum C, Gray SL, Schinner S, Wilson JC, Soos MA, Murgatroyd PR, Williams RM, Acerini CL, Dunger DB, Barford D, Umpleby AM, Wareham NJ, Davies HA, Schafer AJ, Stoffel M, O'Rahilly S, Barroso I\n  TITLE     A family with severe insulin resistance and diabetes due to a mutation in AKT2.\n  JOURNAL   Science 304:1325-8 (2004)\n            DOI:10.1126/science.1096706\nREFERENCE   PMID:22675355\n  AUTHORS   Snel M, Jonker JT, Schoones J, Lamb H, de Roos A, Pijl H, Smit JW, Meinders AE, Jazet IM\n  TITLE     Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions.\n  JOURNAL   Int J Endocrinol 2012:983814 (2012)\n            DOI:10.1155/2012/983814\nREFERENCE   PMID:17130651\n  AUTHORS   Morino K, Petersen KF, Shulman GI\n  TITLE     Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.\n  JOURNAL   Diabetes 55 Suppl 2:S9-S15 (2006)\n            DOI:10.2337/db06-S002\nREFERENCE   PMID:16186396\n  AUTHORS   Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK\n  TITLE     Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.\n  JOURNAL   Diabetes 54:2939-45 (2005)\n            DOI:10.2337/diabetes.54.10.2939\nREFERENCE   PMID:18309108\n  AUTHORS   Kim JA, Wei Y, Sowers JR\n  TITLE     Role of mitochondrial dysfunction in insulin resistance.\n  JOURNAL   Circ Res 102:401-14 (2008)\n            DOI:10.1161/CIRCRESAHA.107.165472\nREFERENCE   PMID:17141630\n  AUTHORS   Steinberg GR, Michell BJ, van Denderen BJ, Watt MJ, Carey AL, Fam BC, Andrikopoulos S, Proietto J, Gorgun CZ, Carling D, Hotamisligil GS, Febbraio MA, Kay TW, Kemp BE\n  TITLE     Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling.\n  JOURNAL   Cell Metab 4:465-74 (2006)\n            DOI:10.1016/j.cmet.2006.11.005\nREFERENCE   PMID:9886945\n  AUTHORS   Ruderman NB, Saha AK, Vavvas D, Witters LA\n  TITLE     Malonyl-CoA, fuel sensing, and insulin resistance.\n  JOURNAL   Am J Physiol 276:E1-E18 (1999)\n            DOI:10.1152/ajpendo.1999.276.1.E1\nREFERENCE   PMID:8048519\n  AUTHORS   Saha AK, Kurowski TG, Colca JR, Ruderman NB\n  TITLE     Lipid abnormalities in tissues of the KKAy mouse: effects of pioglitazone on malonyl-CoA and diacylglycerol.\n  JOURNAL   Am J Physiol 267:E95-101 (1994)\n            DOI:10.1152/ajpendo.1994.267.1.E95\nREFERENCE   PMID:22677645\n  AUTHORS   Blachnio-Zabielska AU, Koutsari C, Tchkonia T, Jensen MD\n  TITLE     Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance.\n  JOURNAL   Obesity (Silver Spring) 20:2341-7 (2012)\n            DOI:10.1038/oby.2012.126\nREFERENCE   PMID:16364488\n  AUTHORS   Larter CZ, Farrell GC\n  TITLE     Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?\n  JOURNAL   J Hepatol 44:253-61 (2006)\n            DOI:10.1016/j.jhep.2005.11.030\nREFERENCE   PMID:15107844\n  AUTHORS   Koo SH, Satoh H, Herzig S, Lee CH, Hedrick S, Kulkarni R, Evans RM, Olefsky J, Montminy M\n  TITLE     PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3.\n  JOURNAL   Nat Med 10:530-4 (2004)\n            DOI:10.1038/nm1044\nREFERENCE   PMID:20466550\n  AUTHORS   Slawson C, Copeland RJ, Hart GW\n  TITLE     O-GlcNAc signaling: a metabolic link between diabetes and cancer?\n  JOURNAL   Trends Biochem Sci 35:547-55 (2010)\n            DOI:10.1016/j.tibs.2010.04.005\nREFERENCE   PMID:23647930\n  AUTHORS   Ruan HB, Singh JP, Li MD, Wu J, Yang X\n  TITLE     Cracking the O-GlcNAc code in metabolism.\n  JOURNAL   Trends Endocrinol Metab 24:301-9 (2013)\n            DOI:10.1016/j.tem.2013.02.002\nREFERENCE   PMID:16756496\n  AUTHORS   Muoio DM, Newgard CB\n  TITLE     Obesity-related derangements in metabolic regulation.\n  JOURNAL   Annu Rev Biochem 75:367-401 (2006)\n            DOI:10.1146/annurev.biochem.75.103004.142512\nREFERENCE   PMID:10923637\n  AUTHORS   Itani SI, Zhou Q, Pories WJ, MacDonald KG, Dohm GL\n  TITLE     Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity.\n  JOURNAL   Diabetes 49:1353-8 (2000)\n            DOI:10.2337/diabetes.49.8.1353\nREL_PATHWAY map00010  Glycolysis / Gluconeogenesis\n            map00061  Fatty acid biosynthesis\n            map00514  Other types of O-glycan biosynthesis\n            map00520  Amino sugar and nucleotide sugar metabolism\n            map04150  mTOR signaling pathway\n            map04151  PI3K-Akt signaling pathway\n            map04668  TNF signaling pathway\n            map04910  Insulin signaling pathway\nKO_PATHWAY  ko04931\n///\n","added":1656608390867},{"name":"map04973","response":"ENTRY       map04973                    Pathway\nNAME        Carbohydrate digestion and absorption\nDESCRIPTION Dietary carbohydrate in humans and omnivorous animals is a major nutrient. The carbohydrates that we ingest vary from the lactose in milk to complex carbohydrates. These carbohydrates are digested to monosaccharides, mostly glucose, galactose and fructose, prior to absorption in the small intestine. Glucose and galactose are initially transported into the enterocyte by SGLT1 located in the apical brush border membrane and then exit through the basolateral membrane by either GLUT2 or exocytosis. In a new model of intestinal glucose absorption, transport by SGLT1 induces rapid insertion and activation of GLUT2 in the brush border membrane by a PKC betaII-dependent mechanism. Moreover, trafficking of apical GLUT2 is rapidly up-regulated by glucose and artificial sweeteners, which act through T1R2 + T1R3/alpha-gustducin to activate PLC-beta2 and PKC-beta II. Fructose is transported separately by the brush border GLUT5 and then released out of the enterocyte into the blood by GLUT2.\nCLASS       Organismal Systems; Digestive system\nPATHWAY_MAP map04973  Carbohydrate digestion and absorption\nDBLINKS     GO: 0044245 0001951\nREFERENCE   PMID:16586532\n  AUTHORS   Drozdowski LA, Thomson AB\n  TITLE     Intestinal sugar transport.\n  JOURNAL   World J Gastroenterol 12:1657-70 (2006)\n            DOI:10.3748/wjg.v12.i11.1657\nREFERENCE   PMID:14642859\n  AUTHORS   Wright EM, Martin MG, Turk E\n  TITLE     Intestinal absorption in health and disease--sugars.\n  JOURNAL   Best Pract Res Clin Gastroenterol 17:943-56 (2003)\n            DOI:10.1016/S1521-6918(03)00107-0\nREFERENCE   PMID:18393659\n  AUTHORS   Kellett GL, Brot-Laroche E, Mace OJ, Leturque A\n  TITLE     Sugar absorption in the intestine: the role of GLUT2.\n  JOURNAL   Annu Rev Nutr 28:35-54 (2008)\n            DOI:10.1146/annurev.nutr.28.061807.155518\nREFERENCE   PMID:19001049\n  AUTHORS   Mace OJ, Lister N, Morgan E, Shepherd E, Affleck J, Helliwell P, Bronk JR, Kellett GL, Meredith D, Boyd R, Pieri M, Bailey PD, Pettcrew R, Foley D\n  TITLE     An energy supply network of nutrient absorption coordinated by calcium and T1R taste receptors in rat small intestine.\n  JOURNAL   J Physiol 587:195-210 (2009)\n            DOI:10.1113/jphysiol.2008.159616\nREFERENCE   PMID:16186415\n  AUTHORS   Kellett GL, Brot-Laroche E\n  TITLE     Apical GLUT2: a major pathway of intestinal sugar absorption.\n  JOURNAL   Diabetes 54:3056-62 (2005)\n            DOI:10.2337/diabetes.54.10.3056\nREFERENCE   PMID:20522896\n  AUTHORS   Goodman BE\n  TITLE     Insights into digestion and absorption of major nutrients in humans.\n  JOURNAL   Adv Physiol Educ 34:44-53 (2010)\n            DOI:10.1152/advan.00094.2009\nREFERENCE   PMID:17222166\n  AUTHORS   Wright EM, Hirayama BA, Loo DF\n  TITLE     Active sugar transport in health and disease.\n  JOURNAL   J Intern Med 261:32-43 (2007)\n            DOI:10.1111/j.1365-2796.2006.01746.x\nREFERENCE   PMID:12512027\n  AUTHORS   Santer R, Hillebrand G, Steinmann B, Schaub J\n  TITLE     Intestinal glucose transport: evidence for a membrane traffic-based pathway in humans.\n  JOURNAL   Gastroenterology 124:34-9 (2003)\n            DOI:10.1053/gast.2003.50009\nREFERENCE   PMID:11562503\n  AUTHORS   Stumpel F, Burcelin R, Jungermann K, Thorens B\n  TITLE     Normal kinetics of intestinal glucose absorption in the absence of GLUT2: evidence for a transport pathway requiring glucose phosphorylation and transfer into the endoplasmic reticulum.\n  JOURNAL   Proc Natl Acad Sci U S A 98:11330-5 (2001)\n            DOI:10.1073/pnas.211357698\nREFERENCE   PMID:15546855\n  AUTHORS   Wright EM, Loo DD, Hirayama BA, Turk E\n  TITLE     Surprising versatility of Na+-glucose cotransporters: SLC5.\n  JOURNAL   Physiology (Bethesda) 19:370-6 (2004)\n            DOI:10.1152/physiol.00026.2004\nREFERENCE   PMID:12750891\n  AUTHORS   Uldry M, Thorens B\n  TITLE     The SLC2 family of facilitated hexose and polyol transporters.\n  JOURNAL   Pflugers Arch 447:480-9 (2004)\n            DOI:10.1007/s00424-003-1085-0\nREFERENCE   PMID:7555019\n  AUTHORS   Van Beers EH, Buller HA, Grand RJ, Einerhand AW, Dekker J\n  TITLE     Intestinal brush border glycohydrolases: structure, function, and development.\n  JOURNAL   Crit Rev Biochem Mol Biol 30:197-262 (1995)\n            DOI:10.3109/10409239509085143\nREFERENCE   PMID:5089892\n  AUTHORS   Marsh MN\n  TITLE     Digestive-absorptive functions of the enterocyte.\n  JOURNAL   Ann R Coll Surg Engl 48:356-68 (1971)\nREFERENCE   PMID:12583961\n  AUTHORS   Guarner F, Malagelada JR\n  TITLE     Gut flora in health and disease.\n  JOURNAL   Lancet 361:512-9 (2003)\n            DOI:10.1016/S0140-6736(03)12489-0\nREFERENCE   PMID:11427691\n  AUTHORS   Topping DL, Clifton PM\n  TITLE     Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides.\n  JOURNAL   Physiol Rev 81:1031-64 (2001)\n            DOI:10.1152/physrev.2001.81.3.1031\nREL_PATHWAY map04530  Tight junction\n            map04742  Taste transduction\n            map04970  Salivary secretion\n            map04972  Pancreatic secretion\nKO_PATHWAY  ko04973\n///\n","added":1656608391696},{"name":"map05230","response":"ENTRY       map05230                    Pathway\nNAME        Central carbon metabolism in cancer\nDESCRIPTION Malignant transformation of cells requires specific adaptations of cellular metabolism to support growth and survival. In the early twentieth century, Otto Warburg established that there are fundamental differences in the central metabolic pathways operating in malignant tissue. He showed that cancer cells consume a large amount of glucose, maintain high rate of glycolysis and convert a majority of glucose into lactic acid even under normal oxygen concentrations (Warburg's Effects). More recently, it has been recognized that the 'Warburg effect' encompasses a similarly increased utilization of glutamine. From the intermediate molecules provided by enhanced glycolysis and glutaminolysis, cancer cells synthesize most of the macromolecules required for the duplication of their biomass and genome. These cancer-specific alterations represent a major consequence of genetic mutations and the ensuing changes of signalling pathways in cancer cells. Three transcription factors, c-MYC, HIF-1 and p53, are key regulators and coordinate regulation of cancer metabolism in different ways, and many other oncogenes and tumor suppressor genes cluster along the signaling pathways that regulate c-MYC, HIF-1 and p53.\nCLASS       Human Diseases; Cancer: overview\nPATHWAY_MAP map05230  Central carbon metabolism in cancer\nREFERENCE   PMID:23279446\n  AUTHORS   Soga T\n  TITLE     Cancer metabolism: key players in metabolic reprogramming.\n  JOURNAL   Cancer Sci 104:275-81 (2013)\n            DOI:10.1111/cas.12085\nREFERENCE   PMID:19460998\n  AUTHORS   Vander Heiden MG, Cantley LC, Thompson CB\n  TITLE     Understanding the Warburg effect: the metabolic requirements of cell proliferation.\n  JOURNAL   Science 324:1029-33 (2009)\n            DOI:10.1126/science.1160809\nREFERENCE   PMID:23071355\n  AUTHORS   Teicher BA, Linehan WM, Helman LJ\n  TITLE     Targeting cancer metabolism.\n  JOURNAL   Clin Cancer Res 18:5537-45 (2012)\n            DOI:10.1158/1078-0432.CCR-12-2587\nREFERENCE   PMID:21127244\n  AUTHORS   Levine AJ, Puzio-Kuter AM\n  TITLE     The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes.\n  JOURNAL   Science 330:1340-4 (2010)\n            DOI:10.1126/science.1193494\nREFERENCE   PMID:24079832\n  AUTHORS   Amoedo ND, Valencia JP, Rodrigues MF, Galina A, Rumjanek FD\n  TITLE     How does the metabolism of tumour cells differ from that of normal cells.\n  JOURNAL   Biosci Rep 33:e00080 (2013)\n            DOI:10.1042/BSR20130066\nREFERENCE   PMID:21258394\n  AUTHORS   Cairns RA, Harris IS, Mak TW\n  TITLE     Regulation of cancer cell metabolism.\n  JOURNAL   Nat Rev Cancer 11:85-95 (2011)\n            DOI:10.1038/nrc2981\nREFERENCE   PMID:22237205\n  AUTHORS   Munoz-Pinedo C, El Mjiyad N, Ricci JE\n  TITLE     Cancer metabolism: current perspectives and future directions.\n  JOURNAL   Cell Death Dis 3:e248 (2012)\n            DOI:10.1038/cddis.2011.123\nREFERENCE   PMID:22156302\n  AUTHORS   Cairns RA, Harris I, McCracken S, Mak TW\n  TITLE     Cancer cell metabolism.\n  JOURNAL   Cold Spring Harb Symp Quant Biol 76:299-311 (2011)\n            DOI:10.1101/sqb.2011.76.012856\nREFERENCE   PMID:18538731\n  AUTHORS   Kroemer G, Pouyssegur J\n  TITLE     Tumor cell metabolism: cancer's Achilles' heel.\n  JOURNAL   Cancer Cell 13:472-82 (2008)\n            DOI:10.1016/j.ccr.2008.05.005\nREFERENCE   PMID:18177721\n  AUTHORS   DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB\n  TITLE     The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.\n  JOURNAL   Cell Metab 7:11-20 (2008)\n            DOI:10.1016/j.cmet.2007.10.002\nREFERENCE   PMID:21508971\n  AUTHORS   Koppenol WH, Bounds PL, Dang CV\n  TITLE     Otto Warburg's contributions to current concepts of cancer metabolism.\n  JOURNAL   Nat Rev Cancer 11:325-37 (2011)\n            DOI:10.1038/nrc3038\nREFERENCE   PMID:21801601\n  AUTHORS   Fogg VC, Lanning NJ, Mackeigan JP\n  TITLE     Mitochondria in cancer: at the crossroads of life and death.\n  JOURNAL   Chin J Cancer 30:526-39 (2011)\n            DOI:10.5732/cjc.011.10018\nREFERENCE   PMID:16982728\n  AUTHORS   Kim JW, Dang CV\n  TITLE     Cancer's molecular sweet tooth and the Warburg effect.\n  JOURNAL   Cancer Res 66:8927-30 (2006)\n            DOI:10.1158/0008-5472.CAN-06-1501\nREFERENCE   PMID:18766298\n  AUTHORS   Yeung SJ, Pan J, Lee MH\n  TITLE     Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer.\n  JOURNAL   Cell Mol Life Sci 65:3981-99 (2008)\n            DOI:10.1007/s00018-008-8224-x\nREFERENCE   PMID:23897900\n  AUTHORS   Li B, Simon MC\n  TITLE     Molecular Pathways: Targeting MYC-induced metabolic reprogramming and oncogenic stress in cancer.\n  JOURNAL   Clin Cancer Res 19:5835-41 (2013)\n            DOI:10.1158/1078-0432.CCR-12-3629\nREFERENCE   PMID:22307140\n  AUTHORS   Shen L, Sun X, Fu Z, Yang G, Li J, Yao L\n  TITLE     The fundamental role of the p53 pathway in tumor metabolism and its implication in tumor therapy.\n  JOURNAL   Clin Cancer Res 18:1561-7 (2012)\n            DOI:10.1158/1078-0432.CCR-11-3040\nREFERENCE   PMID:19270154\n  AUTHORS   Jones RG, Thompson CB\n  TITLE     Tumor suppressors and cell metabolism: a recipe for cancer growth.\n  JOURNAL   Genes Dev 23:537-48 (2009)\n            DOI:10.1101/gad.1756509\nREFERENCE   PMID:21340684\n  AUTHORS   Maddocks OD, Vousden KH\n  TITLE     Metabolic regulation by p53.\n  JOURNAL   J Mol Med (Berl) 89:237-45 (2011)\n            DOI:10.1007/s00109-011-0735-5\nREFERENCE   PMID:22750268\n  AUTHORS   Chen JQ, Russo J\n  TITLE     Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells.\n  JOURNAL   Biochim Biophys Acta 1826:370-84 (2012)\n            DOI:10.1016/j.bbcan.2012.06.004\nREFERENCE   PMID:20520704\n  AUTHORS   Kaelin WG Jr, Thompson CB\n  TITLE     Q&amp;A: Cancer: clues from cell metabolism.\n  JOURNAL   Nature 465:562-4 (2010)\n            DOI:10.1038/465562a\nREFERENCE   PMID:24113830\n  AUTHORS   Galluzzi L, Kepp O, Vander Heiden MG, Kroemer G\n  TITLE     Metabolic targets for cancer therapy.\n  JOURNAL   Nat Rev Drug Discov 12:829-46 (2013)\n            DOI:10.1038/nrd4145\nREFERENCE   PMID:24738035\n  AUTHORS   Phan LM, Yeung SC, Lee MH\n  TITLE     Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies.\n  JOURNAL   Cancer Biol Med 11:1-19 (2014)\n            DOI:10.7497/j.issn.2095-3941.2014.01.001\nREFERENCE   PMID:22101401\n  AUTHORS   Icard P, Poulain L, Lincet H\n  TITLE     Understanding the central role of citrate in the metabolism of cancer cells.\n  JOURNAL   Biochim Biophys Acta 1825:111-6 (2012)\n            DOI:10.1016/j.bbcan.2011.10.007\nREFERENCE   PMID:22349059\n  AUTHORS   Daye D, Wellen KE\n  TITLE     Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis.\n  JOURNAL   Semin Cell Dev Biol 23:362-9 (2012)\n            DOI:10.1016/j.semcdb.2012.02.002\nREFERENCE   PMID:23018234\n  AUTHORS   Chiarugi A, Dolle C, Felici R, Ziegler M\n  TITLE     The NAD metabolome--a key determinant of cancer cell biology.\n  JOURNAL   Nat Rev Cancer 12:741-52 (2012)\n            DOI:10.1038/nrc3340\nREFERENCE   PMID:24398961\n  AUTHORS   Guarente L\n  TITLE     The many faces of sirtuins: Sirtuins and the Warburg effect.\n  JOURNAL   Nat Med 20:24-5 (2014)\n            DOI:10.1038/nm.3438\nREFERENCE   PMID:15916903\n  AUTHORS   Fuchs BC, Bode BP\n  TITLE     Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?\n  JOURNAL   Semin Cancer Biol 15:254-66 (2005)\n            DOI:10.1016/j.semcancer.2005.04.005\nREL_PATHWAY map00010  Glycolysis / Gluconeogenesis\n            map00020  Citrate cycle (TCA cycle)\n            map00030  Pentose phosphate pathway\n            map00190  Oxidative phosphorylation\n            map00250  Alanine, aspartate and glutamate metabolism\n            map00260  Glycine, serine and threonine metabolism\n            map00330  Arginine and proline metabolism\n            map01212  Fatty acid metabolism\n            map04010  MAPK signaling pathway\n            map04066  HIF-1 signaling pathway\n            map04150  mTOR signaling pathway\n            map04151  PI3K-Akt signaling pathway\nKO_PATHWAY  ko05230\n///\n","added":1656608392513},{"name":"map05415","response":"ENTRY       map05415                    Pathway\nNAME        Diabetic cardiomyopathy\nDESCRIPTION Diabetic cardiomyopathy has been defined as left ventricular dysfunction that occurs among patients with diabetes mellitus independent of a recognized cause such as coronary artery disease or hypertension. The pathogenesis of diabetic cardiomyopathy broadly involves hyperglycemia, increased circulating fatty acids, and insulin resistance contributing to reactive oxygen species (ROS) generation, mitochondrial dysfunction, impaired calcium metabolism, Renin-Angiotensin System (RAS) activation, and altered substrate metabolism. These effects result in cardiac fibrosis, hypertrophy, cardiomyocyte death, contractile dysfunction, endothelial cell damage and eventually heart failure. In the process of cardiac fibrosis, cardiac fibroblasts are the final effector cell.\nCLASS       Human Diseases; Cardiovascular disease\nPATHWAY_MAP map05415  Diabetic cardiomyopathy\nDISEASE     H02498  Diabetic cardiomyopathy\nREFERENCE   PMID:30443826\n  AUTHORS   Riehle C, Bauersachs J\n  TITLE     Of mice and men: models and mechanisms of diabetic cardiomyopathy.\n  JOURNAL   Basic Res Cardiol 114:2 (2018)\n            DOI:10.1007/s00395-018-0711-0\nREFERENCE   PMID:24462787\n  AUTHORS   Huynh K, Bernardo BC, McMullen JR, Ritchie RH\n  TITLE     Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.\n  JOURNAL   Pharmacol Ther 142:375-415 (2014)\n            DOI:10.1016/j.pharmthera.2014.01.003\nREFERENCE   PMID:28231848\n  AUTHORS   Lorenzo-Almoros A, Tunon J, Orejas M, Cortes M, Egido J, Lorenzo O\n  TITLE     Diagnostic approaches for diabetic cardiomyopathy.\n  JOURNAL   Cardiovasc Diabetol 16:28 (2017)\n            DOI:10.1186/s12933-017-0506-x\nREFERENCE   PMID:32080423\n  AUTHORS   Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L\n  TITLE     Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.\n  JOURNAL   Nat Rev Cardiol 17:585-607 (2020)\n            DOI:10.1038/s41569-020-0339-2\nREFERENCE   PMID:31212580\n  AUTHORS   Zamora M, Villena JA\n  TITLE     Contribution of Impaired Insulin Signaling to the Pathogenesis of Diabetic Cardiomyopathy.\n  JOURNAL   Int J Mol Sci 20:E2833 (2019)\n            DOI:10.3390/ijms20112833\nREFERENCE   PMID:29605388\n  AUTHORS   Palomer X, Pizarro-Delgado J, Vazquez-Carrera M\n  TITLE     Emerging Actors in Diabetic Cardiomyopathy: Heartbreaker Biomarkers or Therapeutic Targets?\n  JOURNAL   Trends Pharmacol Sci 39:452-467 (2018)\n            DOI:10.1016/j.tips.2018.02.010\nREFERENCE   PMID:28439258\n  AUTHORS   Mishra PK, Ying W, Nandi SS, Bandyopadhyay GK, Patel KK, Mahata SK\n  TITLE     Diabetic Cardiomyopathy: An Immunometabolic Perspective.\n  JOURNAL   Front Endocrinol (Lausanne) 8:72 (2017)\n            DOI:10.3389/fendo.2017.00072\nREFERENCE   PMID:28177068\n  AUTHORS   Chong CR, Clarke K, Levelt E\n  TITLE     Metabolic Remodeling in Diabetic Cardiomyopathy.\n  JOURNAL   Cardiovasc Res 113:422-430 (2017)\n            DOI:10.1093/cvr/cvx018\nREFERENCE   PMID:11742414\n  AUTHORS   Brownlee M\n  TITLE     Biochemistry and molecular cell biology of diabetic complications.\n  JOURNAL   Nature 414:813-20 (2001)\n            DOI:10.1038/414813a\nREFERENCE   PMID:32821697\n  AUTHORS   Gollmer J, Zirlik A, Bugger H\n  TITLE     Established and Emerging Mechanisms of Diabetic Cardiomyopathy.\n  JOURNAL   J Lipid Atheroscler 8:26-47 (2019)\n            DOI:10.12997/jla.2019.8.1.26\nREFERENCE   PMID:17592090\n  AUTHORS   Boudina S, Abel ED\n  TITLE     Diabetic cardiomyopathy revisited.\n  JOURNAL   Circulation 115:3213-23 (2007)\n            DOI:10.1161/CIRCULATIONAHA.106.679597\nREFERENCE   PMID:29109032\n  AUTHORS   Varma U, Koutsifeli P, Benson VL, Mellor KM, Delbridge LMD\n  TITLE     Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.\n  JOURNAL   Biochim Biophys Acta Mol Basis Dis 1864:1949-1959 (2018)\n            DOI:10.1016/j.bbadis.2017.10.035\nREFERENCE   PMID:23147391\n  AUTHORS   Mandavia CH, Aroor AR, Demarco VG, Sowers JR\n  TITLE     Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.\n  JOURNAL   Life Sci 92:601-8 (2013)\n            DOI:10.1016/j.lfs.2012.10.028\nREFERENCE   PMID:21626163\n  AUTHORS   Falcao-Pires I, Leite-Moreira AF\n  TITLE     Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.\n  JOURNAL   Heart Fail Rev 17:325-44 (2012)\n            DOI:10.1007/s10741-011-9257-z\nREFERENCE   PMID:27148064\n  AUTHORS   Westermeier F, Riquelme JA, Pavez M, Garrido V, Diaz A, Verdejo HE, Castro PF, Garcia L, Lavandero S\n  TITLE     New Molecular Insights of Insulin in Diabetic Cardiomyopathy.\n  JOURNAL   Front Physiol 7:125 (2016)\n            DOI:10.3389/fphys.2016.00125\nREFERENCE   PMID:33276047\n  AUTHORS   Randhawa VK, Dhanvantari S, Connelly K\n  TITLE     How Diabetes and Heart Failure Modulate Each Other and Condition Management.\n  JOURNAL   Can J Cardiol S0828-282X(20)31115-6 (2020)\n            DOI:10.1016/j.cjca.2020.11.014\nREFERENCE   PMID:31641426\n  AUTHORS   Athithan L, Gulsin GS, McCann GP, Levelt E\n  TITLE     Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date.\n  JOURNAL   World J Diabetes 10:490-510 (2019)\n            DOI:10.4239/wjd.v10.i10.490\nREFERENCE   PMID:21111987\n  AUTHORS   Murarka S, Movahed MR\n  TITLE     Diabetic cardiomyopathy.\n  JOURNAL   J Card Fail 16:971-9 (2010)\n            DOI:10.1016/j.cardfail.2010.07.249\nREFERENCE   PMID:25085967\n  AUTHORS   Thomas CM, Yong QC, Rosa RM, Seqqat R, Gopal S, Casarini DE, Jones WK, Gupta S, Baker KM, Kumar R\n  TITLE     Cardiac-specific suppression of NF-kappaB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system.\n  JOURNAL   Am J Physiol Heart Circ Physiol 307:H1036-45 (2014)\n            DOI:10.1152/ajpheart.00340.2014\nREFERENCE   PMID:28236380\n  AUTHORS   Brahma MK, Pepin ME, Wende AR\n  TITLE     My Sweetheart Is Broken: Role of Glucose in Diabetic Cardiomyopathy.\n  JOURNAL   Diabetes Metab J 41:1-9 (2017)\n            DOI:10.4093/dmj.2017.41.1.1\nREFERENCE   PMID:18829990\n  AUTHORS   Singh VP, Le B, Khode R, Baker KM, Kumar R\n  TITLE     Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis.\n  JOURNAL   Diabetes 57:3297-306 (2008)\n            DOI:10.2337/db08-0805\nREFERENCE   PMID:18296558\n  AUTHORS   Singh VP, Baker KM, Kumar R\n  TITLE     Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production.\n  JOURNAL   Am J Physiol Heart Circ Physiol 294:H1675-84 (2008)\n            DOI:10.1152/ajpheart.91493.2007\nREFERENCE   PMID:26678809\n  AUTHORS   Jia G, DeMarco VG, Sowers JR\n  TITLE     Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.\n  JOURNAL   Nat Rev Endocrinol 12:144-53 (2016)\n            DOI:10.1038/nrendo.2015.216\nREFERENCE   PMID:18309108\n  AUTHORS   Kim JA, Wei Y, Sowers JR\n  TITLE     Role of mitochondrial dysfunction in insulin resistance.\n  JOURNAL   Circ Res 102:401-14 (2008)\n            DOI:10.1161/CIRCRESAHA.107.165472\nREFERENCE   PMID:30170598\n  AUTHORS   Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuniga FA\n  TITLE     Association between insulin resistance and the development of cardiovascular disease.\n  JOURNAL   Cardiovasc Diabetol 17:122 (2018)\n            DOI:10.1186/s12933-018-0762-4\nREFERENCE   PMID:31269778\n  AUTHORS   Evangelista I, Nuti R, Picchioni T, Dotta F, Palazzuoli A\n  TITLE     Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy.\n  JOURNAL   Int J Mol Sci 20:E3264 (2019)\n            DOI:10.3390/ijms20133264\nREFERENCE   PMID:24307101\n  AUTHORS   Joshi M, Kotha SR, Malireddy S, Selvaraju V, Satoskar AR, Palesty A, McFadden DW, Parinandi NL, Maulik N\n  TITLE     Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria.\n  JOURNAL   Mol Cell Biochem 386:233-49 (2014)\n            DOI:10.1007/s11010-013-1861-x\nREFERENCE   PMID:29867137\n  AUTHORS   Knapp M, Tu X, Wu R\n  TITLE     Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.\n  JOURNAL   Acta Pharmacol Sin 40:1-8 (2019)\n            DOI:10.1038/s41401-018-0042-6\nREFERENCE   PMID:16487830\n  AUTHORS   Asbun J, Villarreal FJ\n  TITLE     The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy.\n  JOURNAL   J Am Coll Cardiol 47:693-700 (2006)\n            DOI:10.1016/j.jacc.2005.09.050\nREFERENCE   PMID:32024054\n  AUTHORS   Levick SP, Widiapradja A\n  TITLE     The Diabetic Cardiac Fibroblast: Mechanisms Underlying Phenotype and Function.\n  JOURNAL   Int J Mol Sci 21:E970 (2020)\n            DOI:10.3390/ijms21030970\nREL_PATHWAY map00010  Glycolysis / Gluconeogenesis\n            map00020  Citrate cycle (TCA cycle)\n            map00190  Oxidative phosphorylation\n            map00520  Amino sugar and nucleotide sugar metabolism\n            map03320  PPAR signaling pathway\n            map04071  Sphingolipid signaling pathway\n            map04150  mTOR signaling pathway\n            map04210  Apoptosis\n            map04260  Cardiac muscle contraction\n            map04350  TGF-beta signaling pathway\n            map04614  Renin-angiotensin system\n            map04910  Insulin signaling pathway\n            map04930  Type II diabetes mellitus\n            map04931  Insulin resistance\n            map04933  AGE-RAGE signaling pathway in diabetic complications\n            map04940  Type I diabetes mellitus\nKO_PATHWAY  ko05415\n///\n","added":1656608393333},{"name":"map00010","response":"ENTRY       map00010                    Pathway\nNAME        Glycolysis / Gluconeogenesis\nDESCRIPTION Glycolysis is the process of converting glucose into pyruvate and generating small amounts of ATP (energy) and NADH (reducing power). It is a central pathway that produces important precursor metabolites: six-carbon compounds of glucose-6P and fructose-6P and three-carbon compounds of glycerone-P, glyceraldehyde-3P, glycerate-3P, phosphoenolpyruvate, and pyruvate [MD:M00001]. Acetyl-CoA, another important precursor metabolite, is produced by oxidative decarboxylation of pyruvate [MD:M00307]. When the enzyme genes of this pathway are examined in completely sequenced genomes, the reaction steps of three-carbon compounds from glycerone-P to pyruvate form a conserved core module [MD:M00002], which is found in almost all organisms and which sometimes contains operon structures in bacterial genomes. Gluconeogenesis is a synthesis pathway of glucose from noncarbohydrate precursors. It is essentially a reversal of glycolysis with minor variations of alternative paths [MD:M00003].\nCLASS       Metabolism; Carbohydrate metabolism\nPATHWAY_MAP map00010  Glycolysis / Gluconeogenesis\nMODULE      M00001  Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate [PATH:map00010]\n            M00002  Glycolysis, core module involving three-carbon compounds [PATH:map00010]\n            M00003  Gluconeogenesis, oxaloacetate => fructose-6P [PATH:map00010]\n            M00307  Pyruvate oxidation, pyruvate => acetyl-CoA [PATH:map00010]\nDBLINKS     GO: 0006096 0006094\nREFERENCE   \n  AUTHORS   Nishizuka Y (ed).\n  TITLE     [Metabolic Maps] (In Japanese)\n  JOURNAL   Tokyo Kagaku Dojin (1980)\nREFERENCE   \n  AUTHORS   Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).\n  TITLE     [Cellular Functions and Metabolic Maps] (In Japanese)\n  JOURNAL   Tokyo Kagaku Dojin (1997)\nREFERENCE   \n  AUTHORS   Michal G.\n  TITLE     Biochemical Pathways\n  JOURNAL   Wiley (1999)\nREL_PATHWAY map00020  Citrate cycle (TCA cycle)\n            map00030  Pentose phosphate pathway\n            map00500  Starch and sucrose metabolism\n            map00620  Pyruvate metabolism\n            map00640  Propanoate metabolism\n            map00710  Carbon fixation in photosynthetic organisms\nKO_PATHWAY  ko00010\n///\n","added":1656608550007},{"name":"C00535","response":"ENTRY       C00535                      Compound\nNAME        Testosterone;\n            17beta-Hydroxy-4-androsten-3-one\nFORMULA     C19H28O2\nEXACT_MASS  288.2089\nMOL_WEIGHT  288.4244\nREMARK      Same as: D00075\nREACTION    R01836 R01838 R02497 R02498 R02499 R02501 R02502 R02503 \n            R10511 R11349\nPATHWAY     map00140  Steroid hormone biosynthesis\n            map00984  Steroid degradation\n            map01100  Metabolic pathways\n            map01120  Microbial metabolism in diverse environments\n            map01522  Endocrine resistance\n            map04913  Ovarian steroidogenesis\n            map04929  GnRH secretion\n            map05200  Pathways in cancer\n            map05215  Prostate cancer\n            map07226  Progesterone, androgen and estrogen receptor agonists/antagonists\nENZYME      1.1.1.51        1.1.1.64        1.1.1.145       1.1.1.239       \n            1.3.1.3         1.3.1.22        1.14.14.1       1.14.14.14      \n            1.14.15.19      2.4.1.17        5.3.3.1\nBRITE       Compounds with biological roles [BR:br08001]\n             Steroids\n              19-Carbon atoms\n               Androstane derivatives\n                C00535  Testosterone\n             Hormones and transmitters\n              Steroid hormones\n               Androgens\n                C00535  Testosterone\n            Lipids [BR:br08002]\n             ST  Sterol lipids\n              ST02 Steroids\n               ST0202 C19 steroids (androgens) and derivatives\n                C00535  17beta-Hydroxy-4-androsten-3-one\n            Phytochemical compounds [BR:br08003]\n             Terpenoids\n              Steroids\n               Androstane\n                C00535  Testosterone\n            Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]\n             G GENITO URINARY SYSTEM AND SEX HORMONES\n              G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM\n               G03B ANDROGENS\n                G03BA 3-oxoandrosten (4) derivatives\n                 G03BA03 Testosterone\n                  D00075  Testosterone (JAN/USP) &lt;US&gt;\n            USP drug classification [BR:br08302]\n             Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)\n              Androgens\n               Testosterone\n                D00075  Testosterone (JAN/USP)\n            Classification of Japanese OTC drugs [BR:br08313]\n             Agents for  urogenital organs and anus\n              31 Other drugs for  urogenital organs and anus\n               D00075  Testosterone (JAN/USP)\n             Agents for integumentary system\n              61 Other agents for integumentary system\n               D00075  Testosterone (JAN/USP)\n            Risk category of Japanese OTC drugs [BR:br08312]\n             First-class OTC drugs\n              Inorganic and organic chemicals\n               Testosterone\n                D00075  Testosterone (JAN/USP)\n            Drug groups [BR:br08330]\n             Hormonal agent\n              DG01590  Androgen receptor agonist\n               DG00460  Testosterone\n                D00075  Testosterone\n              DG02006  Testosterone\n               DG00460  Testosterone\n                D00075  Testosterone\n            Target-based classification of drugs [BR:br08310]\n             Nuclear receptors\n              Estrogen like receptors\n               3-Ketosteroid receptor\n                NR3C4 (AR)\n                 D00075  Testosterone (JAN/USP) &lt;US&gt;\nDBLINKS     CAS: 58-22-0\n            PubChem: 3817\n            ChEBI: 17347\n            LIPIDMAPS: LMST02020002\n            KNApSAcK: C00003675\n            PDB-CCD: TES\n            3DMET: B01283\n            NIKKAJI: J4.590J\nATOM        21\n            1   C1x C    28.4900  -18.2000\n            2   C5x C    28.4900  -19.6000\n            3   C2x C    29.6800  -20.2300\n            4   C2y C    30.8700  -19.6000\n            5   C1z C    30.8700  -18.2000\n            6   C1x C    29.6800  -17.5000\n            7   C1x C    32.0600  -20.2300\n            8   C1x C    33.1800  -19.6000\n            9   C1y C    33.1800  -18.2000\n            10  C1y C    32.0600  -17.5000\n            11  C1y C    34.4400  -17.5000\n            12  C1z C    34.4400  -16.1700\n            13  C1x C    33.1800  -15.4700\n            14  C1x C    32.0600  -16.1700\n            15  O5x O    27.3700  -20.2300\n            16  C1a C    34.4400  -14.8400\n            17  C1a C    30.8700  -16.8700\n            18  C1x C    36.8200  -17.5000\n            19  C1x C    36.8200  -16.1700\n            20  C1y C    35.6300  -15.4700\n            21  O1a O    35.6300  -14.1400\nBOND        24\n            1     1   2 1\n            2     2   3 1\n            3     3   4 2\n            4     4   5 1\n            5     5   6 1\n            6     1   6 1\n            7     4   7 1\n            8     7   8 1\n            9     8   9 1\n            10    9  10 1\n            11    5  10 1\n            12    9  11 1\n            13   11  12 1\n            14   12  13 1\n            15   13  14 1\n            16   10  14 1\n            17    2  15 2\n            18   12  16 1 #Up\n            19    5  17 1 #Up\n            20   11  18 1\n            21   18  19 1\n            22   19  20 1\n            23   12  20 1\n            24   20  21 1 #Up\n///\n","added":1656608559726},{"name":"map00140","response":"ENTRY       map00140                    Pathway\nNAME        Steroid hormone biosynthesis\nDESCRIPTION Steroid hormones derived from cholesterol are a class of biologically active compounds in vertebrates. The cholesterol side-chain cleavage enzyme CYP11A1 catalyzes conversion of cholesterol, a C27 compound, to the first C21 steroid, pregnenolone, which is converted by a bifunctional enzyme complex to the gestagen hormone, progesterone [MD:M00107]. Pregnenolone and progesterone are the starting materials for the three groups of steroids: C21 steroids of glucocorticoids and mineralocorticoids, C19 steroids of androgens, and C18 steroids of estrogens. (i) Progesterone is converted by hydroxylations at carbons 21 and 11 to corticosterone, which is further modified by hydroxylation and oxydoreduction at carbon 18 to yield aldosterone, a mineralcorticoid [MD:M00108]. Cortisol, the main glucocorticoid, is formed from 17alpha-hydroxyprogesterone with 11-deoxycortisol as an intermediate [MD:M00109]. (ii) Male hormone testosterone is formed from pregnenolone by two pathways, delta5 pathway via dehydroepiandrosterone and delta4 pathway via androstenedione [MD:M00110]. The enzyme CYP17A1 is responsible for the 17,20 lyase and 17alpha-hydroxylase activities in respective pathways. (iii) Female hormones estrone and estradiol are formed from testosterone and 4-androstene-3,17-dione by oxidative removal of the C19 methyl group and subsequent aromatization of ring A [MD:M00111]. In addition to these three groups, recent studies show that there is another group, termed neurosteroids, synthesized in the brain rather than the peripheral endocrine gland.\nCLASS       Metabolism; Lipid metabolism\nPATHWAY_MAP map00140  Steroid hormone biosynthesis\nMODULE      M00107  Steroid hormone biosynthesis, cholesterol => prognenolone => progesterone [PATH:map00140]\n            M00108  C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone [PATH:map00140]\n            M00109  C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone [PATH:map00140]\n            M00110  C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone [PATH:map00140]\nDBLINKS     GO: 0034754\nREFERENCE   PMID:10998348\n  AUTHORS   Penning TM, Burczynski ME, Jez JM, Hung CF, Lin HK, Ma H, Moore M, Palackal N, Ratnam K\n  TITLE     Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones.\n  JOURNAL   Biochem J 351:67-77 (2000)\n            DOI:10.1042/bj3510067\nREFERENCE   PMID:11469811\n  AUTHORS   Tomlinson JW, Stewart PM\n  TITLE     Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.\n  JOURNAL   Best Pract Res Clin Endocrinol Metab 15:61-78 (2001)\n            DOI:10.1053/beem.2000.0119\nREFERENCE   PMID:12604236\n  AUTHORS   Higaki Y, Usami N, Shintani S, Ishikura S, El-Kabbani O, Hara A\n  TITLE     Selective and potent inhibitors of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone.\n  JOURNAL   Chem Biol Interact 143-144:503-13 (2003)\n            DOI:10.1016/S0009-2797(02)00206-5\nREFERENCE   PMID:12832414\n  AUTHORS   Thomas JL, Duax WL, Addlagatta A, Brandt S, Fuller RR, Norris W\n  TITLE     Structure/function relationships responsible for coenzyme specificity and the isomerase activity of human type 1 3 beta-hydroxysteroid dehydrogenase/isomerase.\n  JOURNAL   J Biol Chem 278:35483-90 (2003)\n            DOI:10.1074/jbc.M304752200\nREFERENCE   PMID:15642792\n  AUTHORS   Cavigelli SA, Monfort SL, Whitney TK, Mechref YS, Novotny M, McClintock MK\n  TITLE     Frequent serial fecal corticoid measures from rats reflect circadian and ovarian corticosterone rhythms.\n  JOURNAL   J Endocrinol 184:153-63 (2005)\n            DOI:10.1677/joe.1.05935\nREFERENCE   PMID:16413106\n  AUTHORS   Holmes MC, Seckl JR\n  TITLE     The role of 11beta-hydroxysteroid dehydrogenases in the brain.\n  JOURNAL   Mol Cell Endocrinol 248:9-14 (2006)\n            DOI:10.1016/j.mce.2005.12.002\nREFERENCE   PMID:16547389\n  AUTHORS   Matsunaga T, Shintani S, Hara A\n  TITLE     Multiplicity of mammalian reductases for xenobiotic carbonyl compounds.\n  JOURNAL   Drug Metab Pharmacokinet 21:1-18 (2006)\n            DOI:10.2133/dmpk.21.1\nREFERENCE   PMID:17459698\n  AUTHORS   Morris DJ, Latif SA, Hardy MP, Brem AS\n  TITLE     Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.\n  JOURNAL   J Steroid Biochem Mol Biol 104:161-8 (2007)\n            DOI:10.1016/j.jsbmb.2007.03.020\nREFERENCE   PMID:17475203\n  AUTHORS   Sanai M, Endo S, Matsunaga T, Ishikura S, Tajima K, El-Kabbani O, Hara A\n  TITLE     Rat NAD+-dependent 3alpha-hydroxysteroid dehydrogenase (AKR1C17): a member of the aldo-keto reductase family highly expressed in kidney cytosol.\n  JOURNAL   Arch Biochem Biophys 464:122-9 (2007)\n            DOI:10.1016/j.abb.2007.04.003\nREFERENCE   PMID:17926129\n  AUTHORS   Ghayee HK, Auchus RJ\n  TITLE     Basic concepts and recent developments in human steroid hormone biosynthesis.\n  JOURNAL   Rev Endocr Metab Disord 8:289-300 (2007)\n            DOI:10.1007/s11154-007-9052-2\nREL_PATHWAY map00100  Steroid biosynthesis\nKO_PATHWAY  ko00140\n///\n","added":1656608579909},{"name":"map00984","response":"ENTRY       map00984                    Pathway\nNAME        Steroid degradation\nCLASS       Metabolism; Xenobiotics biodegradation and metabolism\nPATHWAY_MAP map00984  Steroid degradation\nDBLINKS     GO: 0006707\nREFERENCE   PMID:21924910\n  AUTHORS   Ouellet H, Johnston JB, de Montellano PR\n  TITLE     Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis.\n  JOURNAL   Trends Microbiol 19:530-9 (2011)\n            DOI:10.1016/j.tim.2011.07.009\nREFERENCE   PMID:17264217\n  AUTHORS   Van der Geize R, Yam K, Heuser T, Wilbrink MH, Hara H, Anderton MC, Sim E, Dijkhuizen L, Davies JE, Mohn WW, Eltis LD\n  TITLE     A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages.\n  JOURNAL   Proc Natl Acad Sci U S A 104:1947-52 (2007)\n            DOI:10.1073/pnas.0605728104\nREFERENCE   PMID:22045806\n  AUTHORS   Thomas ST, VanderVen BC, Sherman DR, Russell DG, Sampson NS\n  TITLE     Pathway profiling in Mycobacterium tuberculosis: elucidation of cholesterol-derived catabolite and enzymes that catalyze its metabolism.\n  JOURNAL   J Biol Chem 286:43668-78 (2011)\n            DOI:10.1074/jbc.M111.313643\nREFERENCE   PMID:20889498\n  AUTHORS   Driscoll MD, McLean KJ, Levy C, Mast N, Pikuleva IA, Lafite P, Rigby SE, Leys D, Munro AW\n  TITLE     Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen.\n  JOURNAL   J Biol Chem 285:38270-82 (2010)\n            DOI:10.1074/jbc.M110.164293\nREFERENCE   PMID:20843794\n  AUTHORS   Johnston JB, Ouellet H, Ortiz de Montellano PR\n  TITLE     Functional redundancy of steroid C26-monooxygenase activity in Mycobacterium tuberculosis revealed by biochemical and genetic analyses.\n  JOURNAL   J Biol Chem 285:36352-60 (2010)\n            DOI:10.1074/jbc.M110.161117\nREFERENCE   PMID:17630785\n  AUTHORS   Yang X, Dubnau E, Smith I, Sampson NS\n  TITLE     Rv1106c from Mycobacterium tuberculosis is a 3beta-hydroxysteroid dehydrogenase.\n  JOURNAL   Biochemistry 46:9058-67 (2007)\n            DOI:10.1021/bi700688x\nREFERENCE   PMID:19875455\n  AUTHORS   Lack NA, Yam KC, Lowe ED, Horsman GP, Owen RL, Sim E, Eltis LD\n  TITLE     Characterization of a carbon-carbon hydrolase from Mycobacterium tuberculosis involved in cholesterol metabolism.\n  JOURNAL   J Biol Chem 285:434-43 (2010)\n            DOI:10.1074/jbc.M109.058081\nREFERENCE   PMID:19843168\n  AUTHORS   Kreit J, Sampson NS\n  TITLE     Cholesterol oxidase: physiological functions.\n  JOURNAL   FEBS J 276:6844-56 (2009)\n            DOI:10.1111/j.1742-4658.2009.07378.x\nREFERENCE   PMID:21056662\n  AUTHORS   Horinouchi M, Hayashi T, Kudo T\n  TITLE     Steroid degradation in Comamonas testosteroni.\n  JOURNAL   J Steroid Biochem Mol Biol 129:4-14 (2012)\n            DOI:10.1016/j.jsbmb.2010.10.008\nREFERENCE   PMID:20554032\n  AUTHORS   Horinouchi M, Kurita T, Hayashi T, Kudo T\n  TITLE     Steroid degradation genes in Comamonas testosteroni TA441: Isolation of genes encoding a Delta4(5)-isomerase and 3alpha- and 3beta-dehydrogenases and evidence for a 100 kb steroid degradation gene hot spot.\n  JOURNAL   J Steroid Biochem Mol Biol 122:253-63 (2010)\n            DOI:10.1016/j.jsbmb.2010.06.002\nREL_PATHWAY map00100  Steroid biosynthesis\n            map00140  Steroid hormone biosynthesis\n            map00622  Xylene degradation\nKO_PATHWAY  ko00984\n///\n","added":1656608580730},{"name":"map01120","response":"ENTRY       map01120          Global    Pathway\nNAME        Microbial metabolism in diverse environments\nPATHWAY_MAP map01120  Microbial metabolism in diverse environments\nMODULE      M00004  Pentose phosphate pathway (Pentose phosphate cycle) [PATH:map01120]\n            M00006  Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P [PATH:map01120]\n            M00007  Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P [PATH:map01120]\n            M00008  Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate [PATH:map01120]\n            M00033  Ectoine biosynthesis, aspartate => ectoine [PATH:map01120]\n            M00165  Reductive pentose phosphate cycle (Calvin cycle) [PATH:map01120]\n            M00166  Reductive pentose phosphate cycle, ribulose-5P => glyceraldehyde-3P [PATH:map01120]\n            M00167  Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P [PATH:map01120]\n            M00168  CAM (Crassulacean acid metabolism), dark [PATH:map01120]\n            M00169  CAM (Crassulacean acid metabolism), light [PATH:map01120]\n            M00170  C4-dicarboxylic acid cycle, phosphoenolpyruvate carboxykinase type [PATH:map01120]\n            M00171  C4-dicarboxylic acid cycle, NAD - malic enzyme type [PATH:map01120]\n            M00172  C4-dicarboxylic acid cycle, NADP - malic enzyme type [PATH:map01120]\n            M00173  Reductive citrate cycle (Arnon-Buchanan cycle) [PATH:map01120]\n            M00174  Methane oxidation, methanotroph, methane => formaldehyde [PATH:map01120]\n            M00175  Nitrogen fixation, nitrogen => ammonia [PATH:map01120]\n            M00176  Assimilatory sulfate reduction, sulfate => H2S [PATH:map01120]\n            M00308  Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P [PATH:map01120]\n            M00309  Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate [PATH:map01120]\n            M00344  Formaldehyde assimilation, xylulose monophosphate pathway [PATH:map01120]\n            M00345  Formaldehyde assimilation, ribulose monophosphate pathway [PATH:map01120]\n            M00346  Formaldehyde assimilation, serine pathway [PATH:map01120]\n            M00356  Methanogenesis, methanol => methane [PATH:map01120]\n            M00357  Methanogenesis, acetate => methane [PATH:map01120]\n            M00358  Coenzyme M biosynthesis [PATH:map01120]\n            M00373  Ethylmalonyl pathway [PATH:map01120]\n            M00374  Dicarboxylate-hydroxybutyrate cycle [PATH:map01120]\n            M00375  Hydroxypropionate-hydroxybutylate cycle [PATH:map01120]\n            M00376  3-Hydroxypropionate bi-cycle [PATH:map01120]\n            M00377  Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway) [PATH:map01120]\n            M00378  F420 biosynthesis, archaea [PATH:map01120]\n            M00418  Toluene degradation, anaerobic, toluene => benzoyl-CoA [PATH:map01120]\n            M00419  Cymene degradation, p-cymene => p-cumate [PATH:map01120]\n            M00422  Acetyl-CoA pathway, CO2 => acetyl-CoA [PATH:map01120]\n            M00528  Nitrification, ammonia => nitrite [PATH:map01120]\n            M00529  Denitrification, nitrate => nitrogen [PATH:map01120]\n            M00530  Dissimilatory nitrate reduction, nitrate => ammonia [PATH:map01120]\n            M00531  Assimilatory nitrate reduction, nitrate => ammonia [PATH:map01120]\n            M00533  Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate [PATH:map01120]\n            M00534  Naphthalene degradation, naphthalene => salicylate [PATH:map01120]\n            M00537  Xylene degradation, xylene => methylbenzoate [PATH:map01120]\n            M00538  Toluene degradation, toluene => benzoate [PATH:map01120]\n            M00539  Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate [PATH:map01120]\n            M00540  Benzoate degradation, cyclohexanecarboxylic acid =>pimeloyl-CoA [PATH:map01120]\n            M00541  Benzoyl-CoA degradation, benzoyl-CoA => 3-hydroxypimeloyl-CoA [PATH:map01120]\n            M00543  Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate [PATH:map01120]\n            M00544  Carbazole degradation, carbazole => 2-oxopent-4-enoate + anthranilate [PATH:map01120]\n            M00545  Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA [PATH:map01120]\n            M00547  Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol [PATH:map01120]\n            M00548  Benzene degradation, benzene => catechol [PATH:map01120]\n            M00550  Ascorbate degradation, ascorbate => D-xylulose-5P [PATH:map01120]\n            M00551  Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol [PATH:map01120]\n            M00563  Methanogenesis, methylamine/dimethylamine/trimethylamine => methane [PATH:map01120]\n            M00567  Methanogenesis, CO2 => methane [PATH:map01120]\n            M00568  Catechol ortho-cleavage, catechol => 3-oxoadipate [PATH:map01120]\n            M00569  Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA [PATH:map01120]\n            M00579  Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate [PATH:map01120]\n            M00580  Pentose phosphate pathway, archaea, fructose 6P => ribose 5P [PATH:map01120]\n            M00595  Thiosulfate oxidation by SOX complex, thiosulfate => sulfate [PATH:map01120]\n            M00596  Dissimilatory sulfate reduction, sulfate => H2S [PATH:map01120]\n            M00608  2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate [PATH:map01120]\n            M00620  Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate [PATH:map01120]\n            M00622  Nicotinate degradation, nicotinate => fumarate [PATH:map01120]\n            M00623  Phthalate degradation, phthalate => protocatechuate [PATH:map01120]\n            M00624  Terephthalate degradation, terephthalate => 3,4-dihydroxybenzoate [PATH:map01120]\n            M00636  Phthalate degradation, phthalate => protocatechuate [PATH:map01120]\n            M00637  Anthranilate degradation, anthranilate => catechol [PATH:map01120]\n            M00638  Salicylate degradation, salicylate => gentisate [PATH:map01120]\n            M00740  Methylaspartate cycle [PATH:map01120]\n            M00804  Complete nitrification, comammox, ammonia => nitrite => nitrate [PATH:map01120]\n            M00810  Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde [PATH:map01120]\n            M00811  Nicotine degradation, pyrrolidine pathway, nicotine => succinate semialdehyde [PATH:map01120]\n            M00836  Coenzyme F430 biosynthesis, sirohydrochlorin => coenzyme F430 [PATH:map01120]\n            M00878  Phenylacetate degradation, phenylaxetate => acetyl-CoA/succinyl-CoA [PATH:map01120]\n            M00915  Caffeine degradation, caffeine => xanthine [PATH:map01120]\n            M00919  Ectoine degradation, ectoine => aspartate [PATH:map01120]\nREL_PATHWAY map00010  Glycolysis / Gluconeogenesis\n            map00020  Citrate cycle (TCA cycle)\n            map00030  Pentose phosphate pathway\n            map00051  Fructose and mannose metabolism\n            map00053  Ascorbate and aldarate metabolism\n            map00230  Purine metabolism\n            map00232  Caffeine metabolism\n            map00260  Glycine, serine and threonine metabolism\n            map00300  Lysine biosynthesis\n            map00310  Lysine degradation\n            map00350  Tyrosine metabolism\n            map00360  Phenylalanine metabolism\n            map00361  Chlorocyclohexane and chlorobenzene degradation\n            map00362  Benzoate degradation\n            map00363  Bisphenol degradation\n            map00364  Fluorobenzoate degradation\n            map00365  Furfural degradation\n            map00440  Phosphonate and phosphinate metabolism\n            map00562  Inositol phosphate metabolism\n            map00620  Pyruvate metabolism\n            map00621  Dioxin degradation\n            map00622  Xylene degradation\n            map00623  Toluene degradation\n            map00624  Polycyclic aromatic hydrocarbon degradation\n            map00625  Chloroalkane and chloroalkene degradation\n            map00626  Naphthalene degradation\n            map00627  Aminobenzoate degradation\n            map00630  Glyoxylate and dicarboxylate metabolism\n            map00633  Nitrotoluene degradation\n            map00642  Ethylbenzene degradation\n            map00643  Styrene degradation\n            map00680  Methane metabolism\n            map00710  Carbon fixation in photosynthetic organisms\n            map00720  Carbon fixation pathways in prokaryotes\n            map00750  Vitamin B6 metabolism\n            map00760  Nicotinate and nicotinamide metabolism\n            map00791  Atrazine degradation\n            map00910  Nitrogen metabolism\n            map00920  Sulfur metabolism\n            map00930  Caprolactam degradation\n            map00984  Steroid degradation\nKO_PATHWAY  ko01120\n///\n","added":1656608581830},{"name":"map01522","response":"ENTRY       map01522          Global    Pathway\nNAME        Endocrine resistance\nDESCRIPTION Endocrine therapy is a key treatment strategy to control or eradicate hormone-responsive breast cancer. The most commonly used endocrine therapy agents are selective estrogen receptor modulators (SERMs, e.g. tamoxifen), estrogen synthesis inhibitors (e.g. aromatase inhibitors (AIs) such as anastrozole, letrozole, and exemestane), and selective estrogen receptor down-regulators (SERDs, e.g. fulvestrant). However, resistance to these agents has become a major clinical obstacle. Mechanisms of endocrine resistance include loss of ER-alpha expression, altered expression of coactivators or coregulators that play a critical role in ER-mediated gene transcription, ligand-independent growth factor signaling cascades that activate kinases and ER-phosphorylation, altered availability of active tamoxifen metabolites regulated by drug-metabolizing enzymes, such as CYP2D6, and deregulation of the cell cycle and apoptotic machinery.\nCLASS       Human Diseases; Drug resistance: antineoplastic\nPATHWAY_MAP map01522  Endocrine resistance\nREFERENCE   PMID:23344024\n  AUTHORS   Garcia-Becerra R, Santos N, Diaz L, Camacho J\n  TITLE     Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.\n  JOURNAL   Int J Mol Sci 14:108-45 (2012)\n            DOI:10.3390/ijms14010108\nREFERENCE   PMID:19701242\n  AUTHORS   Musgrove EA, Sutherland RL\n  TITLE     Biological determinants of endocrine resistance in breast cancer.\n  JOURNAL   Nat Rev Cancer 9:631-43 (2009)\n            DOI:10.1038/nrc2713\nREFERENCE   PMID:22015292\n  AUTHORS   Giuliano M, Schifp R, Osborne CK, Trivedi MV\n  TITLE     Biological mechanisms and clinical implications of endocrine resistance in breast cancer.\n  JOURNAL   Breast 20 Suppl 3:S42-9 (2011)\n            DOI:10.1016/S0960-9776(11)70293-4\nREFERENCE   PMID:25907219\n  AUTHORS   Ma CX, Reinert T, Chmielewska I, Ellis MJ\n  TITLE     Mechanisms of aromatase inhibitor resistance.\n  JOURNAL   Nat Rev Cancer 15:261-75 (2015)\n            DOI:10.1038/nrc3920\nREFERENCE   PMID:24841429\n  AUTHORS   Viedma-Rodriguez R, Baiza-Gutman L, Salamanca-Gomez F, Diaz-Zaragoza M, Martinez-Hernandez G, Ruiz Esparza-Garrido R, Velazquez-Flores MA, Arenas-Aranda D\n  TITLE     Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (review).\n  JOURNAL   Oncol Rep 32:3-15 (2014)\n            DOI:10.3892/or.2014.3190\nREFERENCE   PMID:26849149\n  AUTHORS   Luqmani YA, Alam-Eldin N\n  TITLE     Overcoming Resistance to Endocrine Therapy in Breast Cancer: New Approaches to a Nagging Problem.\n  JOURNAL   Med Princ Pract 25 Suppl 2:28-40 (2016)\n            DOI:10.1159/000444451\nREFERENCE   PMID:22771991\n  AUTHORS   Bianco S, Gevry N\n  TITLE     Endocrine resistance in breast cancer: from cellular signaling pathways to epigenetic mechanisms.\n  JOURNAL   Transcription 3:165-70 (2012)\n            DOI:10.4161/trns.20496\nREFERENCE   PMID:20887199\n  AUTHORS   Osborne CK, Schiff R\n  TITLE     Mechanisms of endocrine resistance in breast cancer.\n  JOURNAL   Annu Rev Med 62:233-47 (2011)\n            DOI:10.1146/annurev-med-070909-182917\nREFERENCE   PMID:23714450\n  AUTHORS   Miller TW\n  TITLE     Endocrine resistance: what do we know?\n  JOURNAL   Am Soc Clin Oncol Educ Book 0011300037 (2013)\n            DOI:10.1200/EdBook_AM.2013.33.e37\nREFERENCE   PMID:23625614\n  AUTHORS   Lonning PE, Eikesdal HP\n  TITLE     Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved.\n  JOURNAL   Endocr Relat Cancer 20:R183-201 (2013)\n            DOI:10.1530/ERC-13-0099\nREFERENCE   PMID:26473850\n  AUTHORS   Egeland NG, Lunde S, Jonsdottir K, Lende TH, Cronin-Fenton D, Gilje B, Janssen EA, Soiland H\n  TITLE     The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients.\n  JOURNAL   Int J Mol Sci 16:24243-75 (2015)\n            DOI:10.3390/ijms161024243\nREFERENCE   PMID:24130921\n  AUTHORS   Chang M\n  TITLE     Tamoxifen resistance in breast cancer.\n  JOURNAL   Biomol Ther (Seoul) 20:256-67 (2012)\n            DOI:10.4062/biomolther.2012.20.3.256\nREFERENCE   PMID:18804516\n  AUTHORS   Zilli M, Grassadonia A, Tinari N, Di Giacobbe A, Gildetti S, Giampietro J, Natoli C, Iacobelli S\n  TITLE     Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer.\n  JOURNAL   Biochim Biophys Acta 1795:62-81 (2009)\n            DOI:10.1016/j.bbcan.2008.08.003\nREFERENCE   PMID:24289103\n  AUTHORS   Mo Z, Liu M, Yang F, Luo H, Li Z, Tu G, Yang G\n  TITLE     GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer.\n  JOURNAL   Breast Cancer Res 15:R114 (2013)\n            DOI:10.1186/bcr3581\nREFERENCE   PMID:24415977\n  AUTHORS   Hasson SP, Rubinek T, Ryvo L, Wolf I\n  TITLE     Endocrine resistance in breast cancer: focus on the phosphatidylinositol 3-kinase/akt/mammalian target of rapamycin signaling pathway.\n  JOURNAL   Breast Care (Basel) 8:248-55 (2013)\n            DOI:10.1159/000354757\nREFERENCE   PMID:15613444\n  AUTHORS   Ring A, Dowsett M\n  TITLE     Mechanisms of tamoxifen resistance.\n  JOURNAL   Endocr Relat Cancer 11:643-58 (2004)\n            DOI:10.1677/erc.1.00776\nREFERENCE   PMID:24565562\n  AUTHORS   Ribeiro JR, Freiman RN\n  TITLE     Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer.\n  JOURNAL   J Steroid Biochem Mol Biol 143:160-73 (2014)\n            DOI:10.1016/j.jsbmb.2014.02.010\nREFERENCE   PMID:20960099\n  AUTHORS   Wang D, Hu L, Zhang G, Zhang L, Chen C\n  TITLE     G protein-coupled receptor 30 in tumor development.\n  JOURNAL   Endocrine 38:29-37 (2010)\n            DOI:10.1007/s12020-010-9363-z\nREFERENCE   PMID:26122181\n  AUTHORS   Jeselsohn R, Buchwalter G, De Angelis C, Brown M, Schiff R\n  TITLE     ESR1 mutations-a mechanism for acquired endocrine resistance in breast cancer.\n  JOURNAL   Nat Rev Clin Oncol 12:573-83 (2015)\n            DOI:10.1038/nrclinonc.2015.117\nREL_PATHWAY map00982  Drug metabolism - cytochrome P450\n            map04010  MAPK signaling pathway\n            map04024  cAMP signaling pathway\n            map04110  Cell cycle\n            map04151  PI3K-Akt signaling pathway\n            map04210  Apoptosis\n            map04330  Notch signaling pathway\n            map04913  Ovarian steroidogenesis\nKO_PATHWAY  ko01522\n///\n","added":1656608582968},{"name":"map04913","response":"ENTRY       map04913                    Pathway\nNAME        Ovarian steroidogenesis\nDESCRIPTION The ovarian steroids, 17-beta estradiol (E2) and progesterone (P4), are critical for normal uterine function, establishment and maintenance of pregnancy, and mammary gland development. Furthermore, the local effects that are essential for normal ovarian physiology are dependent on the endocrine, paracrine, and autocrine actions of E2, P4, and androgens. In most mammals (including humans and mice), ovarian steroidogenesis occurs according to the two-cell/two-gonadotropin theory. This theory describes how granulosa and theca cells work together to make the ovarian steroids. Theca cells respond to LH signaling by increasing the expression of enzymes necessary for the conversion of cholesterol to androgens, such as androstenedione (A) and testosterone (T). Granulosa cells respond to FSH signaling by increasing the expression of enzymes necessary for the conversion of theca-derived androgens into estrogens (E2 and estrone).\nCLASS       Organismal Systems; Endocrine system\nPATHWAY_MAP map04913  Ovarian steroidogenesis\nDBLINKS     GO: 0050810\nREFERENCE   PMID:15541573\n  AUTHORS   Havelock JC, Rainey WE, Carr BR\n  TITLE     Ovarian granulosa cell lines.\n  JOURNAL   Mol Cell Endocrinol 228:67-78 (2004)\n            DOI:10.1016/j.mce.2004.04.018\nREFERENCE   PMID:15831519\n  AUTHORS   Stocco DM, Wang X, Jo Y, Manna PR\n  TITLE     Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: more complicated than we thought.\n  JOURNAL   Mol Endocrinol 19:2647-59 (2005)\n            DOI:10.1210/me.2004-0532\nREFERENCE   PMID:20937107\n  AUTHORS   Wen X, Li D, Tozer AJ, Docherty SM, Iles RK\n  TITLE     Estradiol, progesterone, testosterone profiles in human follicular fluid and cultured granulosa cells from luteinized pre-ovulatory follicles.\n  JOURNAL   Reprod Biol Endocrinol 8:117 (2010)\n            DOI:10.1186/1477-7827-8-117\nREFERENCE   PMID:11704115\n  AUTHORS   Erickson GF, Shimasaki S\n  TITLE     The physiology of folliculogenesis: the role of novel growth factors.\n  JOURNAL   Fertil Steril 76:943-9 (2001)\n            DOI:10.1016/S0015-0282(01)02859-X\nREFERENCE   PMID:11883103\n  AUTHORS   Wood JR, Strauss JF 3rd\n  TITLE     Multiple signal transduction pathways regulate ovarian steroidogenesis.\n  JOURNAL   Rev Endocr Metab Disord 3:33-46 (2002)\n            DOI:10.1023/A:1012748718150\nREFERENCE   PMID:16603089\n  AUTHORS   Drummond AE\n  TITLE     The role of steroids in follicular growth.\n  JOURNAL   Reprod Biol Endocrinol 4:16 (2006)\n            DOI:10.1186/1477-7827-4-16\nREFERENCE   PMID:21862696\n  AUTHORS   Craig ZR, Wang W, Flaws JA\n  TITLE     Endocrine-disrupting chemicals in ovarian function: effects on steroidogenesis, metabolism and nuclear receptor signaling.\n  JOURNAL   Reproduction 142:633-46 (2011)\n            DOI:10.1530/REP-11-0136\nREFERENCE   PMID:20628033\n  AUTHORS   Young JM, McNeilly AS\n  TITLE     Theca: the forgotten cell of the ovarian follicle.\n  JOURNAL   Reproduction 140:489-504 (2010)\n            DOI:10.1530/REP-10-0094\nREFERENCE   PMID:18440223\n  AUTHORS   Diamanti-Kandarakis E, Argyrakopoulou G, Economou F, Kandaraki E, Koutsilieris M\n  TITLE     Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS).\n  JOURNAL   J Steroid Biochem Mol Biol 109:242-6 (2008)\n            DOI:10.1016/j.jsbmb.2008.03.014\nREFERENCE   PMID:11408113\n  AUTHORS   Spicer LJ\n  TITLE     Receptors for insulin-like growth factor-I and tumor necrosis factor-alpha are hormonally regulated in bovine granulosa and thecal cells.\n  JOURNAL   Anim Reprod Sci 67:45-58 (2001)\n            DOI:10.1016/S0378-4320(01)00114-2\nREFERENCE   PMID:10630400\n  AUTHORS   Wang X, Stocco DM\n  TITLE     Cyclic AMP and arachidonic acid: a tale of two pathways.\n  JOURNAL   Mol Cell Endocrinol 158:7-12 (1999)\n            DOI:10.1016/S0303-7207(99)00130-6\nREFERENCE   PMID:17003287\n  AUTHORS   Wang X, Shen CL, Dyson MT, Yin X, Schiffer RB, Grammas P, Stocco DM\n  TITLE     The involvement of epoxygenase metabolites of arachidonic acid in cAMP-stimulated steroidogenesis and steroidogenic acute regulatory protein gene expression.\n  JOURNAL   J Endocrinol 190:871-8 (2006)\n            DOI:10.1677/joe.1.06933\nREFERENCE   PMID:17008391\n  AUTHORS   Miyoshi T, Otsuka F, Inagaki K, Otani H, Takeda M, Suzuki J, Goto J, Ogura T, Makino H\n  TITLE     Differential regulation of steroidogenesis by bone morphogenetic proteins in granulosa cells: involvement of extracellularly regulated kinase signaling and oocyte actions in follicle-stimulating hormone-induced estrogen production.\n  JOURNAL   Endocrinology 148:337-45 (2007)\n            DOI:10.1210/en.2006-0966\nREFERENCE   PMID:11447221\n  AUTHORS   Otsuka F, Moore RK, Shimasaki S\n  TITLE     Biological function and cellular mechanism of bone morphogenetic protein-6 in the ovary.\n  JOURNAL   J Biol Chem 276:32889-95 (2001)\n            DOI:10.1074/jbc.M103212200\nREFERENCE   PMID:14769828\n  AUTHORS   Shimasaki S, Moore RK, Otsuka F, Erickson GF.\n  TITLE     The bone morphogenetic protein system in mammalian reproduction.\n  JOURNAL   Endocr Rev 25:72-101 (2004)\n            DOI:10.1210/er.2003-0007\nREFERENCE   PMID:16414178\n  AUTHORS   Lukacik P, Kavanagh KL, Oppermann U\n  TITLE     Structure and function of human 17beta-hydroxysteroid dehydrogenases.\n  JOURNAL   Mol Cell Endocrinol 248:61-71 (2006)\n            DOI:10.1016/j.mce.2005.12.007\nREL_PATHWAY map00140  Steroid hormone biosynthesis\n            map04350  TGF-beta signaling pathway\n            map04910  Insulin signaling pathway\n            map04912  GnRH signaling pathway\nKO_PATHWAY  ko04913\n///\n","added":1656608584072},{"name":"map04929","response":"ENTRY       map04929                    Pathway\nNAME        GnRH secretion\nDESCRIPTION Hypothalamic gonadotropin-releasing hormone (GnRH) neurons are key regulators of reproduction. They release GnRH into the portal circulation. In turn, GnRH stimulates the pituitary gland to secrete follicle-stimulating hormone and luteinizing hormone (LH) to regulate gonadal functions. Gonadal steroids provide feedback to regulate GnRH release. GnRH neurons express the kisspeptin receptor, GPR 54, and kisspeptins potently stimulate the release of GnRH by depolarising and inducing sustained action potential firing in GnRH neurons. It is also demonstrated that Kisspeptin-GPR54 system positively regulates the GnRH expression  with a time course consistent with activation of Akt and MAP kinase signaling pathways.\nCLASS       Organismal Systems; Endocrine system\nPATHWAY_MAP map04929  GnRH secretion\nREFERENCE   PMID:23550004\n  AUTHORS   Ronnekleiv OK, Kelly MJ\n  TITLE     Kisspeptin excitation of GnRH neurons.\n  JOURNAL   Adv Exp Med Biol 784:113-31 (2013)\n            DOI:10.1007/978-1-4614-6199-9_6\nREFERENCE   PMID:24145132\n  AUTHORS   Beltramo M, Dardente H, Cayla X, Caraty A\n  TITLE     Cellular mechanisms and integrative timing of neuroendocrine control of GnRH secretion by kisspeptin.\n  JOURNAL   Mol Cell Endocrinol 382:387-399 (2014)\n            DOI:10.1016/j.mce.2013.10.015\nREFERENCE   PMID:19770291\n  AUTHORS   Oakley AE, Clifton DK, Steiner RA\n  TITLE     Kisspeptin signaling in the brain.\n  JOURNAL   Endocr Rev 30:713-43 (2009)\n            DOI:10.1210/er.2009-0005\nREFERENCE   PMID:22811428\n  AUTHORS   Pinilla L, Aguilar E, Dieguez C, Millar RP, Tena-Sempere M\n  TITLE     Kisspeptins and reproduction: physiological roles and regulatory mechanisms.\n  JOURNAL   Physiol Rev 92:1235-316 (2012)\n            DOI:10.1152/physrev.00037.2010\nREFERENCE   PMID:20699467\n  AUTHORS   d'Anglemont de Tassigny X, Colledge WH\n  TITLE     The role of kisspeptin signaling in reproduction.\n  JOURNAL   Physiology (Bethesda) 25:207-17 (2010)\n            DOI:10.1152/physiol.00009.2010\nREFERENCE   PMID:19464345\n  AUTHORS   Tena-Sempere M\n  TITLE     Kisspeptin signaling in the brain: recent developments and future challenges.\n  JOURNAL   Mol Cell Endocrinol 314:164-9 (2010)\n            DOI:10.1016/j.mce.2009.05.004\nREFERENCE   PMID:19097915\n  AUTHORS   Colledge WH\n  TITLE     Kisspeptins and GnRH neuronal signalling.\n  JOURNAL   Trends Endocrinol Metab 20:115-21 (2009)\n            DOI:10.1016/j.tem.2008.10.005\nREFERENCE   PMID:18793689\n  AUTHORS   Roa J, Castellano JM, Navarro VM, Handelsman DJ, Pinilla L, Tena-Sempere M\n  TITLE     Kisspeptins and the control of gonadotropin secretion in male and female rodents.\n  JOURNAL   Peptides 30:57-66 (2009)\n            DOI:10.1016/j.peptides.2008.08.009\nREFERENCE   PMID:24907402\n  AUTHORS   Piet R, de Croft S, Liu X, Herbison AE\n  TITLE     Electrical properties of kisspeptin neurons and their regulation of GnRH neurons.\n  JOURNAL   Front Neuroendocrinol 36:15-27 (2015)\n            DOI:10.1016/j.yfrne.2014.05.006\nREFERENCE   PMID:23744639\n  AUTHORS   Zhang C, Bosch MA, Ronnekleiv OK, Kelly MJ\n  TITLE     Kisspeptin activation of TRPC4 channels in female GnRH neurons requires PIP2 depletion and cSrc kinase activation.\n  JOURNAL   Endocrinology 154:2772-83 (2013)\n            DOI:10.1210/en.2013-1180\nREFERENCE   PMID:20816765\n  AUTHORS   Ronnekleiv OK, Bosch MA, Zhang C\n  TITLE     Regulation of endogenous conductances in GnRH neurons by estrogens.\n  JOURNAL   Brain Res 1364:25-34 (2010)\n            DOI:10.1016/j.brainres.2010.08.096\nREFERENCE   PMID:25612870\n  AUTHORS   Ronnekleiv OK, Zhang C, Bosch MA, Kelly MJ\n  TITLE     Kisspeptin and Gonadotropin-Releasing Hormone Neuronal Excitability: Molecular Mechanisms Driven by 17beta-Estradiol.\n  JOURNAL   Neuroendocrinology 102:184-93 (2015)\n            DOI:10.1159/000370311\nREFERENCE   PMID:22343183\n  AUTHORS   Zhang XB, Spergel DJ\n  TITLE     Kisspeptin inhibits high-voltage activated Ca2+ channels in GnRH neurons via multiple Ca2+ influx and release pathways.\n  JOURNAL   Neuroendocrinology 96:68-80 (2012)\n            DOI:10.1159/000335985\nREFERENCE   PMID:19576263\n  AUTHORS   Novaira HJ, Ng Y, Wolfe A, Radovick S\n  TITLE     Kisspeptin increases GnRH mRNA expression and secretion in GnRH secreting neuronal cell lines.\n  JOURNAL   Mol Cell Endocrinol 311:126-34 (2009)\n            DOI:10.1016/j.mce.2009.06.011\nREFERENCE   PMID:25314270\n  AUTHORS   Glanowska KM, Moenter SM\n  TITLE     Differential regulation of GnRH secretion in the preoptic area (POA) and the median eminence (ME) in male mice.\n  JOURNAL   Endocrinology 156:231-41 (2015)\n            DOI:10.1210/en.2014-1458\nREFERENCE   PMID:20886089\n  AUTHORS   Szereszewski JM, Pampillo M, Ahow MR, Offermanns S, Bhattacharya M, Babwah AV\n  TITLE     GPR54 regulates ERK1/2 activity and hypothalamic gene expression in a Galpha(q/11) and beta-arrestin-dependent manner.\n  JOURNAL   PLoS One 5:e12964 (2010)\n            DOI:10.1371/journal.pone.0012964\nREFERENCE   PMID:19710308\n  AUTHORS   Zhang C, Bosch MA, Rick EA, Kelly MJ, Ronnekleiv OK\n  TITLE     17Beta-estradiol regulation of T-type calcium channels in gonadotropin-releasing hormone neurons.\n  JOURNAL   J Neurosci 29:10552-62 (2009)\n            DOI:10.1523/JNEUROSCI.2962-09.2009\nREFERENCE   PMID:23880664\n  AUTHORS   Terasaka T, Otsuka F, Tsukamoto N, Nakamura E, Inagaki K, Toma K, Ogura-Ochi K, Glidewell-Kenney C, Lawson MA, Makino H\n  TITLE     Mutual interaction of kisspeptin, estrogen and bone morphogenetic protein-4 activity in GnRH regulation by GT1-7 cells.\n  JOURNAL   Mol Cell Endocrinol 381:8-15 (2013)\n            DOI:10.1016/j.mce.2013.07.009\nREFERENCE   PMID:22654870\n  AUTHORS   Radovick S, Levine JE, Wolfe A\n  TITLE     Estrogenic regulation of the GnRH neuron.\n  JOURNAL   Front Endocrinol (Lausanne) 3:52 (2012)\n            DOI:10.3389/fendo.2012.00052\nREFERENCE   PMID:16373418\n  AUTHORS   Dungan HM, Clifton DK, Steiner RA\n  TITLE     Minireview: kisspeptin neurons as central processors in the regulation of gonadotropin-releasing hormone secretion.\n  JOURNAL   Endocrinology 147:1154-8 (2006)\n            DOI:10.1210/en.2005-1282\nREFERENCE   PMID:16627563\n  AUTHORS   Kato M, Tanaka N, Usui S, Sakuma Y\n  TITLE     The SK channel blocker apamin inhibits slow afterhyperpolarization currents in rat gonadotropin-releasing hormone neurones.\n  JOURNAL   J Physiol 574:431-42 (2006)\n            DOI:10.1113/jphysiol.2006.110155\nREFERENCE   PMID:23548613\n  AUTHORS   Zhang C, Ronnekleiv OK, Kelly MJ\n  TITLE     Kisspeptin inhibits a slow afterhyperpolarization current via protein kinase C and reduces spike frequency adaptation in GnRH neurons.\n  JOURNAL   Am J Physiol Endocrinol Metab 304:E1237-44 (2013)\n            DOI:10.1152/ajpendo.00058.2013\nREL_PATHWAY map04010  MAPK signaling pathway\n            map04020  Calcium signaling pathway\n            map04151  PI3K-Akt signaling pathway\n            map04912  GnRH signaling pathway\n            map04913  Ovarian steroidogenesis\n            map04915  Estrogen signaling pathway\nKO_PATHWAY  ko04929\n///\n","added":1656608585166},{"name":"map05200","response":"ENTRY       map05200                    Pathway\nNAME        Pathways in cancer\nCLASS       Human Diseases; Cancer: overview\nPATHWAY_MAP map05200  Pathways in cancer\nDISEASE     H01591  Gastrotintestinal stromal tumor\nREFERENCE   \n  AUTHORS   Weinberg RA.\n  TITLE     The biology of cancer\n  JOURNAL   Garland Science, Taylor & Francis Group, LLC (2007)\nREFERENCE   PMID:10647931\n  AUTHORS   Hanahan D, Weinberg RA\n  TITLE     The hallmarks of cancer.\n  JOURNAL   Cell 100:57-70 (2000)\n            DOI:10.1016/S0092-8674(00)81683-9\nREFERENCE   PMID:15000146\n  AUTHORS   Grady WM.\n  TITLE     Genomic instability and colon cancer.\n  JOURNAL   Cancer Metastasis Rev 23:11-27 (2004)\n            DOI:10.1023/A:1025861527711\nREFERENCE   PMID:16555243\n  AUTHORS   Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.\n  TITLE     Microsatellite instability in colorectal cancer.\n  JOURNAL   Br J Surg 93:395-406 (2006)\n            DOI:10.1002/bjs.5328\nREFERENCE   PMID:11078609\n  AUTHORS   Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.\n  TITLE     Hereditary non-polyposis colorectal cancer: an updated review.\n  JOURNAL   Eur J Surg Oncol 26:635-45 (2000)\n            DOI:10.1053/ejso.2000.0974\nREFERENCE   PMID:16699851\n  AUTHORS   Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.\n  TITLE     Colorectal cancer: genetics of development and metastasis.\n  JOURNAL   J Gastroenterol 41:185-92 (2006)\n            DOI:10.1007/s00535-006-1801-6\nREFERENCE   PMID:12621137\n  AUTHORS   Lynch HT, de la Chapelle A.\n  TITLE     Hereditary colorectal cancer.\n  JOURNAL   N Engl J Med 348:919-32 (2003)\n            DOI:10.1056/NEJMra012242\nREFERENCE   PMID:12951588\n  AUTHORS   Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.\n  TITLE     The significance of unstable chromosomes in colorectal cancer.\n  JOURNAL   Nat Rev Cancer 3:695-701 (2003)\n            DOI:10.1038/nrc1165\nREFERENCE   PMID:10505543\n  AUTHORS   Behrens J.\n  TITLE     Cadherins and catenins: role in signal transduction and tumor progression.\n  JOURNAL   Cancer Metastasis Rev 18:15-30 (1999)\n            DOI:10.1023/A:1006200102166\nREFERENCE   PMID:16042571\n  AUTHORS   Behrens J.\n  TITLE     The role of the Wnt signalling pathway in colorectal tumorigenesis.\n  JOURNAL   Biochem Soc Trans 33:672-5 (2005)\n            DOI:10.1042/BST0330672\nREFERENCE   PMID:15349822\n  AUTHORS   Behrens J, Lustig B.\n  TITLE     The Wnt connection to tumorigenesis.\n  JOURNAL   Int J Dev Biol 48:477-87 (2004)\n            DOI:10.1387/ijdb.041815jb\nREFERENCE   PMID:9196022\n  AUTHORS   Polakis P.\n  TITLE     The adenomatous polyposis coli (APC) tumor suppressor.\n  JOURNAL   Biochim Biophys Acta 1332:F127-47 (1997)\n            DOI:10.1016/S0304-419X(97)00008-5\nREFERENCE   PMID:12737309\n  AUTHORS   Janssen KP.\n  TITLE     Murine models of colorectal cancer: studying the role of oncogenic K-ras.\n  JOURNAL   Cell Mol Life Sci 60:495-506 (2003)\n            DOI:10.1007/s000180300041\nREFERENCE   PMID:11459867\n  AUTHORS   Adjei AA.\n  TITLE     Blocking oncogenic Ras signaling for cancer therapy.\n  JOURNAL   J Natl Cancer Inst 93:1062-74 (2001)\n            DOI:10.1093/jnci/93.14.1062\nREFERENCE   PMID:15573119\n  AUTHORS   Arakawa H.\n  TITLE     Netrin-1 and its receptors in tumorigenesis.\n  JOURNAL   Nat Rev Cancer 4:978-87 (2004)\n            DOI:10.1038/nrc1504\nREFERENCE   PMID:15310786\n  AUTHORS   Mehlen P, Fearon ER.\n  TITLE     Role of the dependence receptor DCC in colorectal cancer pathogenesis.\n  JOURNAL   J Clin Oncol 22:3420-8 (2004)\n            DOI:10.1200/JCO.2004.02.019\nREFERENCE   PMID:11223406\n  AUTHORS   Peltomaki P.\n  TITLE     DNA mismatch repair and cancer.\n  JOURNAL   Mutat Res 488:77-85 (2001)\n            DOI:10.1016/S1383-5742(00)00058-2\nREFERENCE   PMID:15711891\n  AUTHORS   Li F, Cao Y, Townsend CM Jr, Ko TC.\n  TITLE     TGF-beta signaling in colon cancer cells.\n  JOURNAL   World J Surg 29:306-11 (2005)\n            DOI:10.1007/s00268-004-7813-6\nREFERENCE   PMID:11170304\n  AUTHORS   Roman C, Saha D, Beauchamp R.\n  TITLE     TGF-beta and colorectal carcinogenesis.\n  JOURNAL   Microsc Res Tech 52:450-7 (2001)\n            DOI:10.1002/1097-0029(20010215)52:4<450::AID-JEMT1030>3.0.CO;2-O\nREFERENCE   PMID:16326109\n  AUTHORS   Watson AJ.\n  TITLE     An overview of apoptosis and the prevention of colorectal cancer.\n  JOURNAL   Crit Rev Oncol Hematol 57:107-21 (2006)\n            DOI:10.1016/j.critrevonc.2005.06.005\nREFERENCE   PMID:15479695\n  AUTHORS   Watson AJ.\n  TITLE     Apoptosis and colorectal cancer.\n  JOURNAL   Gut 53:1701-9 (2004)\n            DOI:10.1136/gut.2004.052704\nREFERENCE   PMID:11477132\n  AUTHORS   Houlston RS.\n  TITLE     What we could do now: molecular pathology of colorectal cancer.\n  JOURNAL   Mol Pathol 54:206-14 (2001)\n            DOI:10.1136/mp.54.4.206\nREFERENCE   \n  AUTHORS   Von Hoff D, Evans D, Hruban R (ed).\n  TITLE     Pancreatic cancer\n  JOURNAL   Jones and Bartlett publishers (2005)\nREFERENCE   \n  AUTHORS   Niitsu Y, Yokota J (ed).\n  TITLE     [Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)\n  JOURNAL   Nankodo (1999)\nREFERENCE   PMID:12459728\n  AUTHORS   Bardeesy N, DePinho RA.\n  TITLE     Pancreatic cancer biology and genetics.\n  JOURNAL   Nat Rev Cancer 2:897-909 (2002)\n            DOI:10.1038/nrc949\nREFERENCE   PMID:11407945\n  AUTHORS   Bardeesy N, Sharpless NE, DePinho RA, Merlino G.\n  TITLE     The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.\n  JOURNAL   Semin Cancer Biol 11:201-18 (2001)\n            DOI:10.1006/scbi.2000.0371\nREFERENCE   PMID:12946833\n  AUTHORS   Cowgill SM, Muscarella P.\n  TITLE     The genetics of pancreatic cancer.\n  JOURNAL   Am J Surg 186:279-86 (2003)\n            DOI:10.1016/S0002-9610(03)00226-5\nREFERENCE   PMID:16702400\n  AUTHORS   Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.\n  TITLE     Genetics and biology of pancreatic ductal adenocarcinoma.\n  JOURNAL   Genes Dev 20:1218-49 (2006)\n            DOI:10.1101/gad.1415606\nREFERENCE   PMID:10740269\n  AUTHORS   Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.\n  TITLE     Understanding Ras: 'it ain't over 'til it's over'.\n  JOURNAL   Trends Cell Biol 10:147-54 (2000)\n            DOI:10.1016/S0962-8924(00)01740-2\nREFERENCE   PMID:12648469\n  AUTHORS   Holbro T, Civenni G, Hynes NE.\n  TITLE     The ErbB receptors and their role in cancer progression.\n  JOURNAL   Exp Cell Res 284:99-110 (2003)\n            DOI:10.1016/S0014-4827(02)00099-X\nREFERENCE   PMID:14967450\n  AUTHORS   Marmor MD, Skaria KB, Yarden Y.\n  TITLE     Signal transduction and oncogenesis by ErbB/HER receptors.\n  JOURNAL   Int J Radiat Oncol Biol Phys 58:903-13 (2004)\n            DOI:10.1016/j.ijrobp.2003.06.002\nREFERENCE   PMID:14586404\n  AUTHORS   DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.\n  TITLE     Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.\n  JOURNAL   Oncogene 22:7781-95 (2003)\n            DOI:10.1038/sj.onc.1206966\nREFERENCE   PMID:12545153\n  AUTHORS   Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.\n  TITLE     Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.\n  JOURNAL   Oncogene 22:319-29 (2003)\n            DOI:10.1038/sj.onc.1206122\nREFERENCE   PMID:14580692\n  AUTHORS   Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.\n  TITLE     Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.\n  JOURNAL   Cancer Lett 201:107-16 (2003)\n            DOI:10.1016/S0304-3835(03)00482-8\nREFERENCE   PMID:12079267\n  AUTHORS   Schmid RM.\n  TITLE     Genetic basis of pancreatic cancer.\n  JOURNAL   Best Pract Res Clin Gastroenterol 16:421-33 (2002)\n            DOI:10.1053/bega.2002.0316\nREFERENCE   PMID:15774796\n  AUTHORS   Elliott RL, Blobe GC.\n  TITLE     Role of transforming growth factor Beta in human cancer.\n  JOURNAL   J Clin Oncol 23:2078-93 (2005)\n            DOI:10.1200/JCO.2005.02.047\nREFERENCE   PMID:15823750\n  AUTHORS   Rudkin TM, Foulkes WD.\n  TITLE     BRCA2: breaks, mistakes and failed separations.\n  JOURNAL   Trends Mol Med 11:145-8 (2005)\n            DOI:10.1016/j.molmed.2005.02.003\nREFERENCE   PMID:11707511\n  AUTHORS   Venkitaraman AR.\n  TITLE     Functions of BRCA1 and BRCA2 in the biological response to DNA damage.\n  JOURNAL   J Cell Sci 114:3591-8 (2001)\nREFERENCE   PMID:15639402\n  AUTHORS   Soni D, King JA, Kaye AH, Hovens CM.\n  TITLE     Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.\n  JOURNAL   J Clin Neurosci 12:1-5 (2005)\n            DOI:10.1016/j.jocn.2004.04.001\nREFERENCE   PMID:12154354\n  AUTHORS   Zhu Y, Parada LF.\n  TITLE     The molecular and genetic basis of neurological tumours.\n  JOURNAL   Nat Rev Cancer 2:616-26 (2002)\n            DOI:10.1038/nrc866\nREFERENCE   PMID:11253051\n  AUTHORS   Holland EC.\n  TITLE     Gliomagenesis: genetic alterations and mouse models.\n  JOURNAL   Nat Rev Genet 2:120-9 (2001)\n            DOI:10.1038/35052535\nREFERENCE   PMID:16700615\n  AUTHORS   Bansal K, Liang ML, Rutka JT.\n  TITLE     Molecular biology of human gliomas.\n  JOURNAL   Technol Cancer Res Treat 5:185-94 (2006)\n            DOI:10.1177/153303460600500302\nREFERENCE   \n  AUTHORS   Tabuchi K (ed).\n  TITLE     [Gliomas: Research and therapy] (In Japanese)\n  JOURNAL   Springer-Verlag Tokyo (2006)\nREFERENCE   PMID:12762887\n  AUTHORS   Kapoor GS, O'Rourke DM.\n  TITLE     Mitogenic signaling cascades in glial tumors.\n  JOURNAL   Neurosurgery 52:1425-34; discussion 1434-5 (2003)\n            DOI:10.1227/01.NEU.0000065135.28143.39\nREFERENCE   PMID:16095998\n  AUTHORS   Hulleman E, Helin K.\n  TITLE     Molecular mechanisms in gliomagenesis.\n  JOURNAL   Adv Cancer Res 94:1-27 (2005)\n            DOI:10.1016/S0065-230X(05)94001-3\nREFERENCE   PMID:11057895\n  AUTHORS   Schlessinger J.\n  TITLE     Cell signaling by receptor tyrosine kinases.\n  JOURNAL   Cell 103:211-25 (2000)\n            DOI:10.1016/S0092-8674(00)00114-8\nREFERENCE   PMID:9643506\n  AUTHORS   Ng HK, Lam PY.\n  TITLE     The molecular genetics of central nervous system tumors.\n  JOURNAL   Pathology 30:196-202 (1998)\n            DOI:10.1080/00313029800169236\nREFERENCE   PMID:12084351\n  AUTHORS   Knobbe CB, Merlo A, Reifenberger G.\n  TITLE     Pten signaling in gliomas.\n  JOURNAL   Neuro-oncol 4:196-211 (2002)\n            DOI:10.1093/neuonc/4.3.196\nREFERENCE   PMID:16557281\n  AUTHORS   Kondo T, Ezzat S, Asa SL.\n  TITLE     Pathogenetic mechanisms in thyroid follicular-cell neoplasia.\n  JOURNAL   Nat Rev Cancer 6:292-306 (2006)\n            DOI:10.1038/nrc1836\nREFERENCE   PMID:16551846\n  AUTHORS   Chiloeches A, Marais R.\n  TITLE     Is BRAF the Achilles' Heel of thyroid cancer?\n  JOURNAL   Clin Cancer Res 12:1661-4 (2006)\n            DOI:10.1158/1078-0432.CCR-06-0051\nREFERENCE   PMID:16946003\n  AUTHORS   Reddi HV, McIver B, Grebe SK, Eberhardt NL\n  TITLE     The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.\n  JOURNAL   Endocrinology 148:932-5 (2007)\n            DOI:10.1210/en.2006-0926\nREFERENCE   PMID:17062879\n  AUTHORS   Santoro M, Melillo RM, Fusco A.\n  TITLE     RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.\n  JOURNAL   Eur J Endocrinol 155:645-653 (2006)\n            DOI:10.1530/eje.1.02289\nREFERENCE   PMID:16242838\n  AUTHORS   Pierotti MA, Greco A.\n  TITLE     Oncogenic rearrangements of the NTRK1/NGF receptor.\n  JOURNAL   Cancer Lett 232:90-8 (2006)\n            DOI:10.1016/j.canlet.2005.07.043\nREFERENCE   PMID:16189702\n  AUTHORS   Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.\n  TITLE     Molecular pathology of well-differentiated thyroid carcinomas.\n  JOURNAL   Virchows Arch 447:787-93 (2005)\n            DOI:10.1007/s00428-005-0065-5\nREFERENCE   PMID:11165748\n  AUTHORS   Gimm O.\n  TITLE     Thyroid cancer.\n  JOURNAL   Cancer Lett 163:143-56 (2001)\n            DOI:10.1016/S0304-3835(00)00697-2\nREFERENCE   PMID:12094241\n  AUTHORS   Williams D.\n  TITLE     Cancer after nuclear fallout: lessons from the Chernobyl accident.\n  JOURNAL   Nat Rev Cancer 2:543-9 (2002)\n            DOI:10.1038/nrc845\nREFERENCE   PMID:16236521\n  AUTHORS   Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.\n  TITLE     The molecular pathogenesis of acute myeloid leukemia.\n  JOURNAL   Crit Rev Oncol Hematol 56:195-221 (2005)\n            DOI:10.1016/j.critrevonc.2004.10.012\nREFERENCE   PMID:12563308\n  AUTHORS   Tenen DG.\n  TITLE     Disruption of differentiation in human cancer: AML shows the way.\n  JOURNAL   Nat Rev Cancer 3:89-101 (2003)\n            DOI:10.1038/nrc989\nREFERENCE   PMID:16146838\n  AUTHORS   Choudhary C, Muller-Tidow C, Berdel WE, Serve H.\n  TITLE     Signal transduction of oncogenic Flt3.\n  JOURNAL   Int J Hematol 82:93-9 (2005)\n            DOI:10.1532/IJH97.05090\nREFERENCE   PMID:12951584\n  AUTHORS   Stirewalt DL, Radich JP.\n  TITLE     The role of FLT3 in haematopoietic malignancies.\n  JOURNAL   Nat Rev Cancer 3:650-65 (2003)\n            DOI:10.1038/nrc1169\nREFERENCE   PMID:16642045\n  AUTHORS   Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.\n  TITLE     Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.\n  JOURNAL   Leukemia 20:911-28 (2006)\n            DOI:10.1038/sj.leu.2404245\nREFERENCE   PMID:15625120\n  AUTHORS   Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.\n  TITLE     Normal and oncogenic forms of the receptor tyrosine kinase kit.\n  JOURNAL   Stem Cells 23:16-43 (2005)\n            DOI:10.1634/stemcells.2004-0117\nREFERENCE   PMID:11721960\n  AUTHORS   Lorsbach RB, Downing JR.\n  TITLE     The role of the AML1 transcription factor in leukemogenesis.\n  JOURNAL   Int J Hematol 74:258-65 (2001)\n            DOI:10.1007/BF02982058\nREFERENCE   PMID:12468433\n  AUTHORS   Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.\n  TITLE     Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.\n  JOURNAL   Blood 101:3164-73 (2003)\n            DOI:10.1182/blood-2002-06-1677\nREFERENCE   PMID:17554387\n  AUTHORS   Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.\n  TITLE     The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.\n  JOURNAL   Leukemia 21:1638-47 (2007)\n            DOI:10.1038/sj.leu.2404732\nREFERENCE   PMID:16352814\n  AUTHORS   Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.\n  TITLE     ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.\n  JOURNAL   Blood 107:3330-8 (2006)\n            DOI:10.1182/blood-2005-07-3068\nREFERENCE   PMID:15719031\n  AUTHORS   Ren R.\n  TITLE     Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.\n  JOURNAL   Nat Rev Cancer 5:172-83 (2005)\n            DOI:10.1038/nrc1567\nREFERENCE   PMID:11071626\n  AUTHORS   Deininger MW, Goldman JM, Melo JV.\n  TITLE     The molecular biology of chronic myeloid leukemia.\n  JOURNAL   Blood 96:3343-56 (2000)\nREFERENCE   PMID:14982876\n  AUTHORS   Calabretta B, Perrotti D.\n  TITLE     The biology of CML blast crisis.\n  JOURNAL   Blood 103:4010-22 (2004)\n            DOI:10.1182/blood-2003-12-4111\nREFERENCE   PMID:10403855\n  AUTHORS   Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM.\n  TITLE     The biology of chronic myeloid leukemia.\n  JOURNAL   N Engl J Med 341:164-72 (1999)\n            DOI:10.1056/NEJM199907153410306\nREFERENCE   PMID:15156182\n  AUTHORS   Mitani K.\n  TITLE     Molecular mechanisms of leukemogenesis by AML1/EVI-1.\n  JOURNAL   Oncogene 23:4263-9 (2004)\n            DOI:10.1038/sj.onc.1207777\nREFERENCE   PMID:16484590\n  AUTHORS   Dong M, Blobe GC.\n  TITLE     Role of transforming growth factor-beta in hematologic malignancies.\n  JOURNAL   Blood 107:4589-96 (2006)\n            DOI:10.1182/blood-2005-10-4169\nREFERENCE   PMID:9834202\n  AUTHORS   Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H.\n  TITLE     The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.\n  JOURNAL   Blood 92:4003-12 (1998)\nREFERENCE   PMID:12801837\n  AUTHORS   Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA.\n  TITLE     p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.\n  JOURNAL   Haematologica 88:622-30 (2003)\nREFERENCE   PMID:11160144\n  AUTHORS   Baldwin AS.\n  TITLE     Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.\n  JOURNAL   J Clin Invest 107:241-6 (2001)\n            DOI:10.1172/JCI11991\nREFERENCE   PMID:12244301\n  AUTHORS   Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.\n  TITLE     PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.\n  JOURNAL   Nat Med 8:1145-52 (2002)\n            DOI:10.1038/nm759\nREFERENCE   PMID:15948971\n  AUTHORS   Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.\n  TITLE     Molecular aetiology and pathogenesis of basal cell carcinoma.\n  JOURNAL   Br J Dermatol 152:1108-24 (2005)\n            DOI:10.1111/j.1365-2133.2005.06587.x\nREFERENCE   PMID:12588368\n  AUTHORS   Saldanha G, Fletcher A, Slater DN.\n  TITLE     Basal cell carcinoma: a dermatopathological and molecular biological update.\n  JOURNAL   Br J Dermatol 148:195-202 (2003)\n            DOI:10.1046/j.1365-2133.2003.05151.x\nREFERENCE   PMID:15978322\n  AUTHORS   Daya-Grosjean L, Couve-Privat S.\n  TITLE     Sonic hedgehog signaling in basal cell carcinomas.\n  JOURNAL   Cancer Lett 225:181-92 (2005)\n            DOI:10.1016/j.canlet.2004.10.003\nREFERENCE   PMID:15468170\n  AUTHORS   Tsai KY, Tsao H.\n  TITLE     The genetics of skin cancer.\n  JOURNAL   Am J Med Genet C Semin Med Genet 131C:82-92 (2004)\n            DOI:10.1002/ajmg.c.30037\nREFERENCE   PMID:16881963\n  AUTHORS   Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.\n  TITLE     Hedgehog signalling in skin development and cancer.\n  JOURNAL   Exp Dermatol 15:667-77 (2006)\n            DOI:10.1111/j.1600-0625.2006.00473.x\nREFERENCE   PMID:16306523\n  AUTHORS   Rubin AI, Chen EH, Ratner D.\n  TITLE     Basal-cell carcinoma.\n  JOURNAL   N Engl J Med 353:2262-9 (2005)\n            DOI:10.1056/NEJMra044151\nREFERENCE   PMID:11276000\n  AUTHORS   Saldanha G.\n  TITLE     The Hedgehog signalling pathway and cancer.\n  JOURNAL   J Pathol 193:427-32 (2001)\n            DOI:10.1002/1096-9896(2000)9999:9999<::AID-PATH815>3.0.CO;2-N\nREFERENCE   PMID:15270885\n  AUTHORS   Saldanha G, Ghura V, Potter L, Fletcher A.\n  TITLE     Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.\n  JOURNAL   Br J Dermatol 151:157-64 (2004)\n            DOI:10.1111/j.1365-2133.2004.06048.x\nREFERENCE   PMID:14737121\n  AUTHORS   Pasca di Magliano M, Hebrok M.\n  TITLE     Hedgehog signalling in cancer formation and maintenance.\n  JOURNAL   Nat Rev Cancer 3:903-11 (2003)\n            DOI:10.1038/nrc1229\nREFERENCE   PMID:15656799\n  AUTHORS   Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.\n  TITLE     Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.\n  JOURNAL   Br J Dermatol 152:43-51 (2005)\n            DOI:10.1111/j.1365-2133.2005.06353.x\nREFERENCE   PMID:14556242\n  AUTHORS   Cohen MM Jr.\n  TITLE     The hedgehog signaling network.\n  JOURNAL   Am J Med Genet A 123:5-28 (2003)\n            DOI:10.1002/ajmg.a.20495\nREFERENCE   PMID:11736900\n  AUTHORS   Yamazaki F, Aragane Y, Kawada A, Tezuka T.\n  TITLE     Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.\n  JOURNAL   Br J Dermatol 145:771-7 (2001)\n            DOI:10.1046/j.1365-2133.2001.04468.x\nREFERENCE   PMID:16054233\n  AUTHORS   Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.\n  TITLE     Role of apoptosis in basal cell and squamous cell carcinoma formation.\n  JOURNAL   Immunol Lett 100:68-72 (2005)\n            DOI:10.1016/j.imlet.2005.06.008\nREFERENCE   PMID:11130178\n  AUTHORS   Toftgard R.\n  TITLE     Hedgehog signalling in cancer.\n  JOURNAL   Cell Mol Life Sci 57:1720-31 (2000)\n            DOI:10.1007/PL00000654\nREFERENCE   PMID:16822996\n  AUTHORS   Miller AJ, Mihm MC Jr.\n  TITLE     Melanoma.\n  JOURNAL   N Engl J Med 355:51-65 (2006)\n            DOI:10.1056/NEJMra052166\nREFERENCE   PMID:12894244\n  AUTHORS   Chin L.\n  TITLE     The genetics of malignant melanoma: lessons from mouse and man.\n  JOURNAL   Nat Rev Cancer 3:559-70 (2003)\n            DOI:10.1038/nrc1145\nREFERENCE   PMID:16750612\n  AUTHORS   Takata M, Saida T.\n  TITLE     Genetic alterations in melanocytic tumors.\n  JOURNAL   J Dermatol Sci 43:1-10 (2006)\n            DOI:10.1016/j.jdermsci.2006.05.002\nREFERENCE   PMID:15841168\n  AUTHORS   Chudnovsky Y, Khavari PA, Adams AE.\n  TITLE     Melanoma genetics and the development of rational therapeutics.\n  JOURNAL   J Clin Invest 115:813-24 (2005)\n            DOI:10.1172/JCI24808\nREFERENCE   PMID:16001050\n  AUTHORS   Merlino G.\n  TITLE     Cancer biology: the weakest link?\n  JOURNAL   Nature 436:33-5 (2005)\n            DOI:10.1038/436033a\nREFERENCE   PMID:16001072\n  AUTHORS   Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.\n  TITLE     Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.\n  JOURNAL   Nature 436:117-22 (2005)\n            DOI:10.1038/nature03664\nREFERENCE   PMID:16899407\n  AUTHORS   Levy C, Khaled M, Fisher DE.\n  TITLE     MITF: master regulator of melanocyte development and melanoma oncogene.\n  JOURNAL   Trends Mol Med 12:406-14 (2006)\n            DOI:10.1016/j.molmed.2006.07.008\nREFERENCE   PMID:15009714\n  AUTHORS   Tsao H, Goel V, Wu H, Yang G, Haluska FG.\n  TITLE     Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.\n  JOURNAL   J Invest Dermatol 122:337-41 (2004)\n            DOI:10.1046/j.0022-202X.2004.22243.x\nREFERENCE   PMID:11224709\n  AUTHORS   Gruss C, Herlyn M.\n  TITLE     Role of cadherins and matrixins in melanoma.\n  JOURNAL   Curr Opin Oncol 13:117-23 (2001)\n            DOI:10.1097/00001622-200103000-00006\nREFERENCE   PMID:15721476\n  AUTHORS   Thompson JF, Scolyer RA, Kefford RF.\n  TITLE     Cutaneous melanoma.\n  JOURNAL   Lancet 365:687-701 (2005)\n            DOI:10.1016/S0140-6736(05)17951-3\nREFERENCE   PMID:14695152\n  AUTHORS   Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.\n  TITLE     NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.\n  JOURNAL   Clin Cancer Res 9:6483-8 (2003)\nREFERENCE   PMID:15557758\n  AUTHORS   Hussein MR.\n  TITLE     The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?\n  JOURNAL   Tumour Biol 25:200-7 (2004)\n            DOI:10.1159/000081103\nREFERENCE   PMID:10843728\n  AUTHORS   Lazar-Molnar E, Hegyesi H, Toth S, Falus A.\n  TITLE     Autocrine and paracrine regulation by cytokines and growth factors in melanoma.\n  JOURNAL   Cytokine 12:547-54 (2000)\n            DOI:10.1006/cyto.1999.0614\nREFERENCE   PMID:16339096\n  AUTHORS   Cohen HT, McGovern FJ.\n  TITLE     Renal-cell carcinoma.\n  JOURNAL   N Engl J Med 353:2477-90 (2005)\n            DOI:10.1056/NEJMra043172\nREFERENCE   PMID:15122209\n  AUTHORS   Pavlovich CP, Schmidt LS.\n  TITLE     Searching for the hereditary causes of renal-cell carcinoma.\n  JOURNAL   Nat Rev Cancer 4:381-93 (2004)\n            DOI:10.1038/nrc1364\nREFERENCE   PMID:14634372\n  AUTHORS   Linehan WM, Walther MM, Zbar B.\n  TITLE     The genetic basis of cancer of the kidney.\n  JOURNAL   J Urol 170:2163-72 (2003)\n            DOI:10.1097/01.ju.0000096060.92397.ed\nREFERENCE   PMID:14685170\n  AUTHORS   Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.\n  TITLE     Met, metastasis, motility and more.\n  JOURNAL   Nat Rev Mol Cell Biol 4:915-25 (2003)\n            DOI:10.1038/nrm1261\nREFERENCE   PMID:15611513\n  AUTHORS   Kim WY, Kaelin WG.\n  TITLE     Role of VHL gene mutation in human cancer.\n  JOURNAL   J Clin Oncol 22:4991-5004 (2004)\n            DOI:10.1200/JCO.2004.05.061\nREFERENCE   PMID:17211469\n  AUTHORS   Sudarshan S, Linehan WM, Neckers L.\n  TITLE     HIF and fumarate hydratase in renal cancer.\n  JOURNAL   Br J Cancer 96:403-7 (2007)\n            DOI:10.1038/sj.bjc.6603547\nREFERENCE   PMID:17287871\n  AUTHORS   Sudarshan S, Pinto PA, Neckers L, Linehan WM.\n  TITLE     Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.\n  JOURNAL   Nat Clin Pract Urol 4:104-10 (2007)\n            DOI:10.1038/ncpuro0711\nREFERENCE   PMID:12351585\n  AUTHORS   Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.\n  TITLE     Understanding familial and non-familial renal cell cancer.\n  JOURNAL   Hum Mol Genet 11:2489-98 (2002)\n            DOI:10.1093/hmg/11.20.2489\nREFERENCE   PMID:17158541\n  AUTHORS   Mitra AP, Datar RH, Cote RJ.\n  TITLE     Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.\n  JOURNAL   J Clin Oncol 24:5552-64 (2006)\n            DOI:10.1200/JCO.2006.08.2073\nREFERENCE   PMID:16474624\n  AUTHORS   Wolff EM, Liang G, Jones PA.\n  TITLE     Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.\n  JOURNAL   Nat Clin Pract Urol 2:502-10 (2005)\n            DOI:10.1038/ncpuro0318\nREFERENCE   PMID:16110317\n  AUTHORS   Wu XR.\n  TITLE     Urothelial tumorigenesis: a tale of divergent pathways.\n  JOURNAL   Nat Rev Cancer 5:713-25 (2005)\n            DOI:10.1038/nrc1697\nREFERENCE   PMID:11103787\n  AUTHORS   Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R.\n  TITLE     Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.\n  JOURNAL   Cancer Res 60:6298-302 (2000)\nREFERENCE   PMID:12850530\n  AUTHORS   Bellmunt J, Hussain M, Dinney CP.\n  TITLE     Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.\n  JOURNAL   Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)\n            DOI:10.1016/S1040-8428(03)00067-2\nREFERENCE   PMID:17149381\n  AUTHORS   Sugano K, Kakizoe T.\n  TITLE     Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.\n  JOURNAL   Nat Clin Pract Urol 3:642-52 (2006)\n            DOI:10.1038/ncpuro0649\nREFERENCE   PMID:15746962\n  AUTHORS   Dunn KL, Espino PS, Drobic B, He S, Davie JR.\n  TITLE     The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.\n  JOURNAL   Biochem Cell Biol 83:1-14 (2005)\n            DOI:10.1139/o04-121\nREFERENCE   PMID:15551095\n  AUTHORS   Williams SG, Stein JP.\n  TITLE     Molecular pathways in bladder cancer.\n  JOURNAL   Urol Res 32:373-85 (2004)\n            DOI:10.1007/s00240-003-0345-y\nREFERENCE   PMID:12878745\n  AUTHORS   Nelson WG, De Marzo AM, Isaacs WB.\n  TITLE     Prostate cancer.\n  JOURNAL   N Engl J Med 349:366-81 (2003)\n            DOI:10.1056/NEJMra021562\nREFERENCE   PMID:15724144\n  AUTHORS   Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.\n  TITLE     The emerging role of the PI3-K-Akt pathway in prostate cancer progression.\n  JOURNAL   Prostate Cancer Prostatic Dis 8:108-18 (2005)\n            DOI:10.1038/sj.pcan.4500776\nREFERENCE   PMID:16551847\n  AUTHORS   Pienta KJ, Bradley D.\n  TITLE     Mechanisms underlying the development of androgen-independent prostate cancer.\n  JOURNAL   Clin Cancer Res 12:1665-71 (2006)\n            DOI:10.1158/1078-0432.CCR-06-0067\nREFERENCE   PMID:11900250\n  AUTHORS   Feldman BJ, Feldman D.\n  TITLE     The development of androgen-independent prostate cancer.\n  JOURNAL   Nat Rev Cancer 1:34-45 (2001)\n            DOI:10.1038/35094009\nREFERENCE   PMID:15082523\n  AUTHORS   Heinlein CA, Chang C.\n  TITLE     Androgen receptor in prostate cancer.\n  JOURNAL   Endocr Rev 25:276-308 (2004)\n            DOI:10.1210/er.2002-0032\nREFERENCE   PMID:9422516\n  AUTHORS   Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.\n  TITLE     Androgen receptor gene and hormonal therapy failure of prostate cancer.\n  JOURNAL   Am J Pathol 152:1-9 (1998)\nREFERENCE   PMID:10835690\n  AUTHORS   Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.\n  TITLE     Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.\n  JOURNAL   Nat Med 6:703-6 (2000)\n            DOI:10.1038/76287\nREFERENCE   PMID:10453277\n  AUTHORS   Macri E, Loda M.\n  TITLE     Role of p27 in prostate carcinogenesis.\n  JOURNAL   Cancer Metastasis Rev 17:337-44 (1998)\n            DOI:10.1023/A:1006133620914\nREFERENCE   PMID:11750244\n  AUTHORS   Steers WD.\n  TITLE     5alpha-reductase activity in the prostate.\n  JOURNAL   Urology 58:17-24; discussion 24 (2001)\n            DOI:10.1016/S0090-4295(01)01299-7\nREFERENCE   PMID:8069858\n  AUTHORS   Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.\n  TITLE     Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.\n  JOURNAL   Cancer Res 54:4920-6 (1994)\nREFERENCE   PMID:11527574\n  AUTHORS   Grimes CA, Jope RS.\n  TITLE     The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.\n  JOURNAL   Prog Neurobiol 65:391-426 (2001)\n            DOI:10.1016/S0301-0082(01)00011-9\nREFERENCE   PMID:15947972\n  AUTHORS   Ryan AJ, Susil B, Jobling TW, Oehler MK.\n  TITLE     Endometrial cancer.\n  JOURNAL   Cell Tissue Res 322:53-61 (2005)\n            DOI:10.1007/s00441-005-1109-5\nREFERENCE   PMID:14747944\n  AUTHORS   Lax SF.\n  TITLE     Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.\n  JOURNAL   Virchows Arch 444:213-23 (2004)\n            DOI:10.1007/s00428-003-0947-3\nREFERENCE   PMID:16508724\n  AUTHORS   Shiozawa T, Konishi I.\n  TITLE     Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.\n  JOURNAL   Int J Clin Oncol 11:13-21 (2006)\n            DOI:10.1007/s10147-005-0546-1\nREFERENCE   PMID:17028294\n  AUTHORS   Hecht JL, Mutter GL.\n  TITLE     Molecular and pathologic aspects of endometrial carcinogenesis.\n  JOURNAL   J Clin Oncol 24:4783-91 (2006)\n            DOI:10.1200/JCO.2006.06.7173\nREFERENCE   PMID:11431710\n  AUTHORS   Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.\n  TITLE     Molecular pathology of endometrial hyperplasia and carcinoma.\n  JOURNAL   Hum Pathol 32:569-77 (2001)\n            DOI:10.1053/hupa.2001.25929\nREFERENCE   PMID:15284264\n  AUTHORS   Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.\n  TITLE     Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.\n  JOURNAL   J Clin Oncol 22:3126-32 (2004)\n            DOI:10.1200/JCO.2004.11.154\nREFERENCE   PMID:7585656\n  AUTHORS   Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.\n  TITLE     Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.\n  JOURNAL   Cancer Res 55:5693-8 (1995)\nREFERENCE   PMID:16248975\n  AUTHORS   Kim D, Chung J.\n  TITLE     Akt: versatile mediator of cell survival and beyond.\n  JOURNAL   J Biochem Mol Biol 35:106-15 (2002)\n            DOI:10.5483/bmbrep.2002.35.1.106\nREFERENCE   PMID:12711111\n  AUTHORS   Sanchez-Cespedes M.\n  TITLE     Dissecting the genetic alterations involved in lung carcinogenesis.\n  JOURNAL   Lung Cancer 40:111-21 (2003)\n            DOI:10.1016/S0169-5002(03)00033-3\nREFERENCE   PMID:11720739\n  AUTHORS   Kaye FJ.\n  TITLE     Molecular biology of lung cancer.\n  JOURNAL   Lung Cancer 34 Suppl 2:S35-41 (2001)\n            DOI:10.1016/S0169-5002(01)00342-7\nREFERENCE   PMID:12616528\n  AUTHORS   Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.\n  TITLE     Apoptosis and lung cancer: a review.\n  JOURNAL   J Cell Biochem 88:885-98 (2003)\n            DOI:10.1002/jcb.10440\nREFERENCE   PMID:11807782\n  AUTHORS   Sartorius UA, Krammer PH.\n  TITLE     Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.\n  JOURNAL   Int J Cancer 97:584-92 (2002)\n            DOI:10.1002/ijc.10096\nREFERENCE   PMID:16064138\n  AUTHORS   Adhikary S, Eilers M.\n  TITLE     Transcriptional regulation and transformation by Myc proteins.\n  JOURNAL   Nat Rev Mol Cell Biol 6:635-45 (2005)\n            DOI:10.1038/nrm1703\nREFERENCE   PMID:11463388\n  AUTHORS   Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.\n  TITLE     A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.\n  JOURNAL   Mol Cell 7:639-50 (2001)\n            DOI:10.1016/S1097-2765(01)00210-6\nREFERENCE   PMID:15109562\n  AUTHORS   Buttery RC, Rintoul RC, Sethi T.\n  TITLE     Small cell lung cancer: the importance of the extracellular matrix.\n  JOURNAL   Int J Biochem Cell Biol 36:1154-60 (2004)\n            DOI:10.1016/S1357-2725(03)00261-9\nREFERENCE   PMID:11559746\n  AUTHORS   Yamada KM, Araki M.\n  TITLE     Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.\n  JOURNAL   J Cell Sci 114:2375-82 (2001)\nREFERENCE   PMID:11905738\n  AUTHORS   Rintoul RC, Sethi T.\n  TITLE     The role of extracellular matrix in small-cell lung cancer.\n  JOURNAL   Lancet Oncol 2:437-42 (2001)\n            DOI:10.1016/S1470-2045(00)00421-6\nREFERENCE   PMID:12243753\n  AUTHORS   Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.\n  TITLE     Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.\n  JOURNAL   Exp Cell Res 279:277-90 (2002)\n            DOI:10.1006/excr.2002.5608\nREFERENCE   PMID:12379883\n  AUTHORS   Osada H, Takahashi T.\n  TITLE     Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.\n  JOURNAL   Oncogene 21:7421-34 (2002)\n            DOI:10.1038/sj.onc.1205802\nREFERENCE   PMID:12741677\n  AUTHORS   Yokota J, Nishioka M, Tani M, Kohno T.\n  TITLE     Genetic alterations responsible for metastatic phenotypes of lung cancer cells.\n  JOURNAL   Clin Exp Metastasis 20:189-93 (2003)\n            DOI:10.1023/a:1022978932215\nREFERENCE   PMID:16870043\n  AUTHORS   Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.\n  TITLE     K-ras mutations in non-small-cell lung carcinoma: a review.\n  JOURNAL   Clin Lung Cancer 8:30-8 (2006)\n            DOI:10.3816/CLC.2006.n.030\nREFERENCE   PMID:15948711\n  AUTHORS   Pfeifer GP, Dammann R.\n  TITLE     Methylation of the tumor suppressor gene RASSF1A in human tumors.\n  JOURNAL   Biochemistry (Mosc) 70:576-83 (2005)\n            DOI:10.1007/s10541-005-0151-y\nREFERENCE   PMID:11902573\n  AUTHORS   Altucci L, Gronemeyer H.\n  TITLE     The promise of retinoids to fight against cancer.\n  JOURNAL   Nat Rev Cancer 1:181-93 (2001)\n            DOI:10.1038/35106036\nREFERENCE   PMID:10944551\n  AUTHORS   Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.\n  TITLE     Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.\n  JOURNAL   J Natl Cancer Inst 92:1303-7 (2000)\n            DOI:10.1093/jnci/92.16.1303\nREFERENCE   PMID:12867060\n  AUTHORS   Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.\n  TITLE     Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.\n  JOURNAL   Lung Cancer 41 Suppl 1:S29-42 (2003)\n            DOI:10.1016/S0169-5002(03)00137-5\nREFERENCE   PMID:16112428\n  AUTHORS   Panani AD, Roussos C.\n  TITLE     Cytogenetic and molecular aspects of lung cancer.\n  JOURNAL   Cancer Lett 239:1-9 (2006)\n            DOI:10.1016/j.canlet.2005.06.030\nREFERENCE   PMID:12407699\n  AUTHORS   Mitsuuchi Y, Testa JR.\n  TITLE     Cytogenetics and molecular genetics of lung cancer.\n  JOURNAL   Am J Med Genet 115:183-8 (2002)\n            DOI:10.1002/ajmg.10692\nREFERENCE   PMID:15942304\n  AUTHORS   Breuer RH, Postmus PE, Smit EF.\n  TITLE     Molecular pathology of non-small-cell lung cancer.\n  JOURNAL   Respiration 72:313-30 (2005)\n            DOI:10.1159/000085376\nREFERENCE   PMID:11895903\n  AUTHORS   Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.\n  TITLE     Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.\n  JOURNAL   Clin Cancer Res 8:734-44 (2002)\nREFERENCE   PMID:16189154\n  AUTHORS   Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.\n  TITLE     Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.\n  JOURNAL   J Clin Pathol 58:1076-80 (2005)\n            DOI:10.1136/jcp.2004.025585\nREFERENCE   PMID:21193867\n  AUTHORS   Lappano R, Maggiolini M\n  TITLE     G protein-coupled receptors: novel targets for drug discovery in cancer.\n  JOURNAL   Nat Rev Drug Discov 10:47-60 (2011)\n            DOI:10.1038/nrd3320\nREFERENCE   PMID:24508914\n  AUTHORS   O'Hayre M, Degese MS, Gutkind JS\n  TITLE     Novel insights into G protein and G protein-coupled receptor signaling in cancer.\n  JOURNAL   Curr Opin Cell Biol 27:126-35 (2014)\n            DOI:10.1016/j.ceb.2014.01.005\nREFERENCE   PMID:17251915\n  AUTHORS   Dorsam RT, Gutkind JS\n  TITLE     G-protein-coupled receptors and cancer.\n  JOURNAL   Nat Rev Cancer 7:79-94 (2007)\n            DOI:10.1038/nrc2069\nREL_PATHWAY map03320  PPAR signaling pathway\n            map04010  MAPK signaling pathway\n            map04020  Calcium signaling pathway\n            map04024  cAMP signaling pathway\n            map04060  Cytokine-cytokine receptor interaction\n            map04066  HIF-1 signaling pathway\n            map04110  Cell cycle\n            map04115  p53 signaling pathway\n            map04150  mTOR signaling pathway\n            map04151  PI3K-Akt signaling pathway\n            map04210  Apoptosis\n            map04310  Wnt signaling pathway\n            map04330  Notch signaling pathway\n            map04340  Hedgehog signaling pathway\n            map04350  TGF-beta signaling pathway\n            map04370  VEGF signaling pathway\n            map04510  Focal adhesion\n            map04512  ECM-receptor interaction\n            map04520  Adherens junction\n            map04630  JAK-STAT signaling pathway\n            map04915  Estrogen signaling pathway\nKO_PATHWAY  ko05200\n///\n","added":1656608586771},{"name":"map05215","response":"ENTRY       map05215                    Pathway\nNAME        Prostate cancer\nDESCRIPTION Prostate cancer constitutes a major health problem in Western countries. It is the most frequently diagnosed cancer among men and the second leading cause of male cancer deaths. The identification of key molecular alterations in prostate-cancer cells implicates carcinogen defenses (GSTP1), growth-factor-signaling pathways (NKX3.1, PTEN, and p27), and androgens (AR) as critical determinants of the phenotype of prostate-cancer cells. Glutathione S-transferases (GSTP1) are detoxifying enzymes. Cells of prostatic intraepithelial neoplasia, devoid of GSTP1, undergo genomic damage mediated by carcinogens. NKX3.1, PTEN, and p27 regulate the growth and survival of prostate cells in the normal prostate. Inadequate levels of PTEN and NKX3.1 lead to a reduction in p27 levels and to increased proliferation and decreased apoptosis. Androgen receptor (AR) is a transcription factor that is normally activated by its androgen ligand. During androgen withdrawal therapy, the AR signal transduction pathway also could be activated by amplification of the AR gene, by AR gene mutations, or by altered activity of AR coactivators. Through these mechanisms, tumor cells lead to the emergence of androgen-independent prostate cancer.\nCLASS       Human Diseases; Cancer: specific types\nPATHWAY_MAP map05215  Prostate cancer\nDISEASE     H00024  Prostate cancer\nREFERENCE   PMID:12878745\n  AUTHORS   Nelson WG, De Marzo AM, Isaacs WB.\n  TITLE     Prostate cancer.\n  JOURNAL   N Engl J Med 349:366-81 (2003)\n            DOI:10.1056/NEJMra021562\nREFERENCE   PMID:15724144\n  AUTHORS   Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.\n  TITLE     The emerging role of the PI3-K-Akt pathway in prostate cancer progression.\n  JOURNAL   Prostate Cancer Prostatic Dis 8:108-18 (2005)\n            DOI:10.1038/sj.pcan.4500776\nREFERENCE   PMID:16551847\n  AUTHORS   Pienta KJ, Bradley D.\n  TITLE     Mechanisms underlying the development of androgen-independent prostate cancer.\n  JOURNAL   Clin Cancer Res 12:1665-71 (2006)\n            DOI:10.1158/1078-0432.CCR-06-0067\nREFERENCE   PMID:11900250\n  AUTHORS   Feldman BJ, Feldman D.\n  TITLE     The development of androgen-independent prostate cancer.\n  JOURNAL   Nat Rev Cancer 1:34-45 (2001)\n            DOI:10.1038/35094009\nREFERENCE   PMID:15082523\n  AUTHORS   Heinlein CA, Chang C.\n  TITLE     Androgen receptor in prostate cancer.\n  JOURNAL   Endocr Rev 25:276-308 (2004)\n            DOI:10.1210/er.2002-0032\nREFERENCE   PMID:9422516\n  AUTHORS   Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.\n  TITLE     Androgen receptor gene and hormonal therapy failure of prostate cancer.\n  JOURNAL   Am J Pathol 152:1-9 (1998)\nREFERENCE   PMID:10835690\n  AUTHORS   Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.\n  TITLE     Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.\n  JOURNAL   Nat Med 6:703-6 (2000)\n            DOI:10.1038/76287\nREFERENCE   PMID:10453277\n  AUTHORS   Macri E, Loda M.\n  TITLE     Role of p27 in prostate carcinogenesis.\n  JOURNAL   Cancer Metastasis Rev 17:337-44 (1998)\n            DOI:10.1023/A:1006133620914\nREFERENCE   PMID:11750244\n  AUTHORS   Steers WD.\n  TITLE     5alpha-reductase activity in the prostate.\n  JOURNAL   Urology 58:17-24; discussion 24 (2001)\n            DOI:10.1016/S0090-4295(01)01299-7\nREFERENCE   PMID:8069858\n  AUTHORS   Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.\n  TITLE     Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.\n  JOURNAL   Cancer Res 54:4920-6 (1994)\nREFERENCE   PMID:11527574\n  AUTHORS   Grimes CA, Jope RS.\n  TITLE     The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.\n  JOURNAL   Prog Neurobiol 65:391-426 (2001)\n            DOI:10.1016/S0301-0082(01)00011-9\nREFERENCE   PMID:21747944\n  AUTHORS   Leshem O, Madar S, Kogan-Sakin I, Kamer I, Goldstein I, Brosh R, Cohen Y, Jacob-Hirsch J, Ehrlich M, Ben-Sasson S, Goldfinger N, Loewenthal R, Gazit E, Rotter V, Berger R\n  TITLE     TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model.\n  JOURNAL   PLoS One 6:e21650 (2011)\n            DOI:10.1371/journal.pone.0021650\nREFERENCE   PMID:20478527\n  AUTHORS   Yu J, Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, Wang X, Wu L, Li J, Hu M, Gong Y, Cheng H, Laxman B, Vellaichamy A, Shankar S, Li Y, Dhanasekaran SM, Morey R, Barrette T, Lonigro RJ, Tomlins SA, Varambally S, Qin ZS, Chinnaiyan AM\n  TITLE     An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.\n  JOURNAL   Cancer Cell 17:443-54 (2010)\n            DOI:10.1016/j.ccr.2010.03.018\nREFERENCE   PMID:19399032\n  AUTHORS   Squire JA\n  TITLE     TMPRSS2-ERG and PTEN loss in prostate cancer.\n  JOURNAL   Nat Genet 41:509-10 (2009)\n            DOI:10.1038/ng0509-509\nREFERENCE   PMID:25915839\n  AUTHORS   Adamo P, Ladomery MR\n  TITLE     The oncogene ERG: a key factor in prostate cancer.\n  JOURNAL   Oncogene 35:403-14 (2016)\n            DOI:10.1038/onc.2015.109\nREFERENCE   PMID:25485532\n  AUTHORS   Burdova A, Bouchal J, Tavandzis S, Kolar Z\n  TITLE     TMPRSS2-ERG gene fusion in prostate cancer.\n  JOURNAL   Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 158:502-10 (2014)\n            DOI:10.5507/bp.2014.065\nREFERENCE   PMID:18172298\n  AUTHORS   Helgeson BE, Tomlins SA, Shah N, Laxman B, Cao Q, Prensner JR, Cao X, Singla N, Montie JE, Varambally S, Mehra R, Chinnaiyan AM\n  TITLE     Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.\n  JOURNAL   Cancer Res 68:73-80 (2008)\n            DOI:10.1158/0008-5472.CAN-07-5352\nREFERENCE   PMID:28968951\n  AUTHORS   Kim H, Datta A, Talwar S, Saleem SN, Mondal D, Abdel-Mageed AB\n  TITLE     Estradiol-ERbeta2 signaling axis confers growth and migration of CRPC cells through TMPRSS2-ETV5 gene fusion.\n  JOURNAL   Oncotarget 8:62820-62833 (2017)\n            DOI:10.18632/oncotarget.11355\nREL_PATHWAY map00140  Steroid hormone biosynthesis\n            map04010  MAPK signaling pathway\n            map04060  Cytokine-cytokine receptor interaction\n            map04110  Cell cycle\n            map04115  p53 signaling pathway\n            map04151  PI3K-Akt signaling pathway\n            map04210  Apoptosis\n            map05202  Transcriptional misregulation in cancer\nKO_PATHWAY  ko05215\n///\n","added":1656608587859},{"name":"map04914","response":"ENTRY       map04914                    Pathway\nNAME        Progesterone-mediated oocyte maturation\nDESCRIPTION Xenopus oocytes are naturally arrested at G2 of meiosis I. Exposure to either insulin/IGF-1 or the steroid hormone progesterone breaks this arrest and induces resumption of the two meiotic division cycles and maturation of the oocyte into a mature, fertilizable egg. This process is termed oocyte maturation. The transition is accompanied by an increase in maturation promoting factor (MPF or Cdc2/cyclin B) which precedes germinal vesicle breakdown (GVBD). Most reports point towards the Mos-MEK1-ERK2 pathway [where ERK is an extracellular signal-related protein kinase, MEK is a MAPK/ERK kinase and Mos is a p42(MAPK) activator] and the polo-like kinase/CDC25 pathway as responsible for the activation of MPF in meiosis, most likely triggered by a decrease in cAMP.\nCLASS       Organismal Systems; Endocrine system\nPATHWAY_MAP map04914  Progesterone-mediated oocyte maturation\nDBLINKS     GO: 0001556\nREFERENCE   PMID:12045215\n  AUTHORS   Schmitt A, Nebreda AR.\n  TITLE     Signalling pathways in oocyte meiotic maturation.\n  JOURNAL   J Cell Sci 115:2457-9 (2002)\nREFERENCE   PMID:12084906\n  AUTHORS   Cato AC, Nestl A, Mink S.\n  TITLE     Rapid actions of steroid receptors in cellular signaling pathways.\n  JOURNAL   Sci STKE 2002:RE9 (2002)\n            DOI:10.1126/stke.2002.138.re9\nREFERENCE   PMID:11730319\n  AUTHORS   Maller JL, Schwab MS, Roberts BT, Gross SD, Taieb FE, Tunquist BJ.\n  TITLE     The pathway of MAP kinase mediation of CSF arrest in Xenopus oocytes.\n  JOURNAL   Biol Cell 93:27-33 (2001)\n            DOI:10.1016/S0248-4900(01)01127-3\nREFERENCE   PMID:11063930\n  AUTHORS   Nebreda AR, Ferby I.\n  TITLE     Regulation of the meiotic cell cycle in oocytes.\n  JOURNAL   Curr Opin Cell Biol 12:666-75 (2000)\n            DOI:10.1016/S0955-0674(00)00150-2\nREFERENCE   PMID:10497333\n  AUTHORS   Ferrell JE Jr.\n  TITLE     Xenopus oocyte maturation: new lessons from a good egg.\n  JOURNAL   Bioessays 21:833-42 (1999)\n            DOI:10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P\nREFERENCE   PMID:12374568\n  AUTHORS   Andersen CB, Sakaue H, Nedachi T, Kovacina KS, Clayberger C, Conti M, Roth RA.\n  TITLE     Protein kinase B/Akt is essential for the insulin- but not progesterone-stimulated resumption of meiosis in Xenopus oocytes.\n  JOURNAL   Biochem J 369:227-38 (2003)\n            DOI:10.1042/BJ20021243\nREFERENCE   PMID:12477927\n  AUTHORS   Duckworth BC, Weaver JS, Ruderman JV.\n  TITLE     G2 arrest in Xenopus oocytes depends on phosphorylation of cdc25 by protein kinase A.\n  JOURNAL   Proc Natl Acad Sci U S A 99:16794-9 (2002)\n            DOI:10.1073/pnas.222661299\nREFERENCE   PMID:11148128\n  AUTHORS   Abrieu A, Doree M, Fisher D.\n  TITLE     The interplay between cyclin-B-Cdc2 kinase (MPF) and MAP kinase during maturation of oocytes.\n  JOURNAL   J Cell Sci 114:257-67 (2001)\nREL_PATHWAY map04010  MAPK signaling pathway\n            map04110  Cell cycle\nKO_PATHWAY  ko04914\n///\n","added":1656608588681},{"name":"map00030","response":"ENTRY       map00030                    Pathway\nNAME        Pentose phosphate pathway\nDESCRIPTION The pentose phosphate pathway is a process of glucose turnover that produces NADPH as reducing equivalents and pentoses as essential parts of nucleotides. There are two different phases in the pathway. One is irreversible oxidative phase in which glucose-6P is converted to ribulose-5P by oxidative decarboxylation, and NADPH is generated [MD:M00006]. The other is reversible non-oxidative phase in which phosphorylated sugars are interconverted to generate xylulose-5P, ribulose-5P, and ribose-5P [MD:M00007]. Phosphoribosyl pyrophosphate (PRPP) formed from ribose-5P [MD:M00005] is an activated compound used in the biosynthesis of histidine and purine/pyrimidine nucleotides. This pathway map also shows the Entner-Doudoroff pathway where 6-P-gluconate is dehydrated and then cleaved into pyruvate and glyceraldehyde-3P [MD:M00008].\nCLASS       Metabolism; Carbohydrate metabolism\nPATHWAY_MAP map00030  Pentose phosphate pathway\nMODULE      M00004  Pentose phosphate pathway (Pentose phosphate cycle) [PATH:map00030]\n            M00005  PRPP biosynthesis, ribose 5P => PRPP [PATH:map00030]\n            M00006  Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P [PATH:map00030]\n            M00007  Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P [PATH:map00030]\n            M00008  Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate [PATH:map00030]\n            M00061  D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P [PATH:map00030]\n            M00308  Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P [PATH:map00030]\n            M00309  Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate [PATH:map00030]\n            M00345  Formaldehyde assimilation, ribulose monophosphate pathway [PATH:map00030]\n            M00580  Pentose phosphate pathway, archaea, fructose 6P => ribose 5P [PATH:map00030]\n            M00631  D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P [PATH:map00030]\n            M00633  Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P [PATH:map00030]\nDBLINKS     GO: 0006098\nREFERENCE   \n  AUTHORS   Nishizuka Y (ed).\n  TITLE     [Metabolic Maps] (In Japanese)\n  JOURNAL   Tokyo Kagaku Dojin (1980)\nREFERENCE   \n  AUTHORS   Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).\n  TITLE     [Cellular Functions and Metabolic Maps] (In Japanese)\n  JOURNAL   Tokyo Kagaku Dojin (1997)\nREFERENCE   \n  AUTHORS   Michal G.\n  TITLE     Biochemical Pathways\n  JOURNAL   Wiley (1999)\nREFERENCE   PMID:12700258\n  AUTHORS   Hove-Jensen B, Rosenkrantz TJ, Haldimann A, Wanner BL.\n  TITLE     Escherichia coli phnN, encoding ribose 1,5-bisphosphokinase activity (phosphoribosyl diphosphate forming): dual role in phosphonate degradation and NAD biosynthesis pathways.\n  JOURNAL   J Bacteriol 185:2793-801 (2003)\n            DOI:10.1128/JB.185.9.2793-2801.2003\nREFERENCE   PMID:16788179\n  AUTHORS   Orita I, Sato T, Yurimoto H, Kato N, Atomi H, Imanaka T, Sakai Y\n  TITLE     The ribulose monophosphate pathway substitutes for the missing pentose phosphate pathway in the archaeon Thermococcus kodakaraensis.\n  JOURNAL   J Bacteriol 188:4698-704 (2006)\n            DOI:10.1128/JB.00492-06\nREFERENCE   PMID:16428816\n  AUTHORS   Kato N, Yurimoto H, Thauer RK\n  TITLE     The physiological role of the ribulose monophosphate pathway in bacteria and archaea.\n  JOURNAL   Biosci Biotechnol Biochem 70:10-21 (2006)\n            DOI:10.1271/bbb.70.10\nREFERENCE   PMID:23279921\n  AUTHORS   Kouril T, Wieloch P, Reimann J, Wagner M, Zaparty M, Albers SV, Schomburg D, Ruoff P, Siebers B\n  TITLE     Unraveling the function of the two Entner-Doudoroff branches in the thermoacidophilic Crenarchaeon Sulfolobus solfataricus P2.\n  JOURNAL   FEBS J 280:1126-38 (2013)\n            DOI:10.1111/febs.12106\nREFERENCE   PMID:16458304\n  AUTHORS   Reher M, Schonheit P\n  TITLE     Glyceraldehyde dehydrogenases from the thermoacidophilic euryarchaeota Picrophilus torridus and Thermoplasma acidophilum, key enzymes of the non-phosphorylative Entner-Doudoroff pathway, constitute a novel enzyme family within the aldehyde dehydrogenase superfamily.\n  JOURNAL   FEBS Lett 580:1198-204 (2006)\n            DOI:10.1016/j.febslet.2006.01.029\nREFERENCE   PMID:20023024\n  AUTHORS   Reher M, Fuhrer T, Bott M, Schonheit P\n  TITLE     The nonphosphorylative Entner-Doudoroff pathway in the thermoacidophilic euryarchaeon Picrophilus torridus involves a novel 2-keto-3-deoxygluconate- specific aldolase.\n  JOURNAL   J Bacteriol 192:964-74 (2010)\n            DOI:10.1128/JB.01281-09\nREL_PATHWAY map00010  Glycolysis / Gluconeogenesis\n            map00040  Pentose and glucuronate interconversions\n            map00052  Galactose metabolism\n            map00230  Purine metabolism\n            map00240  Pyrimidine metabolism\n            map00340  Histidine metabolism\n            map00750  Vitamin B6 metabolism\nKO_PATHWAY  ko00030\n///\n","added":1656608625256},{"name":"map00052","response":"ENTRY       map00052                    Pathway\nNAME        Galactose metabolism\nCLASS       Metabolism; Carbohydrate metabolism\nPATHWAY_MAP map00052  Galactose metabolism\nMODULE      M00309  Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate [PATH:map00052]\n            M00552  D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P [PATH:map00052]\n            M00554  Nucleotide sugar biosynthesis, galactose => UDP-galactose [PATH:map00052]\n            M00632  Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P [PATH:map00052]\n            M00633  Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P [PATH:map00052]\nDBLINKS     GO: 0006012\nREL_PATHWAY map00010  Glycolysis / Gluconeogenesis\n            map00030  Pentose phosphate pathway\n            map00040  Pentose and glucuronate interconversions\n            map00051  Fructose and mannose metabolism\n            map00520  Amino sugar and nucleotide sugar metabolism\nKO_PATHWAY  ko00052\n///\n","added":1656608626108},{"name":"map00520","response":"ENTRY       map00520                    Pathway\nNAME        Amino sugar and nucleotide sugar metabolism\nCLASS       Metabolism; Carbohydrate metabolism\nPATHWAY_MAP map00520  Amino sugar and nucleotide sugar metabolism\nMODULE      M00549  Nucleotide sugar biosynthesis, glucose => UDP-glucose [PATH:map00520]\n            M00554  Nucleotide sugar biosynthesis, galactose => UDP-galactose [PATH:map00520]\n            M00761  Undecaprenylphosphate alpha-L-Ara4N biosynthesis, UDP-GlcA => undecaprenyl phosphate alpha-L-Ara4N [PATH:map00520]\n            M00892  UDP-N-acetyl-D-glucosamine biosynthesis, eukaryotes, glucose => UDP-GlcNAc [PATH:map00520]\n            M00909  UDP-N-acetyl-D-glucosamine biosynthesis, prokaryotes, glucose => UDP-GlcNAc [PATH:map00520]\nDBLINKS     GO: 0006040 0009225\nREFERENCE   PMID:2793832\n  AUTHORS   Wyk P, Reeves P\n  TITLE     Identification and sequence of the gene for abequose synthase, which confers antigenic specificity on group B salmonellae: homology with galactose epimerase.\n  JOURNAL   J Bacteriol 171:5687-93 (1989)\n            DOI:10.1128/JB.171.10.5687-5693.1989\nREFERENCE   PMID:8071227\n  AUTHORS   Thorson JS, Lo SF, Ploux O, He X, Liu HW\n  TITLE     Studies of the biosynthesis of 3,6-dideoxyhexoses: molecular cloning and characterization of the asc (ascarylose) region from Yersinia pseudotuberculosis serogroup VA.\n  JOURNAL   J Bacteriol 176:5483-93 (1994)\n            DOI:10.1128/JB.176.17.5483-5493.1994\nREFERENCE   PMID:8444803\n  AUTHORS   Kessler AC, Haase A, Reeves PR\n  TITLE     Molecular analysis of the 3,6-dideoxyhexose pathway genes of Yersinia pseudotuberculosis serogroup IIA.\n  JOURNAL   J Bacteriol 175:1412-22 (1993)\n            DOI:10.1128/JB.175.5.1412-1422.1993\nREFERENCE   PMID:9811644\n  AUTHORS   Danese PN, Oliver GR, Barr K, Bowman GD, Rick PD, Silhavy TJ\n  TITLE     Accumulation of the enterobacterial common antigen lipid II biosynthetic intermediate stimulates degP transcription in Escherichia coli.\n  JOURNAL   J Bacteriol 180:5875-84 (1998)\n            DOI:10.1128/JB.180.22.5875-5884.1998\nREFERENCE   PMID:10931327\n  AUTHORS   Skurnik M, Peippo A, Ervela E\n  TITLE     Characterization of the O-antigen gene clusters of Yersinia pseudotuberculosis and the cryptic O-antigen gene cluster of Yersinia pestis shows that the plague bacillus is most closely related to and has evolved from Y. pseudotuberculosis serotype O:1b.\n  JOURNAL   Mol Microbiol 37:316-30 (2000)\n            DOI:10.1046/j.1365-2958.2000.01993.x\nREFERENCE   PMID:10984043\n  AUTHORS   Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV\n  TITLE     Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.\n  JOURNAL   Nature 406:959-64 (2000)\n            DOI:10.1038/35023079\nREFERENCE   PMID:11447132\n  AUTHORS   Ringenberg M, Lichtensteiger C, Vimr E\n  TITLE     Redirection of sialic acid metabolism in genetically engineered Escherichia coli.\n  JOURNAL   Glycobiology 11:533-9 (2001)\n            DOI:10.1093/glycob/11.7.533\nREFERENCE   PMID:12562791\n  AUTHORS   McCoy AJ, Sandlin RC, Maurelli AT\n  TITLE     In vitro and in vivo functional activity of Chlamydia MurA, a UDP-N-acetylglucosamine enolpyruvyl transferase involved in peptidoglycan synthesis and fosfomycin resistance.\n  JOURNAL   J Bacteriol 185:1218-28 (2003)\n            DOI:10.1128/JB.185.4.1218-1228.2003\nREFERENCE   PMID:14450717\n  AUTHORS   JACOBSON B, DAVIDSON EA\n  TITLE     Biosynthesis of uronic acids by skin enzymes. I. Uridine diphosphate-D-glucuronic acid-5-epimerase.\n  JOURNAL   J Biol Chem 237:638-42 (1962)\nREFERENCE   PMID:15134748\n  AUTHORS   Seifert GJ\n  TITLE     Nucleotide sugar interconversions and cell wall biosynthesis: how to bring the inside to the outside.\n  JOURNAL   Curr Opin Plant Biol 7:277-84 (2004)\n            DOI:10.1016/j.pbi.2004.03.004\nREFERENCE   PMID:15489439\n  AUTHORS   Uehara T, Park JT\n  TITLE     The N-acetyl-D-glucosamine kinase of Escherichia coli and its role in murein recycling.\n  JOURNAL   J Bacteriol 186:7273-9 (2004)\n            DOI:10.1128/JB.186.21.7273-7279.2004\nREFERENCE   PMID:15695810\n  AUTHORS   Breazeale SD, Ribeiro AA, McClerren AL, Raetz CR.\n  TITLE     A formyltransferase required for polymyxin resistance in Escherichia coli and the modification of lipid A with 4-Amino-4-deoxy-L-arabinose. Identification and function oF UDP-4-deoxy-4-formamido-L-arabinose.\n  JOURNAL   J Biol Chem 280:14154-67 (2005)\n            DOI:10.1074/jbc.M414265200\nREFERENCE   PMID:15809294\n  AUTHORS   Williams GJ, Breazeale SD, Raetz CR, Naismith JH.\n  TITLE     Structure and function of both domains of ArnA, a dual function decarboxylase and a formyltransferase, involved in 4-amino-4-deoxy-L-arabinose biosynthesis.\n  JOURNAL   J Biol Chem 280:23000-8 (2005)\n            DOI:10.1074/jbc.M501534200\nREFERENCE   PMID:16237198\n  AUTHORS   Maliekal P, Vertommen D, Delpierre G, Van Schaftingen E\n  TITLE     Identification of the sequence encoding N-acetylneuraminate-9-phosphate phosphatase.\n  JOURNAL   Glycobiology 16:165-72 (2006)\n            DOI:10.1093/glycob/cwj050\nREFERENCE   PMID:16277754\n  AUTHORS   Campbell CT, Yarema KJ\n  TITLE     Large-scale approaches for glycobiology.\n  JOURNAL   Genome Biol 6:236 (2005)\n            DOI:10.1186/gb-2005-6-11-236\nREFERENCE   PMID:16452451\n  AUTHORS   Uehara T, Suefuji K, Jaeger T, Mayer C, Park JT\n  TITLE     MurQ Etherase is required by Escherichia coli in order to metabolize anhydro-N-acetylmuramic acid obtained either from the environment or from its own cell wall.\n  JOURNAL   J Bacteriol 188:1660-2 (2006)\n            DOI:10.1128/JB.188.4.1660-1662.2006\nREFERENCE   PMID:16995900\n  AUTHORS   Lanot A, Hodge D, Jackson RG, George GL, Elias L, Lim EK, Vaistij FE, Bowles DJ\n  TITLE     The glucosyltransferase UGT72E2 is responsible for monolignol 4-O-glucoside production in Arabidopsis thaliana.\n  JOURNAL   Plant J 48:286-95 (2006)\n            DOI:10.1111/j.1365-313X.2006.02872.x\nREFERENCE   PMID:17085508\n  AUTHORS   Muller R, Morant M, Jarmer H, Nilsson L, Nielsen TH\n  TITLE     Genome-wide analysis of the Arabidopsis leaf transcriptome reveals interaction of phosphate and sugar metabolism.\n  JOURNAL   Plant Physiol 143:156-71 (2007)\n            DOI:10.1104/pp.106.090167\nREFERENCE   PMID:17190829\n  AUTHORS   Oka T, Nemoto T, Jigami Y\n  TITLE     Functional analysis of Arabidopsis thaliana RHM2/MUM4, a multidomain protein involved in UDP-D-glucose to UDP-L-rhamnose conversion.\n  JOURNAL   J Biol Chem 282:5389-403 (2007)\n            DOI:10.1074/jbc.M610196200\nREFERENCE   PMID:17827295\n  AUTHORS   Greenberg DE, Porcella SF, Zelazny AM, Virtaneva K, Sturdevant DE, Kupko JJ 3rd, Barbian KD, Babar A, Dorward DW, Holland SM.\n  TITLE     Genome sequence analysis of the emerging human pathogenic acetic acid bacterium Granulibacter bethesdensis.\n  JOURNAL   J Bacteriol 189:8727-36 (2007)\n            DOI:10.1128/JB.00793-07\nREFERENCE   PMID:18199744\n  AUTHORS   Kotake T, Hojo S, Tajima N, Matsuoka K, Koyama T, Tsumuraya Y\n  TITLE     A bifunctional enzyme with L-fucokinase and GDP-L-fucose pyrophosphorylase activities salvages free L-fucose in Arabidopsis.\n  JOURNAL   J Biol Chem 283:8125-35 (2008)\n            DOI:10.1074/jbc.M710078200\nREFERENCE   PMID:18304669\n  AUTHORS   Vorholter FJ, Schneiker S, Goesmann A, Krause L, Bekel T, Kaiser O, Linke B, Patschkowski T, Ruckert C, Schmid J, Sidhu VK, Sieber V, Tauch A, Watt SA, Weisshaar B, Becker A, Niehaus K, Puhler A.\n  TITLE     The genome of Xanthomonas campestris pv. campestris B100 and its use for the reconstruction of metabolic pathways involved in xanthan biosynthesis.\n  JOURNAL   J Biotechnol 134:33-45 (2008)\n            DOI:10.1016/j.jbiotec.2007.12.013\nREFERENCE   PMID:11479276\n  AUTHORS   Albermann C, Piepersberg W\n  TITLE     Expression and identification of the RfbE protein from Vibrio cholerae O1 and its use for the enzymatic synthesis of GDP-D-perosamine.\n  JOURNAL   Glycobiology 11:655-61 (2001)\n            DOI:10.1093/glycob/11.8.655\nREL_PATHWAY map00010  Glycolysis / Gluconeogenesis\n            map00040  Pentose and glucuronate interconversions\n            map00051  Fructose and mannose metabolism\n            map00052  Galactose metabolism\n            map00053  Ascorbate and aldarate metabolism\n            map00500  Starch and sucrose metabolism\n            map00510  N-Glycan biosynthesis\n            map00523  Polyketide sugar unit biosynthesis\n            map00524  Neomycin, kanamycin and gentamicin biosynthesis\n            map00525  Acarbose and validamycin biosynthesis\n            map00540  Lipopolysaccharide biosynthesis\n            map00550  Peptidoglycan biosynthesis\nKO_PATHWAY  ko00520\n///\n","added":1656608627410},{"name":"map00403","response":"ENTRY       map00403                    Pathway\nNAME        Indole diterpene alkaloid biosynthesis\nDESCRIPTION Indole diterpene alkaloids are a group of meroterpenoids consisting of a partial diterpene structure with four isoprene units and an indole moiety. The common cyclic diterpene skeleton is derived from geranylgeranyl diphosphate (GGPP) and an indole moiety is derived from tryptophan or a tryptophan precursor. They are combined in the initial step of biosynthetic reactions that generate paspaline, the first stable and less modified form required for other forms. Most indole diterpene alkaloids have potent mammalian tremorgenic activities, such as ryegrass staggers in livestock, and some have anti-insect properties. This map shows examples of indole diterpene alkaloids isolated from filamentous fungi.\nCLASS       Metabolism; Biosynthesis of other secondary metabolites\nPATHWAY_MAP map00403  Indole diterpene alkaloid biosynthesis\nMODULE      M00661  Paspaline biosynthesis, geranylgeranyl-PP + indoleglycerol phosphate => paspaline [PATH:map00403]\nREFERENCE   PMID:18262778\n  AUTHORS   Saikia S, Nicholson MJ, Young C, Parker EJ, Scott B\n  TITLE     The genetic basis for indole-diterpene chemical diversity in filamentous fungi.\n  JOURNAL   Mycol Res 112:184-99 (2008)\n            DOI:10.1016/j.mycres.2007.06.015\nREFERENCE   PMID:16494875\n  AUTHORS   Saikia S, Parker EJ, Koulman A, Scott B\n  TITLE     Four gene products are required for the fungal synthesis of the indole-diterpene, paspaline.\n  JOURNAL   FEBS Lett 580:1625-30 (2006)\n            DOI:10.1016/j.febslet.2006.02.008\nREFERENCE   PMID:17428785\n  AUTHORS   Saikia S, Parker EJ, Koulman A, Scott B\n  TITLE     Defining paxilline biosynthesis in Penicillium paxilli: functional characterization of two cytochrome P450 monooxygenases.\n  JOURNAL   J Biol Chem 282:16829-37 (2007)\n            DOI:10.1074/jbc.M701626200\nREFERENCE   PMID:19801473\n  AUTHORS   Nicholson MJ, Koulman A, Monahan BJ, Pritchard BL, Payne GA, Scott B\n  TITLE     Identification of two aflatrem biosynthesis gene loci in Aspergillus flavus and metabolic engineering of Penicillium paxilli to elucidate their function.\n  JOURNAL   Appl Environ Microbiol 75:7469-81 (2009)\n            DOI:10.1128/AEM.02146-08\nREFERENCE   PMID:22750140\n  AUTHORS   Saikia S, Takemoto D, Tapper BA, Lane GA, Fraser K, Scott B\n  TITLE     Functional analysis of an indole-diterpene gene cluster for lolitrem B biosynthesis in the grass endosymbiont Epichloe festucae.\n  JOURNAL   FEBS Lett 586:2563-9 (2012)\n            DOI:10.1016/j.febslet.2012.06.035\nREFERENCE   PMID:23261604\n  AUTHORS   Motoyama T, Hayashi T, Hirota H, Ueki M, Osada H\n  TITLE     Terpendole E, a kinesin Eg5 inhibitor, is a key biosynthetic intermediate of indole-diterpenes in the producing fungus Chaunopycnis alba.\n  JOURNAL   Chem Biol 19:1611-9 (2012)\n            DOI:10.1016/j.chembiol.2012.10.010\nREL_PATHWAY map00400  Phenylalanine, tyrosine and tryptophan biosynthesis\n            map00900  Terpenoid backbone biosynthesis\nKO_PATHWAY  ko00403\n///\n","added":1656608628252},{"name":"map02010","response":"ENTRY       map02010                    Pathway\nNAME        ABC transporters\nDESCRIPTION The ATP-binding cassette (ABC) transporters form one of the largest known protein families, and are widespread in bacteria, archaea, and eukaryotes. They couple ATP hydrolysis to active transport of a wide variety of substrates such as ions, sugars, lipids, sterols, peptides, proteins, and drugs. The structure of a prokaryotic ABC transporter usually consists of three components; typically two integral membrane proteins each having six transmembrane segments, two peripheral proteins that bind and hydrolyze ATP, and a periplasmic (or lipoprotein) substrate-binding protein. Many of the genes for the three components form operons as in fact observed in many bacterial and archaeal genomes. On the other hand, in a typical eukaryotic ABC transporter, the membrane spanning protein and the ATP-binding protein are fused, forming a multi-domain protein with the membrane-spanning domain (MSD) and the nucleotide-binding domain (NBD).\nCLASS       Environmental Information Processing; Membrane transport\nPATHWAY_MAP map02010  ABC transporters\nDBLINKS     GO: 0043190 0043191 0043192\n            TC: 3.A.1\nREFERENCE   PMID:9799792\n  AUTHORS   Tomii K, Kanehisa M.\n  TITLE     A comparative analysis of ABC transporters in complete microbial genomes.\n  JOURNAL   Genome Res 8:1048-59 (1998)\n            DOI:10.1101/gr.8.10.1048\nREFERENCE   PMID:18424520\n  AUTHORS   Sperandeo P, Lau FK, Carpentieri A, De Castro C, Molinaro A, Deho G, Silhavy TJ, Polissi A\n  TITLE     Functional analysis of the protein machinery required for transport of lipopolysaccharide to the outer membrane of Escherichia coli.\n  JOURNAL   J Bacteriol 190:4460-9 (2008)\n            DOI:10.1128/JB.00270-08\nREFERENCE   PMID:18375759\n  AUTHORS   Ruiz N, Gronenberg LS, Kahne D, Silhavy TJ\n  TITLE     Identification of two inner-membrane proteins required for the transport of lipopolysaccharide to the outer membrane of Escherichia coli.\n  JOURNAL   Proc Natl Acad Sci U S A 105:5537-42 (2008)\n            DOI:10.1073/pnas.0801196105\nREFERENCE   PMID:10557362\n  AUTHORS   Omata T, Price GD, Badger MR, Okamura M, Gohta S, Ogawa T\n  TITLE     Identification of an ATP-binding cassette transporter involved in bicarbonate uptake in the cyanobacterium Synechococcus sp. strain PCC 7942.\n  JOURNAL   Proc Natl Acad Sci U S A 96:13571-6 (1999)\n            DOI:10.1073/pnas.96.23.13571\nREFERENCE   PMID:11731493\n  AUTHORS   Quintero MJ, Montesinos ML, Herrero A, Flores E\n  TITLE     Identification of genes encoding amino acid permeases by inactivation of selected ORFs from the Synechocystis genomic sequence.\n  JOURNAL   Genome Res 11:2034-40 (2001)\n            DOI:10.1101/gr.196301\nREFERENCE   PMID:16135226\n  AUTHORS   Picossi S, Montesinos ML, Pernil R, Lichtle C, Herrero A, Flores E\n  TITLE     ABC-type neutral amino acid permease N-I is required for optimal diazotrophic growth and is repressed in the heterocysts of Anabaena sp. strain PCC 7120.\n  JOURNAL   Mol Microbiol 57:1582-92 (2005)\n            DOI:10.1111/j.1365-2958.2005.04791.x\nREFERENCE   PMID:11929526\n  AUTHORS   Valladares A, Montesinos ML, Herrero A, Flores E.\n  TITLE     An ABC-type, high-affinity urea permease identified in cyanobacteria.\n  JOURNAL   Mol Microbiol 43:703-15 (2002)\n            DOI:10.1046/j.1365-2958.2002.02778.x\nREFERENCE   PMID:18326572\n  AUTHORS   Richard-Fogal CL, Frawley ER, Kranz RG\n  TITLE     Topology and function of CcmD in cytochrome c maturation.\n  JOURNAL   J Bacteriol 190:3489-93 (2008)\n            DOI:10.1128/JB.00146-08\nREFERENCE   PMID:16109926\n  AUTHORS   Suzuki H, Koyanagi T, Izuka S, Onishi A, Kumagai H\n  TITLE     The yliA, -B, -C, and -D genes of Escherichia coli K-12 encode a novel glutathione importer with an ATP-binding cassette.\n  JOURNAL   J Bacteriol 187:5861-7 (2005)\n            DOI:10.1128/JB.187.17.5861-5867.2005\nREFERENCE   PMID:17873039\n  AUTHORS   Novikova M, Metlitskaya A, Datsenko K, Kazakov T, Kazakov A, Wanner B, Severinov K\n  TITLE     The Escherichia coli Yej transporter is required for the uptake of translation inhibitor microcin C.\n  JOURNAL   J Bacteriol 189:8361-5 (2007)\n            DOI:10.1128/JB.01028-07\nREFERENCE   PMID:17214741\n  AUTHORS   Tikhonova EB, Devroy VK, Lau SY, Zgurskaya HI\n  TITLE     Reconstitution of the Escherichia coli macrolide transporter: the periplasmic membrane fusion protein MacA stimulates the ATPase activity of MacB.\n  JOURNAL   Mol Microbiol 63:895-910 (2007)\n            DOI:10.1111/j.1365-2958.2006.05549.x\nREFERENCE   PMID:18805970\n  AUTHORS   Yamanaka H, Kobayashi H, Takahashi E, Okamoto K\n  TITLE     MacAB is involved in the secretion of Escherichia coli heat-stable enterotoxin II.\n  JOURNAL   J Bacteriol 190:7693-8 (2008)\n            DOI:10.1128/JB.00853-08\nKO_PATHWAY  ko02010\n///\n","added":1656608629095},{"name":"map04066","response":"ENTRY       map04066                    Pathway\nNAME        HIF-1 signaling pathway\nDESCRIPTION Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that functions as a master regulator of oxygen homeostasis. It consists of two subunits: an inducibly-expressed HIF-1alpha subunit and a constitutively-expressed HIF-1beta subunit. Under normoxia, HIF-1 alpha undergoes hydroxylation at specific prolyl residues which leads to an immediate ubiquitination and subsequent proteasomal degradation of the subunit. In contrast, under hypoxia, HIF-1 alpha subunit becomes stable and interacts with coactivators such as p300/CBP to modulate its transcriptional activity. Eventually, HIF-1 acts as a master regulator of numerous hypoxia-inducible genes under hypoxic conditions. The target genes of HIF-1 encode proteins that increase O2 delivery and mediate adaptive responses to O2 deprivation. Despite its name, HIF-1 is induced not only in response to reduced oxygen availability but also by other stimulants, such as nitric oxide, or various growth factors.\nCLASS       Environmental Information Processing; Signal transduction\nPATHWAY_MAP map04066  HIF-1 signaling pathway\nREFERENCE   PMID:20836033\n  AUTHORS   Semenza GL\n  TITLE     Oxygen homeostasis.\n  JOURNAL   Wiley Interdiscip Rev Syst Biol Med 2:336-61 (2010)\n            DOI:10.1002/wsbm.69\nREFERENCE   PMID:17955264\n  AUTHORS   Mole DR, Ratcliffe PJ\n  TITLE     Cellular oxygen sensing in health and disease.\n  JOURNAL   Pediatr Nephrol 23:681-94 (2008)\n            DOI:10.1007/s00467-007-0632-x\nREFERENCE   PMID:18498744\n  AUTHORS   Kaelin WG Jr, Ratcliffe PJ\n  TITLE     Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.\n  JOURNAL   Mol Cell 30:393-402 (2008)\n            DOI:10.1016/j.molcel.2008.04.009\nREFERENCE   PMID:22205687\n  AUTHORS   Palazon A, Aragones J, Morales-Kastresana A, de Landazuri MO, Melero I\n  TITLE     Molecular pathways: hypoxia response in immune cells fighting or promoting cancer.\n  JOURNAL   Clin Cancer Res 18:1207-13 (2012)\n            DOI:10.1158/1078-0432.CCR-11-1591\nREFERENCE   PMID:20965423\n  AUTHORS   Majmundar AJ, Wong WJ, Simon MC\n  TITLE     Hypoxia-inducible factors and the response to hypoxic stress.\n  JOURNAL   Mol Cell 40:294-309 (2010)\n            DOI:10.1016/j.molcel.2010.09.022\nREFERENCE   PMID:22562152\n  AUTHORS   Greer SN, Metcalf JL, Wang Y, Ohh M\n  TITLE     The updated biology of hypoxia-inducible factor.\n  JOURNAL   EMBO J 31:2448-60 (2012)\n            DOI:10.1038/emboj.2012.125\nREFERENCE   PMID:15448722\n  AUTHORS   Zagorska A, Dulak J\n  TITLE     HIF-1: the knowns and unknowns of hypoxia sensing.\n  JOURNAL   Acta Biochim Pol 51:563-85 (2004)\nREFERENCE   PMID:19364912\n  AUTHORS   Semenza GL\n  TITLE     Regulation of oxygen homeostasis by hypoxia-inducible factor 1.\n  JOURNAL   Physiology (Bethesda) 24:97-106 (2009)\n            DOI:10.1152/physiol.00045.2008\nREFERENCE   PMID:16234508\n  AUTHORS   Wenger RH, Stiehl DP, Camenisch G\n  TITLE     Integration of oxygen signaling at the consensus HRE.\n  JOURNAL   Sci STKE 2005:re12 (2005)\n            DOI:10.1126/stke.3062005re12\nREFERENCE   PMID:15031665\n  AUTHORS   Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW\n  TITLE     Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions.\n  JOURNAL   Exp Mol Med 36:1-12 (2004)\n            DOI:10.1038/emm.2004.1\nREFERENCE   PMID:18259201\n  AUTHORS   Weidemann A, Johnson RS\n  TITLE     Biology of HIF-1alpha.\n  JOURNAL   Cell Death Differ 15:621-7 (2008)\n            DOI:10.1038/cdd.2008.12\nREFERENCE   PMID:11902584\n  AUTHORS   Harris AL\n  TITLE     Hypoxia--a key regulatory factor in tumour growth.\n  JOURNAL   Nat Rev Cancer 2:38-47 (2002)\n            DOI:10.1038/nrc704\nREFERENCE   PMID:19147540\n  AUTHORS   Knaup KX, Jozefowski K, Schmidt R, Bernhardt WM, Weidemann A, Juergensen JS, Warnecke C, Eckardt KU, Wiesener MS\n  TITLE     Mutual regulation of hypoxia-inducible factor and mammalian target of rapamycin as a function of oxygen availability.\n  JOURNAL   Mol Cancer Res 7:88-98 (2009)\n            DOI:10.1158/1541-7786.MCR-08-0288\nREFERENCE   PMID:18505681\n  AUTHORS   Kaluz S, Kaluzova M, Stanbridge EJ\n  TITLE     Regulation of gene expression by hypoxia: integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element.\n  JOURNAL   Clin Chim Acta 395:6-13 (2008)\n            DOI:10.1016/j.cca.2008.05.002\nREFERENCE   PMID:20679415\n  AUTHORS   Cadenas S, Aragones J, Landazuri MO\n  TITLE     Mitochondrial reprogramming through cardiac oxygen sensors in ischaemic heart disease.\n  JOURNAL   Cardiovasc Res 88:219-28 (2010)\n            DOI:10.1093/cvr/cvq256\nREFERENCE   PMID:19861159\n  AUTHORS   Berchner-Pfannschmidt U, Tug S, Kirsch M, Fandrey J\n  TITLE     Oxygen-sensing under the influence of nitric oxide.\n  JOURNAL   Cell Signal 22:349-56 (2010)\n            DOI:10.1016/j.cellsig.2009.10.004\nREL_PATHWAY map00020  Citrate cycle (TCA cycle)\n            map04010  MAPK signaling pathway\n            map04020  Calcium signaling pathway\n            map04120  Ubiquitin mediated proteolysis\n            map04150  mTOR signaling pathway\n            map04151  PI3K-Akt signaling pathway\n            map04370  VEGF signaling pathway\nKO_PATHWAY  ko04066\n///\n","added":1656608629904},{"name":"map04068","response":"ENTRY       map04068                    Pathway\nNAME        FoxO signaling pathway\nDESCRIPTION The forkhead box O (FOXO) family of transcription factors regulates the expression of genes in cellular physiological events including apoptosis, cell-cycle control, glucose metabolism, oxidative stress resistance, and longevity. A central regulatory mechanism of FOXO proteins is phosphorylation by the serine-threonine kinase Akt/protein kinase B (Akt/PKB), downstream of phosphatidylinositol 3-kinase (PI3K), in response to insulin or several growth factors. Phosphorylation at three conserved residues results in the export of FOXO proteins from the nucleus to the cytoplasm, thereby decreasing expression of FOXO target genes. In contrast, the stress-activated c-Jun N-terminal kinase (JNK) and the energy sensing AMP-activated protein kinase (AMPK), upon oxidative and nutrient stress stimuli phosphorylate and activate FoxOs. Aside from PKB, JNK and AMPK, FOXOs are regulated by multiple players through several post-translational modifications, including phosphorylation, but also acetylation, methylation and ubiquitylation.\nCLASS       Environmental Information Processing; Signal transduction\nPATHWAY_MAP map04068  FoxO signaling pathway\nDBLINKS     GO: 0009267\nREFERENCE   PMID:17470511\n  AUTHORS   Glauser DA, Schlegel W\n  TITLE     The emerging role of FOXO transcription factors in pancreatic beta cells.\n  JOURNAL   J Endocrinol 193:195-207 (2007)\n            DOI:10.1677/JOE-06-0191\nREFERENCE   PMID:17522590\n  AUTHORS   van der Horst A, Burgering BM\n  TITLE     Stressing the role of FoxO proteins in lifespan and disease.\n  JOURNAL   Nat Rev Mol Cell Biol 8:440-50 (2007)\n            DOI:10.1038/nrm2190\nREFERENCE   PMID:21440011\n  AUTHORS   Zhang X, Tang N, Hadden TJ, Rishi AK\n  TITLE     Akt, FoxO and regulation of apoptosis.\n  JOURNAL   Biochim Biophys Acta 1813:1978-86 (2011)\n            DOI:10.1016/j.bbamcr.2011.03.010\nREFERENCE   PMID:23325358\n  AUTHORS   Eijkelenboom A, Burgering BM\n  TITLE     FOXOs: signalling integrators for homeostasis maintenance.\n  JOURNAL   Nat Rev Mol Cell Biol 14:83-97 (2013)\n            DOI:10.1038/nrm3507\nREFERENCE   PMID:17569704\n  AUTHORS   Daitoku H, Fukamizu A\n  TITLE     FOXO transcription factors in the regulatory networks of longevity.\n  JOURNAL   J Biochem 141:769-74 (2007)\n            DOI:10.1093/jb/mvm104\nREFERENCE   PMID:19701188\n  AUTHORS   Hedrick SM\n  TITLE     The cunning little vixen: Foxo and the cycle of life and death.\n  JOURNAL   Nat Immunol 10:1057-63 (2009)\n            DOI:10.1038/ni.1784\nREFERENCE   PMID:15516968\n  AUTHORS   Coffer PJ, Burgering BM\n  TITLE     Forkhead-box transcription factors and their role in the immune system.\n  JOURNAL   Nat Rev Immunol 4:889-99 (2004)\n            DOI:10.1038/nri1488\nREFERENCE   PMID:22902436\n  AUTHORS   Ro SH, Liu D, Yeo H, Paik JH\n  TITLE     FoxOs in neural stem cell fate decision.\n  JOURNAL   Arch Biochem Biophys 534:55-63 (2013)\n            DOI:10.1016/j.abb.2012.07.017\nREFERENCE   PMID:18403263\n  AUTHORS   Maiese K, Chong ZZ, Shang YC\n  TITLE     OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins.\n  JOURNAL   Trends Mol Med 14:219-27 (2008)\n            DOI:10.1016/j.molmed.2008.03.002\nREFERENCE   PMID:23801966\n  AUTHORS   Hagenbuchner J, Ausserlechner MJ\n  TITLE     Mitochondria and FOXO3: breath or die.\n  JOURNAL   Front Physiol 4:147 (2013)\n            DOI:10.3389/fphys.2013.00147\nREFERENCE   PMID:18045156\n  AUTHORS   Maiese K, Chong ZZ, Shang YC\n  TITLE     \"Sly as a FOXO\": new paths with Forkhead signaling in the brain.\n  JOURNAL   Curr Neurovasc Res 4:295-302 (2007)\n            DOI:10.2174/156720207782446306\nREFERENCE   PMID:22761423\n  AUTHORS   Oh HM, Yu CR, Dambuza I, Marrero B, Egwuagu CE\n  TITLE     STAT3 protein interacts with Class O Forkhead transcription factors in the cytoplasm and regulates nuclear/cytoplasmic localization of FoxO1 and FoxO3a proteins in CD4(+) T cells.\n  JOURNAL   J Biol Chem 287:30436-43 (2012)\n            DOI:10.1074/jbc.M112.359661\nREFERENCE   PMID:21238503\n  AUTHORS   Huang H, Tindall DJ\n  TITLE     Regulation of FOXO protein stability via ubiquitination and proteasome degradation.\n  JOURNAL   Biochim Biophys Acta 1813:1961-4 (2011)\n            DOI:10.1016/j.bbamcr.2011.01.007\nREFERENCE   PMID:16288288\n  AUTHORS   Greer EL, Brunet A\n  TITLE     FOXO transcription factors at the interface between longevity and tumor suppression.\n  JOURNAL   Oncogene 24:7410-25 (2005)\n            DOI:10.1038/sj.onc.1209086\nREFERENCE   PMID:15084259\n  AUTHORS   Seoane J, Le HV, Shen L, Anderson SA, Massague J\n  TITLE     Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation.\n  JOURNAL   Cell 117:211-23 (2004)\n            DOI:10.1016/S0092-8674(04)00298-3\nREFERENCE   PMID:18951090\n  AUTHORS   Yamagata K, Daitoku H, Takahashi Y, Namiki K, Hisatake K, Kako K, Mukai H, Kasuya Y, Fukamizu A\n  TITLE     Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt.\n  JOURNAL   Mol Cell 32:221-31 (2008)\n            DOI:10.1016/j.molcel.2008.09.013\nREFERENCE   PMID:16964248\n  AUTHORS   van der Horst A, de Vries-Smits AM, Brenkman AB, van Triest MH, van den Broek N, Colland F, Maurice MM, Burgering BM\n  TITLE     FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP.\n  JOURNAL   Nat Cell Biol 8:1064-73 (2006)\n            DOI:10.1038/ncb1469\nREFERENCE   PMID:21613825\n  AUTHORS   Zhang Y, Gan B, Liu D, Paik JH\n  TITLE     FoxO family members in cancer.\n  JOURNAL   Cancer Biol Ther 12:253-9 (2011)\n            DOI:10.4161/cbt.12.4.15954\nREFERENCE   PMID:15005655\n  AUTHORS   Van Der Heide LP, Hoekman MF, Smidt MP\n  TITLE     The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation.\n  JOURNAL   Biochem J 380:297-309 (2004)\n            DOI:10.1042/BJ20040167\nREL_PATHWAY map00010  Glycolysis / Gluconeogenesis\n            map00020  Citrate cycle (TCA cycle)\n            map00190  Oxidative phosphorylation\n            map04010  MAPK signaling pathway\n            map04110  Cell cycle\n            map04120  Ubiquitin mediated proteolysis\n            map04140  Autophagy - animal\n            map04151  PI3K-Akt signaling pathway\n            map04210  Apoptosis\n            map04350  TGF-beta signaling pathway\n            map04630  JAK-STAT signaling pathway\n            map04910  Insulin signaling pathway\nKO_PATHWAY  ko04068\n///\n","added":1656608630722},{"name":"map04152","response":"ENTRY       map04152                    Pathway\nNAME        AMPK signaling pathway\nDESCRIPTION AMP-activated protein kinase (AMPK) is a serine threonine kinase that is highly conserved through evolution. AMPK system acts as a sensor of cellular energy status. It is activated by increases in the cellular AMP:ATP ratio caused by metabolic stresses that either interfere with ATP production (eg, deprivation for glucose or oxygen) or that accelerate ATP consumption (eg, muscle contraction). Several upstream kinases, including liver kinase B1 (LKB1), calcium/calmodulin kinase kinase-beta (CaMKK beta), and TGF-beta-activated kinase-1 (TAK-1), can activate AMPK by phosphorylating a threonine residue on its catalytic alpha-subunit. Once activated, AMPK leads to a concomitant inhibition of energy-consuming biosynthetic pathways, such as protein, fatty acid and glycogen synthesis, and activation of ATP-producing catabolic pathways, such as fatty acid oxidation and glycolysis.\nCLASS       Environmental Information Processing; Signal transduction\nPATHWAY_MAP map04152  AMPK signaling pathway\nDBLINKS     GO: 2000479\nREFERENCE   PMID:19584320\n  AUTHORS   Steinberg GR, Kemp BE\n  TITLE     AMPK in Health and Disease.\n  JOURNAL   Physiol Rev 89:1025-78 (2009)\n            DOI:10.1152/physrev.00011.2008\nREFERENCE   PMID:15509864\n  AUTHORS   Hardie DG.\n  TITLE     The AMP-activated protein kinase pathway--new players upstream and downstream.\n  JOURNAL   J Cell Sci 117:5479-87 (2004)\n            DOI:10.1242/jcs.01540\nREFERENCE   PMID:23747347\n  AUTHORS   Russo GL, Russo M, Ungaro P\n  TITLE     AMP-activated protein kinase: a target for old drugs against diabetes and cancer.\n  JOURNAL   Biochem Pharmacol 86:339-50 (2013)\n            DOI:10.1016/j.bcp.2013.05.023\nREFERENCE   PMID:19393004\n  AUTHORS   Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, Aja S\n  TITLE     AMPK in the brain: its roles in energy balance and neuroprotection.\n  JOURNAL   J Neurochem 109 Suppl 1:17-23 (2009)\n            DOI:10.1111/j.1471-4159.2009.05916.x\nREFERENCE   PMID:20010958\n  AUTHORS   Li J, McCullough LD\n  TITLE     Effects of AMP-activated protein kinase in cerebral ischemia.\n  JOURNAL   J Cereb Blood Flow Metab 30:480-92 (2010)\n            DOI:10.1038/jcbfm.2009.255\nREFERENCE   PMID:22700795\n  AUTHORS   Sanchez AM, Candau RB, Csibi A, Pagano AF, Raibon A, Bernardi H\n  TITLE     The role of AMP-activated protein kinase in the coordination of skeletal muscle turnover and energy homeostasis.\n  JOURNAL   Am J Physiol Cell Physiol 303:C475-85 (2012)\n            DOI:10.1152/ajpcell.00125.2012\nREFERENCE   PMID:16644802\n  AUTHORS   Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, Hue L, Andreelli F\n  TITLE     Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders.\n  JOURNAL   J Physiol 574:41-53 (2006)\n            DOI:10.1113/jphysiol.2006.108506\nREFERENCE   PMID:19629071\n  AUTHORS   Shackelford DB, Shaw RJ\n  TITLE     The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.\n  JOURNAL   Nat Rev Cancer 9:563-75 (2009)\n            DOI:10.1038/nrc2676\nREFERENCE   PMID:22885100\n  AUTHORS   Chung JH, Manganiello V, Dyck JR\n  TITLE     Resveratrol as a calorie restriction mimetic: therapeutic implications.\n  JOURNAL   Trends Cell Biol 22:546-54 (2012)\n            DOI:10.1016/j.tcb.2012.07.004\nREFERENCE   PMID:20357764\n  AUTHORS   Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, Yamaguchi M, Namiki S, Nakayama R, Tabata M, Ogata H, Kubota N, Takamoto I, Hayashi YK, Yamauchi N, Waki H, Fukayama M, Nishino I, Tokuyama K, Ueki K, Oike Y, Ishii S, Hirose K, Shimizu T, Touhara K, Kadowaki T\n  TITLE     Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1.\n  JOURNAL   Nature 464:1313-9 (2010)\n            DOI:10.1038/nature08991\nREFERENCE   PMID:17307971\n  AUTHORS   Towler MC, Hardie DG\n  TITLE     AMP-activated protein kinase in metabolic control and insulin signaling.\n  JOURNAL   Circ Res 100:328-41 (2007)\n            DOI:10.1161/01.RES.0000256090.42690.05\nREFERENCE   PMID:23899560\n  AUTHORS   Richter EA, Hargreaves M\n  TITLE     Exercise, GLUT4, and skeletal muscle glucose uptake.\n  JOURNAL   Physiol Rev 93:993-1017 (2013)\n            DOI:10.1152/physrev.00038.2012\nREFERENCE   PMID:16054041\n  AUTHORS   Kahn BB, Alquier T, Carling D, Hardie DG\n  TITLE     AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.\n  JOURNAL   Cell Metab 1:15-25 (2005)\n            DOI:10.1016/j.cmet.2004.12.003\nREFERENCE   PMID:23565491\n  AUTHORS   Minokoshi Y, Toda C, Okamoto S\n  TITLE     Regulatory role of leptin in glucose and lipid metabolism in skeletal muscle.\n  JOURNAL   Indian J Endocrinol Metab 16:S562-8 (2012)\n            DOI:10.4103/2230-8210.105573\nREFERENCE   PMID:16723978\n  AUTHORS   Guggino WB, Stanton BA\n  TITLE     New insights into cystic fibrosis: molecular switches that regulate CFTR.\n  JOURNAL   Nat Rev Mol Cell Biol 7:426-36 (2006)\n            DOI:10.1038/nrm1949\nREFERENCE   PMID:16479585\n  AUTHORS   Cheng A, Saltiel AR\n  TITLE     More TORC for the gluconeogenic engine.\n  JOURNAL   Bioessays 28:231-4 (2006)\n            DOI:10.1002/bies.20375\nREFERENCE   PMID:19197243\n  AUTHORS   Herrero-Martin G, Hoyer-Hansen M, Garcia-Garcia C, Fumarola C, Farkas T, Lopez-Rivas A, Jaattela M\n  TITLE     TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells.\n  JOURNAL   EMBO J 28:677-85 (2009)\n            DOI:10.1038/emboj.2009.8\nREFERENCE   PMID:19724019\n  AUTHORS   Morris DL, Rui L\n  TITLE     Recent advances in understanding leptin signaling and leptin resistance.\n  JOURNAL   Am J Physiol Endocrinol Metab 297:E1247-59 (2009)\n            DOI:10.1152/ajpendo.00274.2009\nREFERENCE   PMID:18725075\n  AUTHORS   Minokoshi Y, Shiuchi T, Lee S, Suzuki A, Okamoto S\n  TITLE     Role of hypothalamic AMP-kinase in food intake regulation.\n  JOURNAL   Nutrition 24:786-90 (2008)\n            DOI:10.1016/j.nut.2008.06.002\nREFERENCE   PMID:23024365\n  AUTHORS   Miyamoto L, Ebihara K, Kusakabe T, Aotani D, Yamamoto-Kataoka S, Sakai T, Aizawa-Abe M, Yamamoto Y, Fujikura J, Hayashi T, Hosoda K, Nakao K\n  TITLE     Leptin activates hepatic 5'-AMP-activated protein kinase through sympathetic nervous system and alpha1-adrenergic receptor: a potential mechanism for improvement of fatty liver in lipodystrophy by leptin.\n  JOURNAL   J Biol Chem 287:40441-7 (2012)\n            DOI:10.1074/jbc.M112.384545\nREL_PATHWAY map00010  Glycolysis / Gluconeogenesis\n            map00061  Fatty acid biosynthesis\n            map00500  Starch and sucrose metabolism\n            map01040  Biosynthesis of unsaturated fatty acids\n            map04110  Cell cycle\n            map04140  Autophagy - animal\n            map04150  mTOR signaling pathway\n            map04151  PI3K-Akt signaling pathway\n            map04910  Insulin signaling pathway\n            map04920  Adipocytokine signaling pathway\nKO_PATHWAY  ko04152\n///\n","added":1656608631550},{"name":"map04742","response":"ENTRY       map04742                    Pathway\nNAME        Taste transduction\nDESCRIPTION Five basic tastes are recognized by humans and most other animals - bitter, sweet, sour, salty and umami. In vertebrates, taste stimuli are detected by taste receptor cells (TRCs). At least three distinct cell types are found in mammalian taste buds : type I cells, type II cells, and type III cells. Type I cells express epithelial sodium channel (ENaC) and are considered to be the major mediator of perception of low salt. In type II cells, transduction of bitter, sweet and umami is mediated by a canonical PLC-beta/IP3-signaling cascade, which culminates in the opening of the TRPM5 ion channel. This produces a depolarization that may allow CALMH1 channels to open and release ATP, which serves as a neurotransmitter to activate closely associated nerve afferents expressing P2X2, P2X3 receptors and adjacent type III cells expressing P2Y4 receptors. Type II taste cells also secrete acetylcholine (ACh) that appears to stimulate muscarinic receptors, specifically M3, on the same or neighboring Type II cells. This muscarinic feedback augments taste-evoked release of ATP. In type III cells, sour taste is initiated when protons enter through apically located proton-selective ion channels: polycystic kidney disease 2-like 1 protein (PKD2L1) and polycystic kidney disease 1-like 3 protein (PKD1L3) channels. Weak acids may also activate sour cells by penetrating the cell membrane and leading to closure of resting K+ channels and membrane depolarization. Further, voltage-gated Ca2+ channels are activated and release vesicular serotonin (5-HT), norepinephrine (NE) and gamma-aminobutyric acid (GABA). 5-HT and GABA provide negative paracrine feedback onto receptor cells by activating 5-HT1A and GABAA, GABAB receptors, respectively. 5-HT also functions as a transmitter between presynaptic cells and the sensory afferent.\nCLASS       Organismal Systems; Sensory system\nPATHWAY_MAP map04742  Taste transduction\nDBLINKS     GO: 0050909\nREFERENCE   PMID:24607224\n  AUTHORS   Liman ER, Zhang YV, Montell C\n  TITLE     Peripheral coding of taste.\n  JOURNAL   Neuron 81:984-1000 (2014)\n            DOI:10.1016/j.neuron.2014.02.022\nREFERENCE   PMID:24385952\n  AUTHORS   Kinnamon SC, Finger TE\n  TITLE     A taste for ATP: neurotransmission in taste buds.\n  JOURNAL   Front Cell Neurosci 7:264 (2013)\n            DOI:10.3389/fncel.2013.00264\nREFERENCE   PMID:23261954\n  AUTHORS   Roper SD\n  TITLE     Taste buds as peripheral chemosensory processors.\n  JOURNAL   Semin Cell Dev Biol 24:71-9 (2013)\n            DOI:10.1016/j.semcdb.2012.12.002\nREFERENCE   PMID:21481196\n  AUTHORS   Kinnamon SC\n  TITLE     Taste receptor signalling - from tongues to lungs.\n  JOURNAL   Acta Physiol (Oxf) 204:158-68 (2012)\n            DOI:10.1111/j.1748-1716.2011.02308.x\nREFERENCE   PMID:23587289\n  AUTHORS   Kinnamon SC\n  TITLE     Neurosensory transmission without a synapse: new perspectives on taste signaling.\n  JOURNAL   BMC Biol 11:42 (2013)\n            DOI:10.1186/1741-7007-11-42\nREFERENCE   PMID:20696704\n  AUTHORS   Chaudhari N, Roper SD\n  TITLE     The cell biology of taste.\n  JOURNAL   J Cell Biol 190:285-96 (2010)\n            DOI:10.1083/jcb.201003144\nREFERENCE   PMID:19439032\n  AUTHORS   Vandenbeuch A, Kinnamon SC\n  TITLE     Why do taste cells generate action potentials?\n  JOURNAL   J Biol 8:42 (2009)\n            DOI:10.1186/jbiol138\nREFERENCE   PMID:17108952\n  AUTHORS   Chandrashekar J, Hoon MA, Ryba NJ, Zuker CS\n  TITLE     The receptors and cells for mammalian taste.\n  JOURNAL   Nature 444:288-94 (2006)\n            DOI:10.1038/nature05401\nREFERENCE   PMID:23959882\n  AUTHORS   Vandenbeuch A, Anderson CB, Parnes J, Enjyoji K, Robson SC, Finger TE, Kinnamon SC\n  TITLE     Role of the ectonucleotidase NTPDase2 in taste bud function.\n  JOURNAL   Proc Natl Acad Sci U S A 110:14789-94 (2013)\n            DOI:10.1073/pnas.1309468110\nREFERENCE   PMID:23467090\n  AUTHORS   Taruno A, Vingtdeux V, Ohmoto M, Ma Z, Dvoryanchikov G, Li A, Adrien L, Zhao H, Leung S, Abernethy M, Koppel J, Davies P, Civan MM, Chaudhari N, Matsumoto I, Hellekant G, Tordoff MG, Marambaud P, Foskett JK\n  TITLE     CALHM1 ion channel mediates purinergic neurotransmission of sweet, bitter and umami tastes.\n  JOURNAL   Nature 495:223-6 (2013)\n            DOI:10.1038/nature11906\nREFERENCE   PMID:19284629\n  AUTHORS   Gao N, Lu M, Echeverri F, Laita B, Kalabat D, Williams ME, Hevezi P, Zlotnik A, Moyer BD\n  TITLE     Voltage-gated sodium channels in taste bud cells.\n  JOURNAL   BMC Neurosci 10:20 (2009)\n            DOI:10.1186/1471-2202-10-20\nREFERENCE   PMID:25820328\n  AUTHORS   Zheng W, Hussein S, Yang J, Huang J, Zhang F, Hernandez-Anzaldo S, Fernandez-Patron C, Cao Y, Zeng H, Tang J, Chen XZ\n  TITLE     A novel PKD2L1 C-terminal domain critical for trimerization and channel function.\n  JOURNAL   Sci Rep 5:9460 (2015)\n            DOI:10.1038/srep09460\nREFERENCE   PMID:17287577\n  AUTHORS   Shimada S, Ueda T, Ishida Y, Yamamoto T, Ugawa S\n  TITLE     Acid-sensing ion channels in taste buds.\n  JOURNAL   Arch Histol Cytol 69:227-31 (2006)\n            DOI:10.1679/aohc.69.227\nREFERENCE   PMID:22570381\n  AUTHORS   Dando R, Roper SD\n  TITLE     Acetylcholine is released from taste cells, enhancing taste signalling.\n  JOURNAL   J Physiol 590:3009-17 (2012)\n            DOI:10.1113/jphysiol.2012.232009\nREFERENCE   PMID:14715493\n  AUTHORS   Kaya N, Shen T, Lu SG, Zhao FL, Herness S\n  TITLE     A paracrine signaling role for serotonin in rat taste buds: expression and localization of serotonin receptor subtypes.\n  JOURNAL   Am J Physiol Regul Integr Comp Physiol 286:R649-58 (2004)\n            DOI:10.1152/ajpregu.00572.2003\nREL_PATHWAY map04020  Calcium signaling pathway\nKO_PATHWAY  ko04742\n///\n","added":1656608632369},{"name":"map04910","response":"ENTRY       map04910                    Pathway\nNAME        Insulin signaling pathway\nDESCRIPTION Insulin binding to its receptor results in the tyrosine phosphorylation of insulin receptor substrates (IRS) by the insulin receptor tyrosine kinase (INSR). This allows association of IRSs with the regulatory subunit of phosphoinositide 3-kinase (PI3K). PI3K activates 3-phosphoinositide-dependent protein kinase 1 (PDK1), which activates Akt, a serine kinase. Akt in turn deactivates glycogen synthase kinase 3 (GSK-3), leading to activation of glycogen synthase (GYS) and thus glycogen synthesis. Activation of Akt also results in the translocation of GLUT4 vesicles from their intracellular pool to the plasma membrane, where they allow uptake of glucose into the cell. Akt also leads to mTOR-mediated activation of protein synthesis by eIF4 and p70S6K. The translocation of GLUT4 protein is also elicited through the CAP/Cbl/TC10 pathway, once Cbl is phosphorylated by INSR.\n            Other signal transduction proteins interact with IRS including GRB2. GRB2 is part of the cascade including SOS, RAS, RAF and MEK that leads to activation of mitogen-activated protein kinase (MAPK) and mitogenic responses in the form of gene transcription. SHC is another substrate of INSR. When tyrosine phosphorylated, SHC associates with GRB2 and can thus activate the RAS/MAPK pathway independently of IRS-1.\nCLASS       Organismal Systems; Endocrine system\nPATHWAY_MAP map04910  Insulin signaling pathway\nREFERENCE   PMID:14635525\n  AUTHORS   Ogawa W, Kasuga M.\n  TITLE     [Mechanism of insulin action and diabetes mellitus]\n  JOURNAL   Seikagaku 75:1332-44 (2003)\nREFERENCE   PMID:11282018\n  AUTHORS   Bevan P.\n  TITLE     Insulin signalling.\n  JOURNAL   J Cell Sci 114:1429-30 (2001)\nREFERENCE   PMID:12867054\n  AUTHORS   Kanzaki M, Pessin JE.\n  TITLE     Insulin signaling: GLUT4 vesicles exit via the exocyst.\n  JOURNAL   Curr Biol 13:R574-6 (2003)\n            DOI:10.1016/S0960-9822(03)00478-0\nREFERENCE   PMID:10196204\n  AUTHORS   Moodie SA, Alleman-Sposeto J, Gustafson TA.\n  TITLE     Identification of the APS protein as a novel insulin receptor substrate.\n  JOURNAL   J Biol Chem 274:11186-93 (1999)\n            DOI:10.1074/jbc.274.16.11186\nREFERENCE   PMID:15733744\n  AUTHORS   Gual P, Le Marchand-Brustel Y, Tanti JF.\n  TITLE     Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.\n  JOURNAL   Biochimie 87:99-109 (2005)\n            DOI:10.1016/j.biochi.2004.10.019\nREFERENCE   PMID:9748166\n  AUTHORS   Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ.\n  TITLE     Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1.\n  JOURNAL   Science 281:2042-5 (1998)\n            DOI:10.1126/science.281.5385.2042\nREFERENCE   PMID:11742412\n  AUTHORS   Saltiel AR, Kahn CR.\n  TITLE     Insulin signalling and the regulation of glucose and lipid metabolism.\n  JOURNAL   Nature 414:799-806 (2001)\n            DOI:10.1038/414799a\nREFERENCE   PMID:15624019\n  AUTHORS   Inoki K, Corradetti MN, Guan KL.\n  TITLE     Dysregulation of the TSC-mTOR pathway in human disease.\n  JOURNAL   Nat Genet 37:19-24 (2005)\n            DOI:10.1038/ng1494\nREFERENCE   PMID:16288289\n  AUTHORS   Ruggero D, Sonenberg N.\n  TITLE     The Akt of translational control.\n  JOURNAL   Oncogene 24:7426-34 (2005)\n            DOI:10.1038/sj.onc.1209098\nREFERENCE   PMID:10567225\n  AUTHORS   Nave BT, Ouwens M, Withers DJ, Alessi DR, Shepherd PR.\n  TITLE     Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation.\n  JOURNAL   Biochem J 344 Pt 2:427-31 (1999)\n            DOI:10.1042/bj3440427\nREFERENCE   PMID:9445476\n  AUTHORS   Pullen N, Dennis PB, Andjelkovic M, Dufner A, Kozma SC, Hemmings BA, Thomas G.\n  TITLE     Phosphorylation and activation of p70s6k by PDK1.\n  JOURNAL   Science 279:707-10 (1998)\n            DOI:10.1126/science.279.5351.707\nREFERENCE   PMID:9609110\n  AUTHORS   Ogawa W, Matozaki T, Kasuga M.\n  TITLE     Role of binding proteins to IRS-1 in insulin signalling.\n  JOURNAL   Mol Cell Biochem 182:13-22 (1998)\nREFERENCE   PMID:9609111\n  AUTHORS   Ceresa BP, Pessin JE.\n  TITLE     Insulin regulation of the Ras activation/inactivation cycle.\n  JOURNAL   Mol Cell Biochem 182:23-9 (1998)\nREFERENCE   PMID:15229476\n  AUTHORS   Pollak MN, Schernhammer ES, Hankinson SE.\n  TITLE     Insulin-like growth factors and neoplasia.\n  JOURNAL   Nat Rev Cancer 4:505-18 (2004)\n            DOI:10.1038/nrc1387\nREFERENCE   PMID:9346240\n  AUTHORS   Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME.\n  TITLE     Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.\n  JOURNAL   Cell 91:231-41 (1997)\n            DOI:10.1016/S0092-8674(00)80405-5\nREFERENCE   PMID:17344645\n  AUTHORS   Ferre P, Foufelle F\n  TITLE     SREBP-1c transcription factor and lipid homeostasis: clinical perspective.\n  JOURNAL   Horm Res 68:72-82 (2007)\n            DOI:10.1159/000100426\nREFERENCE   PMID:18291668\n  AUTHORS   Raghow R, Yellaturu C, Deng X, Park EA, Elam MB\n  TITLE     SREBPs: the crossroads of physiological and pathological lipid homeostasis.\n  JOURNAL   Trends Endocrinol Metab 19:65-73 (2008)\n            DOI:10.1016/j.tem.2007.10.009\nREFERENCE   PMID:11343120\n  AUTHORS   Clement S, Krause U, Desmedt F, Tanti JF, Behrends J, Pesesse X, Sasaki T, Penninger J, Doherty M, Malaisse W, Dumont JE, Le Marchand-Brustel Y, Erneux C, Hue L, Schurmans S\n  TITLE     The lipid phosphatase SHIP2 controls insulin sensitivity.\n  JOURNAL   Nature 409:92-7 (2001)\n            DOI:10.1038/35051094\nREFERENCE   PMID:12791379\n  AUTHORS   Backers K, Blero D, Paternotte N, Zhang J, Erneux C\n  TITLE     The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases.\n  JOURNAL   Adv Enzyme Regul 43:15-28 (2003)\n            DOI:10.1016/S0065-2571(02)00043-2\nREL_PATHWAY map00010  Glycolysis / Gluconeogenesis\n            map00061  Fatty acid biosynthesis\n            map00500  Starch and sucrose metabolism\n            map04010  MAPK signaling pathway\n            map04070  Phosphatidylinositol signaling system\n            map04210  Apoptosis\nKO_PATHWAY  ko04910\n///\n","added":1656608633206},{"name":"map04922","response":"ENTRY       map04922                    Pathway\nNAME        Glucagon signaling pathway\nDESCRIPTION Glucagon is conventionally regarded as a counterregulatory hormone for insulin and plays a critical anti-hypoglycemic role by maintaining glucose homeostasis in both animals and humans. To increase blood glucose, glucagon promotes hepatic glucose output by increasing glycogenolysis and gluconeogenesis and by decreasing glycogenesis and glycolysis in a concerted fashion via multiple mechanisms. Glucagon also stimulates hepatic mitochondrial beta-oxidation to supply energy for glucose production. Glucagon performs its main effect via activation of adenylate cyclase. The adenylate-cyclase-derived cAMP activates protein kinase A (PKA), which then phosphorylates downstream targets, such as cAMP response element binding protein (CREB) and the bifunctional enzyme 6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatase (one of the isoforms being PFK/FBPase 1, encoded by PFKFB1).\nCLASS       Organismal Systems; Endocrine system\nPATHWAY_MAP map04922  Glucagon signaling pathway\nREFERENCE   PMID:12626323\n  AUTHORS   Jiang G, Zhang BB\n  TITLE     Glucagon and regulation of glucose metabolism.\n  JOURNAL   Am J Physiol Endocrinol Metab 284:E671-8 (2003)\n            DOI:10.1152/ajpendo.00492.2002\nREFERENCE   PMID:24692138\n  AUTHORS   Rui L\n  TITLE     Energy metabolism in the liver.\n  JOURNAL   Compr Physiol 4:177-97 (2014)\n            DOI:10.1002/cphy.c130024\nREFERENCE   PMID:22004992\n  AUTHORS   Jitrapakdee S\n  TITLE     Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis.\n  JOURNAL   Int J Biochem Cell Biol 44:33-45 (2012)\n            DOI:10.1016/j.biocel.2011.10.001\nREFERENCE   PMID:16601267\n  AUTHORS   Desvergne B, Michalik L, Wahli W.\n  TITLE     Transcriptional regulation of metabolism.\n  JOURNAL   Physiol Rev 86:465-514 (2006)\n            DOI:10.1152/physrev.00025.2005\nREFERENCE   PMID:22550228\n  AUTHORS   Hardie DG\n  TITLE     Organismal carbohydrate and lipid homeostasis.\n  JOURNAL   Cold Spring Harb Perspect Biol 4:a006031 (2012)\n            DOI:10.1101/cshperspect.a006031\nREFERENCE   PMID:22796337\n  AUTHORS   Hasenour CM, Berglund ED, Wasserman DH\n  TITLE     Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver.\n  JOURNAL   Mol Cell Endocrinol 366:152-62 (2013)\n            DOI:10.1016/j.mce.2012.06.018\nREFERENCE   PMID:18669612\n  AUTHORS   Quesada I, Tuduri E, Ripoll C, Nadal A\n  TITLE     Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes.\n  JOURNAL   J Endocrinol 199:5-19 (2008)\n            DOI:10.1677/JOE-08-0290\nREFERENCE   PMID:24238363\n  AUTHORS   Oh KJ, Han HS, Kim MJ, Koo SH\n  TITLE     CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis.\n  JOURNAL   BMB Rep 46:567-74 (2013)\n            DOI:10.5483/BMBRep.2013.46.12.248\nREFERENCE   PMID:16479585\n  AUTHORS   Cheng A, Saltiel AR\n  TITLE     More TORC for the gluconeogenic engine.\n  JOURNAL   Bioessays 28:231-4 (2006)\n            DOI:10.1002/bies.20375\nREFERENCE   PMID:21346730\n  AUTHORS   Altarejos JY, Montminy M\n  TITLE     CREB and the CRTC co-activators: sensors for hormonal and metabolic signals.\n  JOURNAL   Nat Rev Mol Cell Biol 12:141-51 (2011)\n            DOI:10.1038/nrm3072\nREFERENCE   PMID:24393785\n  AUTHORS   Pernicova I, Korbonits M\n  TITLE     Metformin--mode of action and clinical implications for diabetes and cancer.\n  JOURNAL   Nat Rev Endocrinol 10:143-56 (2014)\n            DOI:10.1038/nrendo.2013.256\nREFERENCE   PMID:20735177\n  AUTHORS   Hirota K, Fukamizu A\n  TITLE     Transcriptional regulation of energy metabolism in the liver.\n  JOURNAL   J Recept Signal Transduct Res 30:403-9 (2010)\n            DOI:10.3109/10799893.2010.509730\nREFERENCE   PMID:21941300\n  AUTHORS   Chalkiadaki A, Guarente L\n  TITLE     Metabolic signals regulate SIRT1 expression.\n  JOURNAL   EMBO Rep 12:985-6 (2011)\n            DOI:10.1038/embor.2011.179\nREFERENCE   PMID:22249520\n  AUTHORS   Chalkiadaki A, Guarente L\n  TITLE     Sirtuins mediate mammalian metabolic responses to nutrient availability.\n  JOURNAL   Nat Rev Endocrinol 8:287-96 (2012)\n            DOI:10.1038/nrendo.2011.225\nREFERENCE   PMID:19912989\n  AUTHORS   Tang BL, Chua CE\n  TITLE     Is systemic activation of Sirt1 beneficial for ageing-associated metabolic disorders?\n  JOURNAL   Biochem Biophys Res Commun 391:6-10 (2010)\n            DOI:10.1016/j.bbrc.2009.11.016\nREFERENCE   PMID:22503562\n  AUTHORS   Ozcan L, Wong CC, Li G, Xu T, Pajvani U, Park SK, Wronska A, Chen BX, Marks AR, Fukamizu A, Backs J, Singer HA, Yates JR 3rd, Accili D, Tabas I\n  TITLE     Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity.\n  JOURNAL   Cell Metab 15:739-51 (2012)\n            DOI:10.1016/j.cmet.2012.03.002\nREFERENCE   PMID:22495310\n  AUTHORS   Wang Y, Li G, Goode J, Paz JC, Ouyang K, Screaton R, Fischer WH, Chen J, Tabas I, Montminy M\n  TITLE     Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes.\n  JOURNAL   Nature 485:128-32 (2012)\n            DOI:10.1038/nature10988\nREL_PATHWAY map00010  Glycolysis / Gluconeogenesis\n            map00020  Citrate cycle (TCA cycle)\n            map00061  Fatty acid biosynthesis\n            map00190  Oxidative phosphorylation\n            map04020  Calcium signaling pathway\n            map04024  cAMP signaling pathway\n            map04068  FoxO signaling pathway\n            map04910  Insulin signaling pathway\nKO_PATHWAY  ko04922\n///\n","added":1656608634051},{"name":"map04930","response":"ENTRY       map04930                    Pathway\nNAME        Type II diabetes mellitus\nDESCRIPTION Insulin resistance is strongly associated with type II diabetes. \"Diabetogenic\" factors including FFA, TNFalpha and cellular stress induce insulin resistance through inhibition of IRS1 functions. Serine/threonine phosphorylation, interaction with SOCS, regulation of the expression, modification of the cellular localization, and degradation represent the molecular mechanisms stimulated by them. Various kinases (ERK, JNK, IKKbeta, PKCzeta, PKCtheta and mTOR) are involved in this process.\n            The development of type II diabetes requires impaired beta-cell function. Chronic hyperglycemia has been shown to induce multiple defects in beta-cells. Hyperglycemia has been proposed to lead to large amounts of reactive oxygen species (ROS) in beta-cells, with subsequent damage to cellular components including PDX-1. Loss of PDX-1, a critical regulator of insulin promoter activity, has also been proposed as an important mechanism leading to beta-cell dysfunction.\n            Although there is little doubt as to the importance of genetic factors in type II diabetes, genetic analysis is difficult due to complex interaction among multiple susceptibility genes and between genetic and environmental factors. Genetic studies have therefore given very diverse results. Kir6.2 and IRS are two of the candidate genes. It is known that Kir6.2 and IRS play central roles in insulin secretion and insulin signal transmission, respectively.\nCLASS       Human Diseases; Endocrine and metabolic disease\nPATHWAY_MAP map04930  Type II diabetes mellitus\nDISEASE     H00409  Type 2 diabetes mellitus\nREFERENCE   PMID:15823385\n  AUTHORS   Stumvoll M, Goldstein BJ, van Haeften TW.\n  TITLE     Type 2 diabetes: principles of pathogenesis and therapy.\n  JOURNAL   Lancet 365:1333-46 (2005)\n            DOI:10.1016/S0140-6736(05)61032-X\nREFERENCE   PMID:15733744\n  AUTHORS   Gual P, Le Marchand-Brustel Y, Tanti JF.\n  TITLE     Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.\n  JOURNAL   Biochimie 87:99-109 (2005)\n            DOI:10.1016/j.biochi.2004.10.019\nREFERENCE   PMID:11078440\n  AUTHORS   Henquin JC.\n  TITLE     Triggering and amplifying pathways of regulation of insulin secretion by glucose.\n  JOURNAL   Diabetes 49:1751-60 (2000)\n            DOI:10.2337/diabetes.49.11.1751\nREFERENCE   PMID:11272200\n  AUTHORS   Chandra J, Zhivotovsky B, Zaitsev S, Juntti-Berggren L, Berggren PO, Orrenius S.\n  TITLE     Role of apoptosis in pancreatic beta-cell death in diabetes.\n  JOURNAL   Diabetes 50 Suppl 1:S44-7 (2001)\n            DOI:10.2337/diabetes.50.2007.S44\nREFERENCE   PMID:15759102\n  AUTHORS   Kaneto H, Matsuoka TA, Nakatani Y, Kawamori D, Miyatsuka T, Matsuhisa M, Yamasaki Y.\n  TITLE     Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes.\n  JOURNAL   J Mol Med 83:429-39 (2005)\n            DOI:10.1007/s00109-005-0640-x\nREFERENCE   PMID:12480546\n  AUTHORS   Sakai K, Matsumoto K, Nishikawa T, Suefuji M, Nakamaru K, Hirashima Y, Kawashima J, Shirotani T, Ichinose K, Brownlee M, Araki E.\n  TITLE     Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells.\n  JOURNAL   Biochem Biophys Res Commun 300:216-22 (2003)\n            DOI:10.1016/S0006-291X(02)02832-2\nREFERENCE   PMID:11390407\n  AUTHORS   Kaneto H, Xu G, Song KH, Suzuma K, Bonner-Weir S, Sharma A, Weir GC.\n  TITLE     Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress.\n  JOURNAL   J Biol Chem 276:31099-104 (2001)\n            DOI:10.1074/jbc.M104115200\nREFERENCE   PMID:9011569\n  AUTHORS   Matsuoka T, Kajimoto Y, Watada H, Kaneto H, Kishimoto M, Umayahara Y, Fujitani Y, Kamada T, Kawamori R, Yamasaki Y.\n  TITLE     Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells.\n  JOURNAL   J Clin Invest 99:144-50 (1997)\n            DOI:10.1172/JCI119126\nREFERENCE   PMID:7491105\n  AUTHORS   Sharma A, Olson LK, Robertson RP, Stein R.\n  TITLE     The reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression.\n  JOURNAL   Mol Endocrinol 9:1127-34 (1995)\n            DOI:10.1210/mend.9.9.7491105\nREFERENCE   PMID:15258147\n  AUTHORS   Robertson RP.\n  TITLE     Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes.\n  JOURNAL   J Biol Chem 279:42351-4 (2004)\n            DOI:10.1074/jbc.R400019200\nREFERENCE   PMID:9974390\n  AUTHORS   Eto K, Tsubamoto Y, Terauchi Y, Sugiyama T, Kishimoto T, Takahashi N, Yamauchi N, Kubota N, Murayama S, Aizawa T, Akanuma Y, Aizawa S, Kasai H, Yazaki Y, Kadowaki T.\n  TITLE     Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion.\n  JOURNAL   Science 283:981-5 (1999)\n            DOI:10.1126/science.283.5404.981\nREFERENCE   PMID:11325516\n  AUTHORS   Novelli M, Fabregat ME, Fernandez-Alvarez J, Gomis R, Masiello P.\n  TITLE     Metabolic and functional studies on isolated islets in a new rat model of type 2 diabetes.\n  JOURNAL   Mol Cell Endocrinol 175:57-66 (2001)\n            DOI:10.1016/S0303-7207(01)00400-2\nREFERENCE   PMID:15585596\n  AUTHORS   Yang SN, Berggren PO.\n  TITLE     Beta-cell CaV channel regulation in physiology and pathophysiology.\n  JOURNAL   Am J Physiol Endocrinol Metab 288:E16-28 (2005)\n            DOI:10.1152/ajpendo.00042.2004\nREL_PATHWAY map04210  Apoptosis\n            map04910  Insulin signaling pathway\n            map04920  Adipocytokine signaling pathway\n            map04950  Maturity onset diabetes of the young\nKO_PATHWAY  ko04930\n///\n","added":1656608634906},{"name":"map04932","response":"ENTRY       map04932                    Pathway\nNAME        Non-alcoholic fatty liver disease\nDESCRIPTION Non-alcoholic fatty liver disease (NAFLD) represents a spectrum ranging from simple steatosis to more severe steatohepatitis with hepatic inflammation and fibrosis, known as nonalcoholic steatohepatitis (NASH). NASH may further lead to cirrhosis and hepatocellular carcinoma (HCC). This map shows a stage-dependent progression of NAFLD. In the first stage of NAFLD, excess lipid accumulation has been demonstrated. The main cause is the induction of insulin resistance, which leads to a defect in insulin suppression of free fatty acids (FAAs) disposal. In addition, two transcription factors, SREBP-1c and PPAR-alpha, activate key enzymes of lipogenesis and increase the synthesis of FAAs in liver. In the second stage, as a consequence of the progression to NASH, the production of reactive oxygen species (ROS) is enhanced due to oxidation stress through mitochondrial beta-oxidation of fatty acids and endoplamic reticulum (ER) stress, leading to lipid peroxidation. The lipid peroxidation can further cause the production of cytokines (Fas ligand, TNF-alpha, IL-8 and TGF), promoting cell death, inflammation and fibrosis. The activation of JNK, which is induced by ER stress, TNF-alpha and FAAs, is also associated with NAFLD progression. Increased JNK promotes cytokine production and initiation of HCC.\nCLASS       Human Diseases; Endocrine and metabolic disease\nPATHWAY_MAP map04932  Non-alcoholic fatty liver disease\nDISEASE     H01333  Non-alcoholic fatty liver disease\nREFERENCE   PMID:23545492\n  AUTHORS   Naik A, Kosir R, Rozman D\n  TITLE     Genomic aspects of NAFLD pathogenesis.\n  JOURNAL   Genomics 102:84-95 (2013)\n            DOI:10.1016/j.ygeno.2013.03.007\nREFERENCE   PMID:19352614\n  AUTHORS   Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L\n  TITLE     Molecular mechanisms involved in NAFLD progression.\n  JOURNAL   J Mol Med (Berl) 87:679-95 (2009)\n            DOI:10.1007/s00109-009-0464-1\nREFERENCE   PMID:22705006\n  AUTHORS   Seki E, Brenner DA, Karin M\n  TITLE     A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches.\n  JOURNAL   Gastroenterology 143:307-20 (2012)\n            DOI:10.1053/j.gastro.2012.06.004\nREFERENCE   PMID:21038418\n  AUTHORS   Tilg H, Moschen AR\n  TITLE     Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.\n  JOURNAL   Hepatology 52:1836-46 (2010)\n            DOI:10.1002/hep.24001\nREFERENCE   PMID:16364488\n  AUTHORS   Larter CZ, Farrell GC\n  TITLE     Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?\n  JOURNAL   J Hepatol 44:253-61 (2006)\n            DOI:10.1016/j.jhep.2005.11.030\nREFERENCE   PMID:22570745\n  AUTHORS   Farrell GC, van Rooyen D, Gan L, Chitturi S\n  TITLE     NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.\n  JOURNAL   Gut Liver 6:149-71 (2012)\n            DOI:10.5009/gnl.2012.6.2.149\nREFERENCE   PMID:20619513\n  AUTHORS   Shapiro H, Tehilla M, Attal-Singer J, Bruck R, Luzzatti R, Singer P\n  TITLE     The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease.\n  JOURNAL   Clin Nutr 30:6-19 (2011)\n            DOI:10.1016/j.clnu.2010.06.001\nREFERENCE   PMID:20303879\n  AUTHORS   Hotamisligil GS\n  TITLE     Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.\n  JOURNAL   Cell 140:900-17 (2010)\n            DOI:10.1016/j.cell.2010.02.034\nREFERENCE   PMID:17498512\n  AUTHORS   Parekh S, Anania FA\n  TITLE     Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.\n  JOURNAL   Gastroenterology 132:2191-207 (2007)\n            DOI:10.1053/j.gastro.2007.03.055\nREFERENCE   PMID:16374858\n  AUTHORS   Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, Czaja MJ\n  TITLE     JNK1 but not JNK2 promotes the development of steatohepatitis in mice.\n  JOURNAL   Hepatology 43:163-72 (2006)\n            DOI:10.1002/hep.20999\nREFERENCE   PMID:22940046\n  AUTHORS   Leung TM, Nieto N\n  TITLE     CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.\n  JOURNAL   J Hepatol 58:395-8 (2013)\n            DOI:10.1016/j.jhep.2012.08.018\nREFERENCE   PMID:14685853\n  AUTHORS   Zafrani ES\n  TITLE     Non-alcoholic fatty liver disease: an emerging pathological spectrum.\n  JOURNAL   Virchows Arch 444:3-12 (2004)\n            DOI:10.1007/s00428-003-0943-7\nREFERENCE   PMID:12891546\n  AUTHORS   Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ\n  TITLE     Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.\n  JOURNAL   Gastroenterology 125:437-43 (2003)\n            DOI:10.1016/S0016-5085(03)00907-7\nREFERENCE   PMID:16406828\n  AUTHORS   Begriche K, Igoudjil A, Pessayre D, Fromenty B\n  TITLE     Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.\n  JOURNAL   Mitochondrion 6:1-28 (2006)\n            DOI:10.1016/j.mito.2005.10.004\nREFERENCE   PMID:9285483\n  AUTHORS   Leonarduzzi G, Scavazza A, Biasi F, Chiarpotto E, Camandola S, Vogel S, Dargel R, Poli G\n  TITLE     The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis.\n  JOURNAL   FASEB J 11:851-7 (1997)\n            DOI:10.1096/fasebj.11.11.9285483\nREFERENCE   PMID:21145844\n  AUTHORS   Malhi H, Kaufman RJ\n  TITLE     Endoplasmic reticulum stress in liver disease.\n  JOURNAL   J Hepatol 54:795-809 (2011)\n            DOI:10.1016/j.jhep.2010.11.005\nREFERENCE   PMID:18242193\n  AUTHORS   Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM\n  TITLE     Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases.\n  JOURNAL   Free Radic Biol Med 44:1259-72 (2008)\n            DOI:10.1016/j.freeradbiomed.2007.12.029\nREFERENCE   PMID:18061659\n  AUTHORS   Serviddio G, Sastre J, Bellanti F, Vina J, Vendemiale G, Altomare E\n  TITLE     Mitochondrial involvement in non-alcoholic steatohepatitis.\n  JOURNAL   Mol Aspects Med 29:22-35 (2008)\n            DOI:10.1016/j.mam.2007.09.014\nREFERENCE   PMID:23299992\n  AUTHORS   Begriche K, Massart J, Robin MA, Bonnet F, Fromenty B\n  TITLE     Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.\n  JOURNAL   Hepatology 58:1497-507 (2013)\n            DOI:10.1002/hep.26226\nREL_PATHWAY map00061  Fatty acid biosynthesis\n            map00190  Oxidative phosphorylation\n            map03320  PPAR signaling pathway\n            map04141  Protein processing in endoplasmic reticulum\n            map04151  PI3K-Akt signaling pathway\n            map04210  Apoptosis\n            map04668  TNF signaling pathway\n            map04920  Adipocytokine signaling pathway\n            map04930  Type II diabetes mellitus\nKO_PATHWAY  ko04932\n///\n","added":1656608635741},{"name":"map04933","response":"ENTRY       map04933                    Pathway\nNAME        AGE-RAGE signaling pathway in diabetic complications\nDESCRIPTION Advanced glycation end products (AGEs) are a complex group of compounds produced through the non-enzymatic glycation and oxidation of proteins, lipids and nucleic acids, primarily due to aging and under certain pathologic condition such as huperglycemia. Some of the best chemically characterized AGEs include N-epsilon-carboxy-methyl-lysine (CML), N-epsilon-carboxy-ethyl-lysine (CEL), and Imidazolone. The major receptor for AGEs, known as receptor for advanced glycation end products (RAGE or AGER), belongs to the immunoglobulin superfamily and has been described as a pattern recognition receptor. AGE/RAGE signaling elicits activation of multiple intracellular signal pathways involving NADPH oxidase, protein kinase C, and MAPKs, then resulting in NF-kappaB activity. NF-kappa B promotes the expression of pro-inflammatory cytokines such as IL-1, IL-6 and TNF-alpha and a variety of atherosclerosis-related genes, including VCAM-1, tissue factor, VEGF, and RAGE. In addition, JAK-STAT-mediated and PI3K-Akt-dependent pathways are induced via RAGE, which in turn participate in cell proliferation and apoptosis respectively. Hypoxia-mediated induction of Egr-1 was also shown to require the AGE-RAGE interaction. The results of these signal transductions have been reported to be the possible mechanism that initates diabetic complications.\nCLASS       Human Diseases; Endocrine and metabolic disease\nPATHWAY_MAP map04933  AGE-RAGE signaling pathway in diabetic complications\nDBLINKS     GO: 1904603\nREFERENCE   PMID:21261520\n  AUTHORS   Kanwar YS, Sun L, Xie P, Liu FY, Chen S\n  TITLE     A glimpse of various pathogenetic mechanisms of diabetic nephropathy.\n  JOURNAL   Annu Rev Pathol 6:395-423 (2011)\n            DOI:10.1146/annurev.pathol.4.110807.092150\nREFERENCE   PMID:21111800\n  AUTHORS   Yamagishi S\n  TITLE     Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes.\n  JOURNAL   Exp Gerontol 46:217-24 (2011)\n            DOI:10.1016/j.exger.2010.11.007\nREFERENCE   PMID:23961320\n  AUTHORS   Roy B\n  TITLE     Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fractures.\n  JOURNAL   World J Diabetes 4:101-13 (2013)\n            DOI:10.4239/wjd.v4.i4.101\nREFERENCE   PMID:22558488\n  AUTHORS   Hegab Z, Gibbons S, Neyses L, Mamas MA\n  TITLE     Role of advanced glycation end products in cardiovascular disease.\n  JOURNAL   World J Cardiol 4:90-102 (2012)\n            DOI:10.4330/wjc.v4.i4.90\nREFERENCE   PMID:19404313\n  AUTHORS   Calcutt NA, Cooper ME, Kern TS, Schmidt AM\n  TITLE     Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials.\n  JOURNAL   Nat Rev Drug Discov 8:417-29 (2009)\n            DOI:10.1038/nrd2476\nREFERENCE   PMID:11180401\n  AUTHORS   Huang JS, Guh JY, Chen HC, Hung WC, Lai YH, Chuang LY\n  TITLE     Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells.\n  JOURNAL   J Cell Biochem 81:102-13 (2001)\n            DOI:10.1002/1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO;2-Y\nREFERENCE   PMID:21680901\n  AUTHORS   Meloche J, Paulin R, Courboulin A, Lambert C, Barrier M, Bonnet P, Bisserier M, Roy M, Sussman MA, Agharazii M, Bonnet S\n  TITLE     RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes.\n  JOURNAL   Arterioscler Thromb Vasc Biol 31:2114-24 (2011)\n            DOI:10.1161/ATVBAHA.111.230573\nREFERENCE   PMID:11684565\n  AUTHORS   Guh JY, Huang JS, Chen HC, Hung WC, Lai YH, Chuang LY\n  TITLE     Advanced glycation end product-induced proliferation in NRK-49F cells is dependent on the JAK2/STAT5 pathway and cyclin D1.\n  JOURNAL   Am J Kidney Dis 38:1096-104 (2001)\n            DOI:10.1053/ajkd.2001.28616\nREFERENCE   PMID:16894049\n  AUTHORS   Goldin A, Beckman JA, Schmidt AM, Creager MA\n  TITLE     Advanced glycation end products: sparking the development of diabetic vascular injury.\n  JOURNAL   Circulation 114:597-605 (2006)\n            DOI:10.1161/CIRCULATIONAHA.106.621854\nREFERENCE   PMID:21590515\n  AUTHORS   Zong H, Ward M, Stitt AW\n  TITLE     AGEs, RAGE, and diabetic retinopathy.\n  JOURNAL   Curr Diab Rep 11:244-52 (2011)\n            DOI:10.1007/s11892-011-0198-7\nREFERENCE   PMID:21440603\n  AUTHORS   Yamagishi S, Maeda S, Matsui T, Ueda S, Fukami K, Okuda S\n  TITLE     Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes.\n  JOURNAL   Biochim Biophys Acta 1820:663-71 (2012)\n            DOI:10.1016/j.bbagen.2011.03.014\nREFERENCE   PMID:23776698\n  AUTHORS   Shi L, Yu X, Yang H, Wu X\n  TITLE     Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p38 MAPK pathways.\n  JOURNAL   PLoS One 8:e66781 (2013)\n            DOI:10.1371/journal.pone.0066781\nREFERENCE   PMID:17005604\n  AUTHORS   Alikhani M, Maclellan CM, Raptis M, Vora S, Trackman PC, Graves DT\n  TITLE     Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor.\n  JOURNAL   Am J Physiol Cell Physiol 292:C850-6 (2007)\n            DOI:10.1152/ajpcell.00356.2006\nREFERENCE   PMID:20300563\n  AUTHORS   Alikhani M, Roy S, Graves DT\n  TITLE     FOXO1 plays an essential role in apoptosis of retinal pericytes.\n  JOURNAL   Mol Vis 16:408-15 (2010)\nREFERENCE   PMID:20470857\n  AUTHORS   Sheikpranbabu S, Haribalaganesh R, Lee KJ, Gurunathan S\n  TITLE     Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability.\n  JOURNAL   Biochimie 92:1040-51 (2010)\n            DOI:10.1016/j.biochi.2010.05.004\nREFERENCE   PMID:18922799\n  AUTHORS   Hudson BI, Kalea AZ, Del Mar Arriero M, Harja E, Boulanger E, D'Agati V, Schmidt AM\n  TITLE     Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42.\n  JOURNAL   J Biol Chem 283:34457-68 (2008)\n            DOI:10.1074/jbc.M801465200\nREFERENCE   PMID:11375353\n  AUTHORS   Yeh CH, Sturgis L, Haidacher J, Zhang XN, Sherwood SJ, Bjercke RJ, Juhasz O, Crow MT, Tilton RG, Denner L\n  TITLE     Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion.\n  JOURNAL   Diabetes 50:1495-504 (2001)\n            DOI:10.2337/diabetes.50.6.1495\nREFERENCE   PMID:12709399\n  AUTHORS   Li JH, Huang XR, Zhu HJ, Oldfield M, Cooper M, Truong LD, Johnson RJ, Lan HY\n  TITLE     Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease.\n  JOURNAL   FASEB J 18:176-8 (2004)\n            DOI:10.1096/fj.02-1117fje\nREFERENCE   PMID:18323529\n  AUTHORS   Chang JS, Wendt T, Qu W, Kong L, Zou YS, Schmidt AM, Yan SF\n  TITLE     Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products.\n  JOURNAL   Circ Res 102:905-13 (2008)\n            DOI:10.1161/CIRCRESAHA.107.165308\nREFERENCE   PMID:15569303\n  AUTHORS   Fukami K, Ueda S, Yamagishi S, Kato S, Inagaki Y, Takeuchi M, Motomiya Y, Bucala R, Iida S, Tamaki K, Imaizumi T, Cooper ME, Okuda S\n  TITLE     AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction.\n  JOURNAL   Kidney Int 66:2137-47 (2004)\n            DOI:10.1111/j.1523-1755.2004.66004.x\nREL_PATHWAY map04010  MAPK signaling pathway\n            map04020  Calcium signaling pathway\n            map04110  Cell cycle\n            map04151  PI3K-Akt signaling pathway\n            map04350  TGF-beta signaling pathway\n            map04614  Renin-angiotensin system\n            map04630  JAK-STAT signaling pathway\nKO_PATHWAY  ko04933\n///\n","added":1656608636570},{"name":"map04976","response":"ENTRY       map04976                    Pathway\nNAME        Bile secretion\nDESCRIPTION Bile is a vital secretion, essential for digestion and absorption of fats and fat-soluble vitamins in the small intestine. Moreover, bile is an important route of elimination for excess cholesterol and many waste product, bilirubin, drugs and toxic compounds. Bile secretion depends on the function of membrane transport systems in hepatocytes and cholangiocytes and on the structural and functional integrity of the biliary tree. The hepatocytes generate the so-called primary bile in their canaliculi. Cholangiocytes modify the canalicular bile by secretory and reabsorptive processes as bile passes through the bile ducts. The main solutes in bile are bile acids, which stimulate bile secretion osmotically, as well as facilitate the intestinal absorption of dietary lipids by their detergent properties. Bile acids are also important signalling molecules. Through the activation of nuclear receptors, they regulate their own synthesis and transport rates.\nCLASS       Organismal Systems; Digestive system\nPATHWAY_MAP map04976  Bile secretion\nDBLINKS     GO: 0032782\nREFERENCE   PMID:11826283\n  AUTHORS   Meier PJ, Stieger B\n  TITLE     Bile salt transporters.\n  JOURNAL   Annu Rev Physiol 64:635-61 (2002)\n            DOI:10.1146/annurev.physiol.64.082201.100300\nREFERENCE   PMID:10728790\n  AUTHORS   Kullak-Ublick GA, Beuers U, Paumgartner G\n  TITLE     Hepatobiliary transport.\n  JOURNAL   J Hepatol 32:3-18 (2000)\n            DOI:10.1016/S0168-8278(00)80411-0\nREFERENCE   PMID:18668439\n  AUTHORS   Kosters A, Karpen SJ\n  TITLE     Bile acid transporters in health and disease.\n  JOURNAL   Xenobiotica 38:1043-71 (2008)\n            DOI:10.1080/00498250802040584\nREFERENCE   PMID:14999673\n  AUTHORS   Anwer MS\n  TITLE     Cellular regulation of hepatic bile acid transport in health and cholestasis.\n  JOURNAL   Hepatology 39:581-90 (2004)\n            DOI:10.1002/hep.20090\nREFERENCE   PMID:17404808\n  AUTHORS   Alrefai WA, Gill RK\n  TITLE     Bile acid transporters: structure, function, regulation and pathophysiological implications.\n  JOURNAL   Pharm Res 24:1803-23 (2007)\n            DOI:10.1007/s11095-007-9289-1\nREFERENCE   PMID:12663868\n  AUTHORS   Trauner M, Boyer JL\n  TITLE     Bile salt transporters: molecular characterization, function, and regulation.\n  JOURNAL   Physiol Rev 83:633-71 (2003)\n            DOI:10.1152/physrev.00027.2002\nREFERENCE   PMID:20103563\n  AUTHORS   Klaassen CD, Aleksunes LM\n  TITLE     Xenobiotic, bile acid, and cholesterol transporters: function and regulation.\n  JOURNAL   Pharmacol Rev 62:1-96 (2010)\n            DOI:10.1124/pr.109.002014\nREFERENCE   PMID:15758646\n  AUTHORS   Trauner M, Wagner M, Fickert P, Zollner G\n  TITLE     Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis.\n  JOURNAL   J Clin Gastroenterol 39:S111-24 (2005)\n            DOI:10.1097/01.mcg.0000155551.37266.26\nREFERENCE   PMID:14659471\n  AUTHORS   Arrese M, Trauner M\n  TITLE     Molecular aspects of bile formation and cholestasis.\n  JOURNAL   Trends Mol Med 9:558-64 (2003)\n            DOI:10.1016/j.molmed.2003.10.002\nREFERENCE   PMID:18837079\n  AUTHORS   Esteller A\n  TITLE     Physiology of bile secretion.\n  JOURNAL   World J Gastroenterol 14:5641-9 (2008)\n            DOI:10.3748/wjg.14.5641\nREFERENCE   PMID:12483266\n  AUTHORS   Takikawa H\n  TITLE     Hepatobiliary transport of bile acids and organic anions.\n  JOURNAL   J Hepatobiliary Pancreat Surg 9:443-7 (2002)\n            DOI:10.1007/s005340200055\nREFERENCE   PMID:11316487\n  AUTHORS   St-Pierre MV, Kullak-Ublick GA, Hagenbuch B, Meier PJ\n  TITLE     Transport of bile acids in hepatic and non-hepatic tissues.\n  JOURNAL   J Exp Biol 204:1673-86 (2001)\nREFERENCE   PMID:18670431\n  AUTHORS   Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K\n  TITLE     Targeting bile-acid signalling for metabolic diseases.\n  JOURNAL   Nat Rev Drug Discov 7:678-93 (2008)\n            DOI:10.1038/nrd2619\nREFERENCE   PMID:15975683\n  AUTHORS   Pauli-Magnus C, Stieger B, Meier Y, Kullak-Ublick GA, Meier PJ\n  TITLE     Enterohepatic transport of bile salts and genetics of cholestasis.\n  JOURNAL   J Hepatol 43:342-57 (2005)\n            DOI:10.1016/j.jhep.2005.03.017\nREFERENCE   PMID:18081658\n  AUTHORS   Pellicoro A, Faber KN\n  TITLE     Review article: The function and regulation of proteins involved in bile salt biosynthesis and transport.\n  JOURNAL   Aliment Pharmacol Ther 26 Suppl 2:149-60 (2007)\n            DOI:10.1111/j.1365-2036.2007.03522.x\nREFERENCE   PMID:19482594\n  AUTHORS   Jonker JW, Stedman CA, Liddle C, Downes M\n  TITLE     Hepatobiliary ABC transporters: physiology, regulation and implications for disease.\n  JOURNAL   Front Biosci 14:4904-20 (2009)\n            DOI:10.2741/3576\nREFERENCE   PMID:19273385\n  AUTHORS   Modica S, Bellafante E, Moschetta A\n  TITLE     Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio.\n  JOURNAL   Front Biosci 14:4719-45 (2009)\n            DOI:10.2741/3563\nREFERENCE   PMID:16706681\n  AUTHORS   Cai SY, Boyer JL\n  TITLE     FXR: a target for cholestatic syndromes?\n  JOURNAL   Expert Opin Ther Targets 10:409-21 (2006)\n            DOI:10.1517/14728222.10.3.409\nREFERENCE   PMID:19273238\n  AUTHORS   Ballatori N, Li N, Fang F, Boyer JL, Christian WV, Hammond CL\n  TITLE     OST alpha-OST beta: a key membrane transporter of bile acids and conjugated steroids.\n  JOURNAL   Front Biosci 14:2829-44 (2009)\n            DOI:10.2741/3416\nREFERENCE   PMID:18377365\n  AUTHORS   Roma MG, Crocenzi FA, Sanchez Pozzi EA\n  TITLE     Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects.\n  JOURNAL   Clin Sci (Lond) 114:567-88 (2008)\n            DOI:10.1042/CS20070227\nREFERENCE   PMID:18371245\n  AUTHORS   Arrese M, Macias RI, Briz O, Perez MJ, Marin JJ\n  TITLE     Molecular pathogenesis of intrahepatic cholestasis of pregnancy.\n  JOURNAL   Expert Rev Mol Med 10:e9 (2008)\n            DOI:10.1017/S1462399408000628\nREL_PATHWAY map00120  Primary bile acid biosynthesis\n            map04144  Endocytosis\n            map04530  Tight junction\n            map04975  Fat digestion and absorption\nKO_PATHWAY  ko04976\n///\n","added":1656608637410},{"name":"map04978","response":"ENTRY       map04978                    Pathway\nNAME        Mineral absorption\nDESCRIPTION Minerals are one of the five fundamental groups of nutrients needed to sustain life. Of the minerals, calcium plays innumerable roles in our bodies, serving as a main component of bone as well as an intracellular messenger in muscle contraction/relaxation, neural networks, the immune system, and endocrine/exocrine cells. Iron, copper, and other metals are required for redox reactions (as cofactors) and for oxygen transport and binding (in hemoglobin and myoglobin). Many enzymes require specific metal atoms to complete their catalytic functions. Animal tissues need moderate quantities of some elements (Ca, P, K, Na, Mg, S, and Cl) and trace amounts of others (Mn, Fe, I, Co, Cr, Cu, Zn, and Se). The minerals are absorbed by either passive or active transport systems through the intestinal mucosa, often using specialized transport proteins, such as ferritin for Fe3+ and vitamin D-induced protein for calcium.\nCLASS       Organismal Systems; Digestive system\nPATHWAY_MAP map04978  Mineral absorption\nREFERENCE   PMID:18277073\n  AUTHORS   Perez AV, Picotto G, Carpentieri AR, Rivoira MA, Peralta Lopez ME, Tolosa de Talamoni NG\n  TITLE     Minireview on regulation of intestinal calcium absorption. Emphasis on molecular mechanisms of transcellular pathway.\n  JOURNAL   Digestion 77:22-34 (2008)\n            DOI:10.1159/000116623\nREFERENCE   PMID:18598134\n  AUTHORS   Khanal RC, Nemere I\n  TITLE     Regulation of intestinal calcium transport.\n  JOURNAL   Annu Rev Nutr 28:179-96 (2008)\n            DOI:10.1146/annurev.nutr.010308.161202\nREFERENCE   PMID:15618484\n  AUTHORS   Hoenderop JG, Nilius B, Bindels RJ\n  TITLE     Calcium absorption across epithelia.\n  JOURNAL   Physiol Rev 85:373-422 (2005)\n            DOI:10.1152/physrev.00003.2004\nREFERENCE   PMID:12520535\n  AUTHORS   Bouillon R, Van Cromphaut S, Carmeliet G\n  TITLE     Intestinal calcium absorption: Molecular vitamin D mediated mechanisms.\n  JOURNAL   J Cell Biochem 88:332-9 (2003)\n            DOI:10.1002/jcb.10360\nREFERENCE   PMID:17943492\n  AUTHORS   Chua AC, Graham RM, Trinder D, Olynyk JK\n  TITLE     The regulation of cellular iron metabolism.\n  JOURNAL   Crit Rev Clin Lab Sci 44:413-59 (2007)\n            DOI:10.1080/10408360701428257\nREFERENCE   PMID:18636652\n  AUTHORS   West AR, Oates PS\n  TITLE     Mechanisms of heme iron absorption: current questions and controversies.\n  JOURNAL   World J Gastroenterol 14:4101-10 (2008)\n            DOI:10.3748/wjg.14.4101\nREFERENCE   PMID:17194590\n  AUTHORS   Dunn LL, Rahmanto YS, Richardson DR\n  TITLE     Iron uptake and metabolism in the new millennium.\n  JOURNAL   Trends Cell Biol 17:93-100 (2007)\n            DOI:10.1016/j.tcb.2006.12.003\nREFERENCE   PMID:16565477\n  AUTHORS   Donovan A, Roy CN, Andrews NC\n  TITLE     The ins and outs of iron homeostasis.\n  JOURNAL   Physiology (Bethesda) 21:115-23 (2006)\n            DOI:10.1152/physiol.00052.2005\nREFERENCE   PMID:18779306\n  AUTHORS   Lonnerdal B\n  TITLE     Intestinal regulation of copper homeostasis: a developmental perspective.\n  JOURNAL   Am J Clin Nutr 88:846S-50S (2008)\n            DOI:10.1093/ajcn/88.3.846S\nREFERENCE   PMID:18779302\n  AUTHORS   Prohaska JR\n  TITLE     Role of copper transporters in copper homeostasis.\n  JOURNAL   Am J Clin Nutr 88:826S-9S (2008)\n            DOI:10.1093/ajcn/88.3.826S\nREFERENCE   PMID:20120011\n  AUTHORS   Wang X, Zhou B\n  TITLE     Dietary zinc absorption: A play of Zips and ZnTs in the gut.\n  JOURNAL   IUBMB Life 62:176-82 (2010)\n            DOI:10.1002/iub.291\nREFERENCE   PMID:19400752\n  AUTHORS   Lichten LA, Cousins RJ\n  TITLE     Mammalian zinc transporters: nutritional and physiologic regulation.\n  JOURNAL   Annu Rev Nutr 29:153-76 (2009)\n            DOI:10.1146/annurev-nutr-033009-083312\nREFERENCE   PMID:18301276\n  AUTHORS   Quamme GA\n  TITLE     Recent developments in intestinal magnesium absorption.\n  JOURNAL   Curr Opin Gastroenterol 24:230-5 (2008)\n            DOI:10.1097/MOG.0b013e3282f37b59\nREFERENCE   PMID:19448074\n  AUTHORS   Donowitz M, Mohan S, Zhu CX, Chen TE, Lin R, Cha B, Zachos NC, Murtazina R, Sarker R, Li X\n  TITLE     NHE3 regulatory complexes.\n  JOURNAL   J Exp Biol 212:1638-46 (2009)\n            DOI:10.1242/jeb.028605\nREFERENCE   PMID:21054167\n  AUTHORS   Kato A, Romero MF\n  TITLE     Regulation of Electroneutral NaCl Absorption by the Small Intestine.\n  JOURNAL   Annu Rev Physiol 73:261-81 (2011)\n            DOI:10.1146/annurev-physiol-012110-142244\nREFERENCE   PMID:19729436\n  AUTHORS   Sabbagh Y, O'Brien SP, Song W, Boulanger JH, Stockmann A, Arbeeny C, Schiavi SC\n  TITLE     Intestinal npt2b plays a major role in phosphate absorption and homeostasis.\n  JOURNAL   J Am Soc Nephrol 20:2348-58 (2009)\n            DOI:10.1681/ASN.2009050559\nREFERENCE   PMID:16431934\n  AUTHORS   Marks J, Srai SK, Biber J, Murer H, Unwin RJ, Debnam ES\n  TITLE     Intestinal phosphate absorption and the effect of vitamin D: a comparison of rats with mice.\n  JOURNAL   Exp Physiol 91:531-7 (2006)\n            DOI:10.1113/expphysiol.2005.032516\nREL_PATHWAY map00860  Porphyrin metabolism\n            map04530  Tight junction\n            map04973  Carbohydrate digestion and absorption\n            map04974  Protein digestion and absorption\nKO_PATHWAY  ko04978\n///\n","added":1656608638253}],"find":[{"name":"Starch and sucrose metabolism","response":"path:map00500\tStarch and sucrose metabolism\n","added":1656608361961},{"name":"Streptomycin biosynthesis","response":"path:map00521\tStreptomycin biosynthesis\n","added":1656608362877},{"name":"Neomycin","response":"path:map00524\tNeomycin, kanamycin and gentamicin biosynthesis\n","added":1656608363746},{"name":" kanamycin and gentamicin biosynthesis","response":"path:map00524\tNeomycin, kanamycin and gentamicin biosynthesis\n","added":1656608364629},{"name":"Inositol phosphate metabolism","response":"path:map00562\tInositol phosphate metabolism\n","added":1656608365540},{"name":"Biosynthesis of various antibiotics","response":"path:map00998\tBiosynthesis of various antibiotics\n","added":1656608366461},{"name":"Biosynthesis of terpenoids and steroids","response":"path:map01062\tBiosynthesis of terpenoids and steroids\n","added":1656608367389},{"name":"Metabolic pathways","response":"path:map01100\tMetabolic pathways\n","added":1656608368333},{"name":"Biosynthesis of secondary metabolites","response":"path:map00997\tBiosynthesis of various other secondary metabolites\npath:map00999\tBiosynthesis of various plant secondary metabolites\npath:map01060\tBiosynthesis of plant secondary metabolites\npath:map01110\tBiosynthesis of secondary metabolites\n","added":1656608369263},{"name":"Two-component system","response":"path:map02020\tTwo-component system\n","added":1656608370157},{"name":"Phosphotransferase system (PTS)","response":"path:map02060\tPhosphotransferase system (PTS)\n","added":1656608371135},{"name":"Insulin secretion","response":"path:map04911\tInsulin secretion\n","added":1656608372020},{"name":"Prolactin signaling pathway","response":"path:map04917\tProlactin signaling pathway\n","added":1656608372942},{"name":"Thyroid hormone synthesis","response":"path:map04918\tThyroid hormone synthesis\npath:map04928\tParathyroid hormone synthesis, secretion and action\n","added":1656608373828},{"name":"Insulin resistance","response":"path:map04931\tInsulin resistance\n","added":1656608374737},{"name":"Carbohydrate digestion and absorption","response":"path:map04973\tCarbohydrate digestion and absorption\n","added":1656608375643},{"name":"Biofilm formation - Vibrio cholerae","response":"","added":1656608376530},{"name":"Central carbon metabolism in cancer","response":"path:map05230\tCentral carbon metabolism in cancer\n","added":1656608377448},{"name":"Diabetic cardiomyopathy","response":"path:map05415\tDiabetic cardiomyopathy\n","added":1656608378368},{"name":"Streptomycin","response":"path:map00521\tStreptomycin biosynthesis\n","added":1656608507138},{"name":"Steroid hormone biosynthesis","response":"path:map00140\tSteroid hormone biosynthesis\n","added":1656608571217},{"name":"Steroid degradation","response":"path:map00984\tSteroid degradation\n","added":1656608572103},{"name":"Microbial metabolism in diverse environments","response":"path:map01120\tMicrobial metabolism in diverse environments\n","added":1656608573003},{"name":"Endocrine resistance","response":"path:map01522\tEndocrine resistance\n","added":1656608573881},{"name":"Ovarian steroidogenesis","response":"path:map04913\tOvarian steroidogenesis\n","added":1656608574754},{"name":"GnRH secretion","response":"path:map04929\tGnRH secretion\n","added":1656608575653},{"name":"Pathways in cancer","response":"path:map05200\tPathways in cancer\n","added":1656608576536},{"name":"Prostate cancer","response":"path:map05215\tProstate cancer\n","added":1656608577409},{"name":"Progesterone","response":"path:map04914\tProgesterone-mediated oocyte maturation\npath:map07226\tProgesterone, androgen and estrogen receptor agonists/antagonists\n","added":1656608578274},{"name":" androgen and estrogen receptor agonists/antagonists","response":"","added":1656608579095},{"name":"Glycolysis / Gluconeogenesis","response":"","added":1656608608779},{"name":"Pentose phosphate pathway","response":"path:map00030\tPentose phosphate pathway\n","added":1656608609690},{"name":"Galactose metabolism","response":"path:map00052\tGalactose metabolism\n","added":1656608610687},{"name":"Amino sugar and nucleotide sugar metabolism","response":"path:map00520\tAmino sugar and nucleotide sugar metabolism\n","added":1656608611593},{"name":"Indole alkaloid biosynthesis","response":"path:map00403\tIndole diterpene alkaloid biosynthesis\npath:map00901\tIndole alkaloid biosynthesis\n","added":1656608612462},{"name":"ABC transporters","response":"path:map02010\tABC transporters\n","added":1656608613383},{"name":"HIF-1 signaling pathway","response":"path:map04066\tHIF-1 signaling pathway\n","added":1656608614277},{"name":"FoxO signaling pathway","response":"path:map04068\tFoxO signaling pathway\n","added":1656608615188},{"name":"Meiosis - yeast","response":"","added":1656608616206},{"name":"AMPK signaling pathway","response":"path:map04152\tAMPK signaling pathway\n","added":1656608617136},{"name":"Taste transduction","response":"path:map04742\tTaste transduction\n","added":1656608618056},{"name":"Insulin signaling pathway","response":"path:map04910\tInsulin signaling pathway\n","added":1656608618928},{"name":"Glucagon signaling pathway","response":"path:map04922\tGlucagon signaling pathway\n","added":1656608619795},{"name":"Type II diabetes mellitus","response":"path:map04930\tType II diabetes mellitus\n","added":1656608620690},{"name":"Non-alcoholic fatty liver disease","response":"path:map04932\tNon-alcoholic fatty liver disease\n","added":1656608621675},{"name":"AGE-RAGE signaling pathway in diabetic complications","response":"path:map04933\tAGE-RAGE signaling pathway in diabetic complications\n","added":1656608622592},{"name":"Bile secretion","response":"path:map04976\tBile secretion\n","added":1656608623526},{"name":"Mineral absorption","response":"path:map04978\tMineral absorption\n","added":1656608624427}]}